CINXE.COM

<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><title>MS Barometer</title><meta name="viewport" content="minimum-scale=1, initial-scale=1, width=device-width"/><meta name="next-head-count" content="3"/><meta name="theme-color" content="#2675a7"/><script async="" src="https://www.googletagmanager.com/gtag/js?id=G-P2R1239YHL"></script><script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', '', { page_path: window.location.pathname }); </script><meta property="og:url" content="https://msbarometer.eu"/><meta property="og:type" content="website"/><meta property="og:title" content="EMSP - Barometer "/><meta name="twitter:card" content="summary"/><meta property="og:description" content="Visit the MS Barometer project"/><meta property="og:image" content="https://barometer.ams3.digitaloceanspaces.com/__LOGO__/logo.png"/><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin /><link rel="preload" href="/_next/static/css/12291914bcd4fd0f.css" as="style"/><link rel="stylesheet" href="/_next/static/css/12291914bcd4fd0f.css" data-n-g=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script src="/_next/static/chunks/webpack-a146a8ef8f1e9d05.js" defer=""></script><script src="/_next/static/chunks/framework-5a46ced06405f0e2.js" defer=""></script><script src="/_next/static/chunks/main-540e6d8abd3fcc30.js" defer=""></script><script src="/_next/static/chunks/pages/_app-bbf14c852303d926.js" defer=""></script><script src="/_next/static/chunks/8595-ec394c30adf06bb0.js" defer=""></script><script src="/_next/static/chunks/5675-70bb402692fa2767.js" defer=""></script><script src="/_next/static/chunks/2759-6d9173b34e542f29.js" defer=""></script><script src="/_next/static/chunks/2237-e5a757853c814a1c.js" defer=""></script><script src="/_next/static/chunks/305-cf8f2f3c60375614.js" defer=""></script><script src="/_next/static/chunks/5140-7f7ea7ed46dee80a.js" defer=""></script><script src="/_next/static/chunks/5831-42f6ca34def2b265.js" defer=""></script><script src="/_next/static/chunks/6159-03feca6218e10a86.js" defer=""></script><script src="/_next/static/chunks/8171-fd82b98f5ee79ade.js" defer=""></script><script src="/_next/static/chunks/pages/%5Bedition%5D-f9054dd007c03798.js" defer=""></script><script src="/_next/static/O58h6gsZqJ66cxMs6ZM1d/_buildManifest.js" defer=""></script><script src="/_next/static/O58h6gsZqJ66cxMs6ZM1d/_ssgManifest.js" defer=""></script><style id="jss-server-side">.MuiSvgIcon-root { fill: currentColor; width: 1em; height: 1em; display: inline-block; font-size: 1.5rem; transition: fill 200ms cubic-bezier(0.4, 0, 0.2, 1) 0ms; flex-shrink: 0; user-select: none; } .MuiSvgIcon-colorPrimary { color: #2675a7; } .MuiSvgIcon-colorSecondary { color: #db6b1f; } .MuiSvgIcon-colorAction { color: rgba(0, 0, 0, 0.54); } .MuiSvgIcon-colorError { color: #f44336; } .MuiSvgIcon-colorDisabled { color: rgba(0, 0, 0, 0.26); } .MuiSvgIcon-fontSizeInherit { font-size: inherit; } .MuiSvgIcon-fontSizeSmall { font-size: 1.25rem; } .MuiSvgIcon-fontSizeLarge { font-size: 2.1875rem; } html { box-sizing: border-box; -webkit-font-smoothing: antialiased; -moz-osx-font-smoothing: grayscale; } *, *::before, *::after { box-sizing: inherit; } strong, b { font-weight: 700; } body { color: rgba(0, 0, 0, 0.87); margin: 0; font-size: 0.875rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 1.43; letter-spacing: 0.01071em; background-color: #FFFFFF; } @media print { body { background-color: #fff; } } body::backdrop { background-color: #FFFFFF; } .MuiPaper-root { color: rgba(0, 0, 0, 0.87); transition: box-shadow 300ms cubic-bezier(0.4, 0, 0.2, 1) 0ms; background-color: #fff; } .MuiPaper-rounded { border-radius: 4px; } .MuiPaper-outlined { border: 1px solid rgba(0, 0, 0, 0.12); } .MuiPaper-elevation0 { box-shadow: none; } .MuiPaper-elevation1 { box-shadow: 0px 2px 1px -1px rgba(0,0,0,0.2),0px 1px 1px 0px rgba(0,0,0,0.14),0px 1px 3px 0px rgba(0,0,0,0.12); } .MuiPaper-elevation2 { box-shadow: 0px 3px 1px -2px rgba(0,0,0,0.2),0px 2px 2px 0px rgba(0,0,0,0.14),0px 1px 5px 0px rgba(0,0,0,0.12); } .MuiPaper-elevation3 { box-shadow: 0px 3px 3px -2px rgba(0,0,0,0.2),0px 3px 4px 0px rgba(0,0,0,0.14),0px 1px 8px 0px rgba(0,0,0,0.12); } .MuiPaper-elevation4 { box-shadow: 0px 2px 4px -1px rgba(0,0,0,0.2),0px 4px 5px 0px rgba(0,0,0,0.14),0px 1px 10px 0px rgba(0,0,0,0.12); } .MuiPaper-elevation5 { box-shadow: 0px 3px 5px -1px rgba(0,0,0,0.2),0px 5px 8px 0px rgba(0,0,0,0.14),0px 1px 14px 0px rgba(0,0,0,0.12); } .MuiPaper-elevation6 { box-shadow: 0px 3px 5px -1px rgba(0,0,0,0.2),0px 6px 10px 0px rgba(0,0,0,0.14),0px 1px 18px 0px rgba(0,0,0,0.12); } .MuiPaper-elevation7 { box-shadow: 0px 4px 5px -2px rgba(0,0,0,0.2),0px 7px 10px 1px rgba(0,0,0,0.14),0px 2px 16px 1px rgba(0,0,0,0.12); } .MuiPaper-elevation8 { box-shadow: 0px 5px 5px -3px rgba(0,0,0,0.2),0px 8px 10px 1px rgba(0,0,0,0.14),0px 3px 14px 2px rgba(0,0,0,0.12); } .MuiPaper-elevation9 { box-shadow: 0px 5px 6px -3px rgba(0,0,0,0.2),0px 9px 12px 1px rgba(0,0,0,0.14),0px 3px 16px 2px rgba(0,0,0,0.12); } .MuiPaper-elevation10 { box-shadow: 0px 6px 6px -3px rgba(0,0,0,0.2),0px 10px 14px 1px rgba(0,0,0,0.14),0px 4px 18px 3px rgba(0,0,0,0.12); } .MuiPaper-elevation11 { box-shadow: 0px 6px 7px -4px rgba(0,0,0,0.2),0px 11px 15px 1px rgba(0,0,0,0.14),0px 4px 20px 3px rgba(0,0,0,0.12); } .MuiPaper-elevation12 { box-shadow: 0px 7px 8px -4px rgba(0,0,0,0.2),0px 12px 17px 2px rgba(0,0,0,0.14),0px 5px 22px 4px rgba(0,0,0,0.12); } .MuiPaper-elevation13 { box-shadow: 0px 7px 8px -4px rgba(0,0,0,0.2),0px 13px 19px 2px rgba(0,0,0,0.14),0px 5px 24px 4px rgba(0,0,0,0.12); } .MuiPaper-elevation14 { box-shadow: 0px 7px 9px -4px rgba(0,0,0,0.2),0px 14px 21px 2px rgba(0,0,0,0.14),0px 5px 26px 4px rgba(0,0,0,0.12); } .MuiPaper-elevation15 { box-shadow: 0px 8px 9px -5px rgba(0,0,0,0.2),0px 15px 22px 2px rgba(0,0,0,0.14),0px 6px 28px 5px rgba(0,0,0,0.12); } .MuiPaper-elevation16 { box-shadow: 0px 8px 10px -5px rgba(0,0,0,0.2),0px 16px 24px 2px rgba(0,0,0,0.14),0px 6px 30px 5px rgba(0,0,0,0.12); } .MuiPaper-elevation17 { box-shadow: 0px 8px 11px -5px rgba(0,0,0,0.2),0px 17px 26px 2px rgba(0,0,0,0.14),0px 6px 32px 5px rgba(0,0,0,0.12); } .MuiPaper-elevation18 { box-shadow: 0px 9px 11px -5px rgba(0,0,0,0.2),0px 18px 28px 2px rgba(0,0,0,0.14),0px 7px 34px 6px rgba(0,0,0,0.12); } .MuiPaper-elevation19 { box-shadow: 0px 9px 12px -6px rgba(0,0,0,0.2),0px 19px 29px 2px rgba(0,0,0,0.14),0px 7px 36px 6px rgba(0,0,0,0.12); } .MuiPaper-elevation20 { box-shadow: 0px 10px 13px -6px rgba(0,0,0,0.2),0px 20px 31px 3px rgba(0,0,0,0.14),0px 8px 38px 7px rgba(0,0,0,0.12); } .MuiPaper-elevation21 { box-shadow: 0px 10px 13px -6px rgba(0,0,0,0.2),0px 21px 33px 3px rgba(0,0,0,0.14),0px 8px 40px 7px rgba(0,0,0,0.12); } .MuiPaper-elevation22 { box-shadow: 0px 10px 14px -6px rgba(0,0,0,0.2),0px 22px 35px 3px rgba(0,0,0,0.14),0px 8px 42px 7px rgba(0,0,0,0.12); } .MuiPaper-elevation23 { box-shadow: 0px 11px 14px -7px rgba(0,0,0,0.2),0px 23px 36px 3px rgba(0,0,0,0.14),0px 9px 44px 8px rgba(0,0,0,0.12); } .MuiPaper-elevation24 { box-shadow: 0px 11px 15px -7px rgba(0,0,0,0.2),0px 24px 38px 3px rgba(0,0,0,0.14),0px 9px 46px 8px rgba(0,0,0,0.12); } .MuiButtonBase-root { color: inherit; border: 0; cursor: pointer; margin: 0; display: inline-flex; outline: 0; padding: 0; position: relative; align-items: center; user-select: none; border-radius: 0; vertical-align: middle; -moz-appearance: none; justify-content: center; text-decoration: none; background-color: transparent; -webkit-appearance: none; -webkit-tap-highlight-color: transparent; } .MuiButtonBase-root::-moz-focus-inner { border-style: none; } .MuiButtonBase-root.Mui-disabled { cursor: default; pointer-events: none; } @media print { .MuiButtonBase-root { color-adjust: exact; } } .MuiIconButton-root { flex: 0 0 auto; color: rgba(0, 0, 0, 0.54); padding: 12px; overflow: visible; font-size: 1.5rem; text-align: center; transition: background-color 150ms cubic-bezier(0.4, 0, 0.2, 1) 0ms; border-radius: 50%; } .MuiIconButton-root:hover { background-color: rgba(0, 0, 0, 0.04); } .MuiIconButton-root.Mui-disabled { color: rgba(0, 0, 0, 0.26); background-color: transparent; } @media (hover: none) { .MuiIconButton-root:hover { background-color: transparent; } } .MuiIconButton-edgeStart { margin-left: -12px; } .MuiIconButton-sizeSmall.MuiIconButton-edgeStart { margin-left: -3px; } .MuiIconButton-edgeEnd { margin-right: -12px; } .MuiIconButton-sizeSmall.MuiIconButton-edgeEnd { margin-right: -3px; } .MuiIconButton-colorInherit { color: inherit; } .MuiIconButton-colorPrimary { color: #2675a7; } .MuiIconButton-colorPrimary:hover { background-color: rgba(38, 117, 167, 0.04); } @media (hover: none) { .MuiIconButton-colorPrimary:hover { background-color: transparent; } } .MuiIconButton-colorSecondary { color: #db6b1f; } .MuiIconButton-colorSecondary:hover { background-color: rgba(219, 107, 31, 0.04); } @media (hover: none) { .MuiIconButton-colorSecondary:hover { background-color: transparent; } } .MuiIconButton-sizeSmall { padding: 3px; font-size: 1.125rem; } .MuiIconButton-label { width: 100%; display: flex; align-items: inherit; justify-content: inherit; } .MuiTypography-root { margin: 0; } .MuiTypography-body2 { font-size: 0.875rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 1.43; letter-spacing: 0.01071em; } .MuiTypography-body1 { font-size: 1rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 1.5; letter-spacing: 0.00938em; } .MuiTypography-caption { font-size: 0.75rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 1.66; letter-spacing: 0.03333em; } .MuiTypography-button { font-size: 0.875rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 500; line-height: 1.75; letter-spacing: 0.02857em; text-transform: uppercase; } .MuiTypography-h1 { font-size: 3.5rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 300; line-height: 1.167; letter-spacing: -0.01562em; } @media (min-width:625px) { .MuiTypography-h1 { font-size: 4.7129rem; } } @media (min-width:960px) { .MuiTypography-h1 { font-size: 5.3556rem; } } @media (min-width:1280px) { .MuiTypography-h1 { font-size: 5.9983rem; } } .MuiTypography-h2 { font-size: 2.375rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 300; line-height: 1.2; letter-spacing: -0.00833em; } @media (min-width:625px) { .MuiTypography-h2 { font-size: 3.125rem; } } @media (min-width:960px) { .MuiTypography-h2 { font-size: 3.3333rem; } } @media (min-width:1280px) { .MuiTypography-h2 { font-size: 3.75rem; } } .MuiTypography-h3 { font-size: 2rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 1.167; letter-spacing: 0em; } @media (min-width:625px) { .MuiTypography-h3 { font-size: 2.5707rem; } } @media (min-width:960px) { .MuiTypography-h3 { font-size: 2.7849rem; } } @media (min-width:1280px) { .MuiTypography-h3 { font-size: 2.9991rem; } } .MuiTypography-h4 { font-size: 1.5625rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 1.235; letter-spacing: 0.00735em; } @media (min-width:625px) { .MuiTypography-h4 { font-size: 1.8219rem; } } @media (min-width:960px) { .MuiTypography-h4 { font-size: 2.0243rem; } } @media (min-width:1280px) { .MuiTypography-h4 { font-size: 2.0243rem; } } .MuiTypography-h5 { font-size: 1.25rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 1.334; letter-spacing: 0em; } @media (min-width:625px) { .MuiTypography-h5 { font-size: 1.3118rem; } } @media (min-width:960px) { .MuiTypography-h5 { font-size: 1.4993rem; } } @media (min-width:1280px) { .MuiTypography-h5 { font-size: 1.4993rem; } } .MuiTypography-h6 { font-size: 1.125rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 500; line-height: 1.6; letter-spacing: 0.0075em; } @media (min-width:625px) { .MuiTypography-h6 { font-size: 1.25rem; } } @media (min-width:960px) { .MuiTypography-h6 { font-size: 1.25rem; } } @media (min-width:1280px) { .MuiTypography-h6 { font-size: 1.25rem; } } .MuiTypography-subtitle1 { font-size: 1rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 1.75; letter-spacing: 0.00938em; } .MuiTypography-subtitle2 { font-size: 0.875rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 500; line-height: 1.57; letter-spacing: 0.00714em; } .MuiTypography-overline { font-size: 0.75rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 2.66; letter-spacing: 0.08333em; text-transform: uppercase; } .MuiTypography-srOnly { width: 1px; height: 1px; overflow: hidden; position: absolute; } .MuiTypography-alignLeft { text-align: left; } .MuiTypography-alignCenter { text-align: center; } .MuiTypography-alignRight { text-align: right; } .MuiTypography-alignJustify { text-align: justify; } .MuiTypography-noWrap { overflow: hidden; white-space: nowrap; text-overflow: ellipsis; } .MuiTypography-gutterBottom { margin-bottom: 0.35em; } .MuiTypography-paragraph { margin-bottom: 16px; } .MuiTypography-colorInherit { color: inherit; } .MuiTypography-colorPrimary { color: #2675a7; } .MuiTypography-colorSecondary { color: #db6b1f; } .MuiTypography-colorTextPrimary { color: rgba(0, 0, 0, 0.87); } .MuiTypography-colorTextSecondary { color: rgba(0, 0, 0, 0.54); } .MuiTypography-colorError { color: #f44336; } .MuiTypography-displayInline { display: inline; } .MuiTypography-displayBlock { display: block; } .MuiButton-root { color: rgba(0, 0, 0, 0.87); padding: 6px 16px; font-size: 0.875rem; min-width: 64px; box-sizing: border-box; transition: background-color 250ms cubic-bezier(0.4, 0, 0.2, 1) 0ms,box-shadow 250ms cubic-bezier(0.4, 0, 0.2, 1) 0ms,border 250ms cubic-bezier(0.4, 0, 0.2, 1) 0ms; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 500; line-height: 1.75; border-radius: 4px; letter-spacing: 0.02857em; text-transform: uppercase; } .MuiButton-root:hover { text-decoration: none; background-color: rgba(0, 0, 0, 0.04); } .MuiButton-root.Mui-disabled { color: rgba(0, 0, 0, 0.26); } @media (hover: none) { .MuiButton-root:hover { background-color: transparent; } } .MuiButton-root:hover.Mui-disabled { background-color: transparent; } .MuiButton-label { width: 100%; display: inherit; align-items: inherit; justify-content: inherit; } .MuiButton-text { padding: 6px 8px; } .MuiButton-textPrimary { color: #2675a7; } .MuiButton-textPrimary:hover { background-color: rgba(38, 117, 167, 0.04); } @media (hover: none) { .MuiButton-textPrimary:hover { background-color: transparent; } } .MuiButton-textSecondary { color: #db6b1f; } .MuiButton-textSecondary:hover { background-color: rgba(219, 107, 31, 0.04); } @media (hover: none) { .MuiButton-textSecondary:hover { background-color: transparent; } } .MuiButton-outlined { border: 1px solid rgba(0, 0, 0, 0.23); padding: 5px 15px; } .MuiButton-outlined.Mui-disabled { border: 1px solid rgba(0, 0, 0, 0.12); } .MuiButton-outlinedPrimary { color: #2675a7; border: 1px solid rgba(38, 117, 167, 0.5); } .MuiButton-outlinedPrimary:hover { border: 1px solid #2675a7; background-color: rgba(38, 117, 167, 0.04); } @media (hover: none) { .MuiButton-outlinedPrimary:hover { background-color: transparent; } } .MuiButton-outlinedSecondary { color: #db6b1f; border: 1px solid rgba(219, 107, 31, 0.5); } .MuiButton-outlinedSecondary:hover { border: 1px solid #db6b1f; background-color: rgba(219, 107, 31, 0.04); } .MuiButton-outlinedSecondary.Mui-disabled { border: 1px solid rgba(0, 0, 0, 0.26); } @media (hover: none) { .MuiButton-outlinedSecondary:hover { background-color: transparent; } } .MuiButton-contained { color: rgba(0, 0, 0, 0.87); box-shadow: 0px 3px 1px -2px rgba(0,0,0,0.2),0px 2px 2px 0px rgba(0,0,0,0.14),0px 1px 5px 0px rgba(0,0,0,0.12); background-color: #e0e0e0; } .MuiButton-contained:hover { box-shadow: 0px 2px 4px -1px rgba(0,0,0,0.2),0px 4px 5px 0px rgba(0,0,0,0.14),0px 1px 10px 0px rgba(0,0,0,0.12); background-color: #d5d5d5; } .MuiButton-contained.Mui-focusVisible { box-shadow: 0px 3px 5px -1px rgba(0,0,0,0.2),0px 6px 10px 0px rgba(0,0,0,0.14),0px 1px 18px 0px rgba(0,0,0,0.12); } .MuiButton-contained:active { box-shadow: 0px 5px 5px -3px rgba(0,0,0,0.2),0px 8px 10px 1px rgba(0,0,0,0.14),0px 3px 14px 2px rgba(0,0,0,0.12); } .MuiButton-contained.Mui-disabled { color: rgba(0, 0, 0, 0.26); box-shadow: none; background-color: rgba(0, 0, 0, 0.12); } @media (hover: none) { .MuiButton-contained:hover { box-shadow: 0px 3px 1px -2px rgba(0,0,0,0.2),0px 2px 2px 0px rgba(0,0,0,0.14),0px 1px 5px 0px rgba(0,0,0,0.12); background-color: #e0e0e0; } } .MuiButton-contained:hover.Mui-disabled { background-color: rgba(0, 0, 0, 0.12); } .MuiButton-containedPrimary { color: #fff; background-color: #2675a7; } .MuiButton-containedPrimary:hover { background-color: rgb(26, 81, 116); } @media (hover: none) { .MuiButton-containedPrimary:hover { background-color: #2675a7; } } .MuiButton-containedSecondary { color: #fff; background-color: #db6b1f; } .MuiButton-containedSecondary:hover { background-color: rgb(153, 74, 21); } @media (hover: none) { .MuiButton-containedSecondary:hover { background-color: #db6b1f; } } .MuiButton-disableElevation { box-shadow: none; } .MuiButton-disableElevation:hover { box-shadow: none; } .MuiButton-disableElevation.Mui-focusVisible { box-shadow: none; } .MuiButton-disableElevation:active { box-shadow: none; } .MuiButton-disableElevation.Mui-disabled { box-shadow: none; } .MuiButton-colorInherit { color: inherit; border-color: currentColor; } .MuiButton-textSizeSmall { padding: 4px 5px; font-size: 0.8125rem; } .MuiButton-textSizeLarge { padding: 8px 11px; font-size: 0.9375rem; } .MuiButton-outlinedSizeSmall { padding: 3px 9px; font-size: 0.8125rem; } .MuiButton-outlinedSizeLarge { padding: 7px 21px; font-size: 0.9375rem; } .MuiButton-containedSizeSmall { padding: 4px 10px; font-size: 0.8125rem; } .MuiButton-containedSizeLarge { padding: 8px 22px; font-size: 0.9375rem; } .MuiButton-fullWidth { width: 100%; } .MuiButton-startIcon { display: inherit; margin-left: -4px; margin-right: 8px; } .MuiButton-startIcon.MuiButton-iconSizeSmall { margin-left: -2px; } .MuiButton-endIcon { display: inherit; margin-left: 8px; margin-right: -4px; } .MuiButton-endIcon.MuiButton-iconSizeSmall { margin-right: -2px; } .MuiButton-iconSizeSmall > *:first-child { font-size: 18px; } .MuiButton-iconSizeMedium > *:first-child { font-size: 20px; } .MuiButton-iconSizeLarge > *:first-child { font-size: 22px; } .MuiButtonGroup-root { display: inline-flex; border-radius: 4px; } .MuiButtonGroup-contained { box-shadow: 0px 3px 1px -2px rgba(0,0,0,0.2),0px 2px 2px 0px rgba(0,0,0,0.14),0px 1px 5px 0px rgba(0,0,0,0.12); } .MuiButtonGroup-disableElevation { box-shadow: none; } .MuiButtonGroup-fullWidth { width: 100%; } .MuiButtonGroup-vertical { flex-direction: column; } .MuiButtonGroup-grouped { min-width: 40px; } .MuiButtonGroup-groupedHorizontal:not(:first-child) { border-top-left-radius: 0; border-bottom-left-radius: 0; } .MuiButtonGroup-groupedHorizontal:not(:last-child) { border-top-right-radius: 0; border-bottom-right-radius: 0; } .MuiButtonGroup-groupedVertical:not(:first-child) { border-top-left-radius: 0; border-top-right-radius: 0; } .MuiButtonGroup-groupedVertical:not(:last-child) { border-bottom-left-radius: 0; border-bottom-right-radius: 0; } .MuiButtonGroup-groupedTextHorizontal:not(:last-child) { border-right: 1px solid rgba(0, 0, 0, 0.23); } .MuiButtonGroup-groupedTextVertical:not(:last-child) { border-bottom: 1px solid rgba(0, 0, 0, 0.23); } .MuiButtonGroup-groupedTextPrimary:not(:last-child) { border-color: rgba(38, 117, 167, 0.5); } .MuiButtonGroup-groupedTextSecondary:not(:last-child) { border-color: rgba(219, 107, 31, 0.5); } .MuiButtonGroup-groupedOutlinedHorizontal:not(:first-child) { margin-left: -1px; } .MuiButtonGroup-groupedOutlinedHorizontal:not(:last-child) { border-right-color: transparent; } .MuiButtonGroup-groupedOutlinedVertical:not(:first-child) { margin-top: -1px; } .MuiButtonGroup-groupedOutlinedVertical:not(:last-child) { border-bottom-color: transparent; } .MuiButtonGroup-groupedOutlinedPrimary:hover { border-color: #2675a7; } .MuiButtonGroup-groupedOutlinedSecondary:hover { border-color: #db6b1f; } .MuiButtonGroup-groupedContained { box-shadow: none; } .MuiButtonGroup-groupedContainedHorizontal:not(:last-child) { border-right: 1px solid #bdbdbd; } .MuiButtonGroup-groupedContainedHorizontal:not(:last-child).Mui-disabled { border-right: 1px solid rgba(0, 0, 0, 0.26); } .MuiButtonGroup-groupedContainedVertical:not(:last-child) { border-bottom: 1px solid #bdbdbd; } .MuiButtonGroup-groupedContainedVertical:not(:last-child).Mui-disabled { border-bottom: 1px solid rgba(0, 0, 0, 0.26); } .MuiButtonGroup-groupedContainedPrimary:not(:last-child) { border-color: rgb(26, 81, 116); } .MuiButtonGroup-groupedContainedSecondary:not(:last-child) { border-color: rgb(153, 74, 21); } .MuiCard-root { overflow: hidden; } .MuiCardContent-root { padding: 16px; } .MuiCardContent-root:last-child { padding-bottom: 24px; } .jss93 { padding: 9px; } .jss96 { top: 0; left: 0; width: 100%; cursor: inherit; height: 100%; margin: 0; opacity: 0; padding: 0; z-index: 1; position: absolute; } .MuiCheckbox-root { color: rgba(0, 0, 0, 0.54); } .MuiCheckbox-colorPrimary.Mui-checked { color: #2675a7; } .MuiCheckbox-colorPrimary.Mui-disabled { color: rgba(0, 0, 0, 0.26); } .MuiCheckbox-colorPrimary.Mui-checked:hover { background-color: rgba(38, 117, 167, 0.04); } @media (hover: none) { .MuiCheckbox-colorPrimary.Mui-checked:hover { background-color: transparent; } } .MuiCheckbox-colorSecondary.Mui-checked { color: #db6b1f; } .MuiCheckbox-colorSecondary.Mui-disabled { color: rgba(0, 0, 0, 0.26); } .MuiCheckbox-colorSecondary.Mui-checked:hover { background-color: rgba(219, 107, 31, 0.04); } @media (hover: none) { .MuiCheckbox-colorSecondary.Mui-checked:hover { background-color: transparent; } } @keyframes mui-auto-fill {} @keyframes mui-auto-fill-cancel {} .MuiInputBase-root { color: rgba(0, 0, 0, 0.87); cursor: text; display: inline-flex; position: relative; font-size: 1rem; box-sizing: border-box; align-items: center; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 1.1876em; letter-spacing: 0.00938em; } .MuiInputBase-root.Mui-disabled { color: rgba(0, 0, 0, 0.38); cursor: default; } .MuiInputBase-multiline { padding: 6px 0 7px; } .MuiInputBase-multiline.MuiInputBase-marginDense { padding-top: 3px; } .MuiInputBase-fullWidth { width: 100%; } .MuiInputBase-input { font: inherit; color: currentColor; width: 100%; border: 0; height: 1.1876em; margin: 0; display: block; padding: 6px 0 7px; min-width: 0; background: none; box-sizing: content-box; animation-name: mui-auto-fill-cancel; letter-spacing: inherit; animation-duration: 10ms; -webkit-tap-highlight-color: transparent; } .MuiInputBase-input::-webkit-input-placeholder { color: currentColor; opacity: 0.42; transition: opacity 200ms cubic-bezier(0.4, 0, 0.2, 1) 0ms; } .MuiInputBase-input::-moz-placeholder { color: currentColor; opacity: 0.42; transition: opacity 200ms cubic-bezier(0.4, 0, 0.2, 1) 0ms; } .MuiInputBase-input:-ms-input-placeholder { color: currentColor; opacity: 0.42; transition: opacity 200ms cubic-bezier(0.4, 0, 0.2, 1) 0ms; } .MuiInputBase-input::-ms-input-placeholder { color: currentColor; opacity: 0.42; transition: opacity 200ms cubic-bezier(0.4, 0, 0.2, 1) 0ms; } .MuiInputBase-input:focus { outline: 0; } .MuiInputBase-input:invalid { box-shadow: none; } .MuiInputBase-input::-webkit-search-decoration { -webkit-appearance: none; } .MuiInputBase-input.Mui-disabled { opacity: 1; } .MuiInputBase-input:-webkit-autofill { animation-name: mui-auto-fill; animation-duration: 5000s; } label[data-shrink=false] + .MuiInputBase-formControl .MuiInputBase-input::-webkit-input-placeholder { opacity: 0 !important; } label[data-shrink=false] + .MuiInputBase-formControl .MuiInputBase-input::-moz-placeholder { opacity: 0 !important; } label[data-shrink=false] + .MuiInputBase-formControl .MuiInputBase-input:-ms-input-placeholder { opacity: 0 !important; } label[data-shrink=false] + .MuiInputBase-formControl .MuiInputBase-input::-ms-input-placeholder { opacity: 0 !important; } label[data-shrink=false] + .MuiInputBase-formControl .MuiInputBase-input:focus::-webkit-input-placeholder { opacity: 0.42; } label[data-shrink=false] + .MuiInputBase-formControl .MuiInputBase-input:focus::-moz-placeholder { opacity: 0.42; } label[data-shrink=false] + .MuiInputBase-formControl .MuiInputBase-input:focus:-ms-input-placeholder { opacity: 0.42; } label[data-shrink=false] + .MuiInputBase-formControl .MuiInputBase-input:focus::-ms-input-placeholder { opacity: 0.42; } .MuiInputBase-inputMarginDense { padding-top: 3px; } .MuiInputBase-inputMultiline { height: auto; resize: none; padding: 0; } .MuiInputBase-inputTypeSearch { -moz-appearance: textfield; -webkit-appearance: textfield; } .MuiFormControl-root { border: 0; margin: 0; display: inline-flex; padding: 0; position: relative; min-width: 0; flex-direction: column; vertical-align: top; } .MuiFormControl-marginNormal { margin-top: 16px; margin-bottom: 8px; } .MuiFormControl-marginDense { margin-top: 8px; margin-bottom: 4px; } .MuiFormControl-fullWidth { width: 100%; } .MuiFormLabel-root { color: rgba(0, 0, 0, 0.54); padding: 0; font-size: 1rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 1; letter-spacing: 0.00938em; } .MuiFormLabel-root.Mui-focused { color: #2675a7; } .MuiFormLabel-root.Mui-disabled { color: rgba(0, 0, 0, 0.38); } .MuiFormLabel-root.Mui-error { color: #f44336; } .MuiFormLabel-colorSecondary.Mui-focused { color: #db6b1f; } .MuiFormLabel-asterisk.Mui-error { color: #f44336; } .MuiGrid-container { width: 100%; display: flex; flex-wrap: wrap; box-sizing: border-box; } .MuiGrid-item { margin: 0; box-sizing: border-box; } .MuiGrid-zeroMinWidth { min-width: 0; } .MuiGrid-direction-xs-column { flex-direction: column; } .MuiGrid-direction-xs-column-reverse { flex-direction: column-reverse; } .MuiGrid-direction-xs-row-reverse { flex-direction: row-reverse; } .MuiGrid-wrap-xs-nowrap { flex-wrap: nowrap; } .MuiGrid-wrap-xs-wrap-reverse { flex-wrap: wrap-reverse; } .MuiGrid-align-items-xs-center { align-items: center; } .MuiGrid-align-items-xs-flex-start { align-items: flex-start; } .MuiGrid-align-items-xs-flex-end { align-items: flex-end; } .MuiGrid-align-items-xs-baseline { align-items: baseline; } .MuiGrid-align-content-xs-center { align-content: center; } .MuiGrid-align-content-xs-flex-start { align-content: flex-start; } .MuiGrid-align-content-xs-flex-end { align-content: flex-end; } .MuiGrid-align-content-xs-space-between { align-content: space-between; } .MuiGrid-align-content-xs-space-around { align-content: space-around; } .MuiGrid-justify-xs-center { justify-content: center; } .MuiGrid-justify-xs-flex-end { justify-content: flex-end; } .MuiGrid-justify-xs-space-between { justify-content: space-between; } .MuiGrid-justify-xs-space-around { justify-content: space-around; } .MuiGrid-justify-xs-space-evenly { justify-content: space-evenly; } .MuiGrid-spacing-xs-1 { width: calc(100% + 8px); margin: -4px; } .MuiGrid-spacing-xs-1 > .MuiGrid-item { padding: 4px; } .MuiGrid-spacing-xs-2 { width: calc(100% + 16px); margin: -8px; } .MuiGrid-spacing-xs-2 > .MuiGrid-item { padding: 8px; } .MuiGrid-spacing-xs-3 { width: calc(100% + 24px); margin: -12px; } .MuiGrid-spacing-xs-3 > .MuiGrid-item { padding: 12px; } .MuiGrid-spacing-xs-4 { width: calc(100% + 32px); margin: -16px; } .MuiGrid-spacing-xs-4 > .MuiGrid-item { padding: 16px; } .MuiGrid-spacing-xs-5 { width: calc(100% + 40px); margin: -20px; } .MuiGrid-spacing-xs-5 > .MuiGrid-item { padding: 20px; } .MuiGrid-spacing-xs-6 { width: calc(100% + 48px); margin: -24px; } .MuiGrid-spacing-xs-6 > .MuiGrid-item { padding: 24px; } .MuiGrid-spacing-xs-7 { width: calc(100% + 56px); margin: -28px; } .MuiGrid-spacing-xs-7 > .MuiGrid-item { padding: 28px; } .MuiGrid-spacing-xs-8 { width: calc(100% + 64px); margin: -32px; } .MuiGrid-spacing-xs-8 > .MuiGrid-item { padding: 32px; } .MuiGrid-spacing-xs-9 { width: calc(100% + 72px); margin: -36px; } .MuiGrid-spacing-xs-9 > .MuiGrid-item { padding: 36px; } .MuiGrid-spacing-xs-10 { width: calc(100% + 80px); margin: -40px; } .MuiGrid-spacing-xs-10 > .MuiGrid-item { padding: 40px; } .MuiGrid-grid-xs-auto { flex-grow: 0; max-width: none; flex-basis: auto; } .MuiGrid-grid-xs-true { flex-grow: 1; max-width: 100%; flex-basis: 0; } .MuiGrid-grid-xs-1 { flex-grow: 0; max-width: 8.333333%; flex-basis: 8.333333%; } .MuiGrid-grid-xs-2 { flex-grow: 0; max-width: 16.666667%; flex-basis: 16.666667%; } .MuiGrid-grid-xs-3 { flex-grow: 0; max-width: 25%; flex-basis: 25%; } .MuiGrid-grid-xs-4 { flex-grow: 0; max-width: 33.333333%; flex-basis: 33.333333%; } .MuiGrid-grid-xs-5 { flex-grow: 0; max-width: 41.666667%; flex-basis: 41.666667%; } .MuiGrid-grid-xs-6 { flex-grow: 0; max-width: 50%; flex-basis: 50%; } .MuiGrid-grid-xs-7 { flex-grow: 0; max-width: 58.333333%; flex-basis: 58.333333%; } .MuiGrid-grid-xs-8 { flex-grow: 0; max-width: 66.666667%; flex-basis: 66.666667%; } .MuiGrid-grid-xs-9 { flex-grow: 0; max-width: 75%; flex-basis: 75%; } .MuiGrid-grid-xs-10 { flex-grow: 0; max-width: 83.333333%; flex-basis: 83.333333%; } .MuiGrid-grid-xs-11 { flex-grow: 0; max-width: 91.666667%; flex-basis: 91.666667%; } .MuiGrid-grid-xs-12 { flex-grow: 0; max-width: 100%; flex-basis: 100%; } @media (min-width:625px) { .MuiGrid-grid-sm-auto { flex-grow: 0; max-width: none; flex-basis: auto; } .MuiGrid-grid-sm-true { flex-grow: 1; max-width: 100%; flex-basis: 0; } .MuiGrid-grid-sm-1 { flex-grow: 0; max-width: 8.333333%; flex-basis: 8.333333%; } .MuiGrid-grid-sm-2 { flex-grow: 0; max-width: 16.666667%; flex-basis: 16.666667%; } .MuiGrid-grid-sm-3 { flex-grow: 0; max-width: 25%; flex-basis: 25%; } .MuiGrid-grid-sm-4 { flex-grow: 0; max-width: 33.333333%; flex-basis: 33.333333%; } .MuiGrid-grid-sm-5 { flex-grow: 0; max-width: 41.666667%; flex-basis: 41.666667%; } .MuiGrid-grid-sm-6 { flex-grow: 0; max-width: 50%; flex-basis: 50%; } .MuiGrid-grid-sm-7 { flex-grow: 0; max-width: 58.333333%; flex-basis: 58.333333%; } .MuiGrid-grid-sm-8 { flex-grow: 0; max-width: 66.666667%; flex-basis: 66.666667%; } .MuiGrid-grid-sm-9 { flex-grow: 0; max-width: 75%; flex-basis: 75%; } .MuiGrid-grid-sm-10 { flex-grow: 0; max-width: 83.333333%; flex-basis: 83.333333%; } .MuiGrid-grid-sm-11 { flex-grow: 0; max-width: 91.666667%; flex-basis: 91.666667%; } .MuiGrid-grid-sm-12 { flex-grow: 0; max-width: 100%; flex-basis: 100%; } } @media (min-width:960px) { .MuiGrid-grid-md-auto { flex-grow: 0; max-width: none; flex-basis: auto; } .MuiGrid-grid-md-true { flex-grow: 1; max-width: 100%; flex-basis: 0; } .MuiGrid-grid-md-1 { flex-grow: 0; max-width: 8.333333%; flex-basis: 8.333333%; } .MuiGrid-grid-md-2 { flex-grow: 0; max-width: 16.666667%; flex-basis: 16.666667%; } .MuiGrid-grid-md-3 { flex-grow: 0; max-width: 25%; flex-basis: 25%; } .MuiGrid-grid-md-4 { flex-grow: 0; max-width: 33.333333%; flex-basis: 33.333333%; } .MuiGrid-grid-md-5 { flex-grow: 0; max-width: 41.666667%; flex-basis: 41.666667%; } .MuiGrid-grid-md-6 { flex-grow: 0; max-width: 50%; flex-basis: 50%; } .MuiGrid-grid-md-7 { flex-grow: 0; max-width: 58.333333%; flex-basis: 58.333333%; } .MuiGrid-grid-md-8 { flex-grow: 0; max-width: 66.666667%; flex-basis: 66.666667%; } .MuiGrid-grid-md-9 { flex-grow: 0; max-width: 75%; flex-basis: 75%; } .MuiGrid-grid-md-10 { flex-grow: 0; max-width: 83.333333%; flex-basis: 83.333333%; } .MuiGrid-grid-md-11 { flex-grow: 0; max-width: 91.666667%; flex-basis: 91.666667%; } .MuiGrid-grid-md-12 { flex-grow: 0; max-width: 100%; flex-basis: 100%; } } @media (min-width:1280px) { .MuiGrid-grid-lg-auto { flex-grow: 0; max-width: none; flex-basis: auto; } .MuiGrid-grid-lg-true { flex-grow: 1; max-width: 100%; flex-basis: 0; } .MuiGrid-grid-lg-1 { flex-grow: 0; max-width: 8.333333%; flex-basis: 8.333333%; } .MuiGrid-grid-lg-2 { flex-grow: 0; max-width: 16.666667%; flex-basis: 16.666667%; } .MuiGrid-grid-lg-3 { flex-grow: 0; max-width: 25%; flex-basis: 25%; } .MuiGrid-grid-lg-4 { flex-grow: 0; max-width: 33.333333%; flex-basis: 33.333333%; } .MuiGrid-grid-lg-5 { flex-grow: 0; max-width: 41.666667%; flex-basis: 41.666667%; } .MuiGrid-grid-lg-6 { flex-grow: 0; max-width: 50%; flex-basis: 50%; } .MuiGrid-grid-lg-7 { flex-grow: 0; max-width: 58.333333%; flex-basis: 58.333333%; } .MuiGrid-grid-lg-8 { flex-grow: 0; max-width: 66.666667%; flex-basis: 66.666667%; } .MuiGrid-grid-lg-9 { flex-grow: 0; max-width: 75%; flex-basis: 75%; } .MuiGrid-grid-lg-10 { flex-grow: 0; max-width: 83.333333%; flex-basis: 83.333333%; } .MuiGrid-grid-lg-11 { flex-grow: 0; max-width: 91.666667%; flex-basis: 91.666667%; } .MuiGrid-grid-lg-12 { flex-grow: 0; max-width: 100%; flex-basis: 100%; } } @media (min-width:1920px) { .MuiGrid-grid-xl-auto { flex-grow: 0; max-width: none; flex-basis: auto; } .MuiGrid-grid-xl-true { flex-grow: 1; max-width: 100%; flex-basis: 0; } .MuiGrid-grid-xl-1 { flex-grow: 0; max-width: 8.333333%; flex-basis: 8.333333%; } .MuiGrid-grid-xl-2 { flex-grow: 0; max-width: 16.666667%; flex-basis: 16.666667%; } .MuiGrid-grid-xl-3 { flex-grow: 0; max-width: 25%; flex-basis: 25%; } .MuiGrid-grid-xl-4 { flex-grow: 0; max-width: 33.333333%; flex-basis: 33.333333%; } .MuiGrid-grid-xl-5 { flex-grow: 0; max-width: 41.666667%; flex-basis: 41.666667%; } .MuiGrid-grid-xl-6 { flex-grow: 0; max-width: 50%; flex-basis: 50%; } .MuiGrid-grid-xl-7 { flex-grow: 0; max-width: 58.333333%; flex-basis: 58.333333%; } .MuiGrid-grid-xl-8 { flex-grow: 0; max-width: 66.666667%; flex-basis: 66.666667%; } .MuiGrid-grid-xl-9 { flex-grow: 0; max-width: 75%; flex-basis: 75%; } .MuiGrid-grid-xl-10 { flex-grow: 0; max-width: 83.333333%; flex-basis: 83.333333%; } .MuiGrid-grid-xl-11 { flex-grow: 0; max-width: 91.666667%; flex-basis: 91.666667%; } .MuiGrid-grid-xl-12 { flex-grow: 0; max-width: 100%; flex-basis: 100%; } } .MuiInputLabel-root { display: block; transform-origin: top left; } .MuiInputLabel-formControl { top: 0; left: 0; position: absolute; transform: translate(0, 24px) scale(1); } .MuiInputLabel-marginDense { transform: translate(0, 21px) scale(1); } .MuiInputLabel-shrink { transform: translate(0, 1.5px) scale(0.75); transform-origin: top left; } .MuiInputLabel-animated { transition: color 200ms cubic-bezier(0.0, 0, 0.2, 1) 0ms,transform 200ms cubic-bezier(0.0, 0, 0.2, 1) 0ms; } .MuiInputLabel-filled { z-index: 1; transform: translate(12px, 20px) scale(1); pointer-events: none; } .MuiInputLabel-filled.MuiInputLabel-marginDense { transform: translate(12px, 17px) scale(1); } .MuiInputLabel-filled.MuiInputLabel-shrink { transform: translate(12px, 10px) scale(0.75); } .MuiInputLabel-filled.MuiInputLabel-shrink.MuiInputLabel-marginDense { transform: translate(12px, 7px) scale(0.75); } .MuiInputLabel-outlined { z-index: 1; transform: translate(14px, 20px) scale(1); pointer-events: none; } .MuiInputLabel-outlined.MuiInputLabel-marginDense { transform: translate(14px, 12px) scale(1); } .MuiInputLabel-outlined.MuiInputLabel-shrink { transform: translate(14px, -6px) scale(0.75); } .jss24 { top: -5px; left: 0; right: 0; bottom: 0; margin: 0; padding: 0 8px; overflow: hidden; position: absolute; border-style: solid; border-width: 1px; border-radius: inherit; pointer-events: none; } .jss25 { padding: 0; text-align: left; transition: width 150ms cubic-bezier(0.0, 0, 0.2, 1) 0ms; line-height: 11px; } .jss26 { width: auto; height: 11px; display: block; padding: 0; font-size: 0.75em; max-width: 0.01px; text-align: left; transition: max-width 50ms cubic-bezier(0.0, 0, 0.2, 1) 0ms; visibility: hidden; } .jss26 > span { display: inline-block; padding-left: 5px; padding-right: 5px; } .jss27 { max-width: 1000px; transition: max-width 100ms cubic-bezier(0.0, 0, 0.2, 1) 50ms; } .MuiOutlinedInput-root { position: relative; border-radius: 4px; } .MuiOutlinedInput-root:hover .MuiOutlinedInput-notchedOutline { border-color: rgba(0, 0, 0, 0.87); } @media (hover: none) { .MuiOutlinedInput-root:hover .MuiOutlinedInput-notchedOutline { border-color: rgba(0, 0, 0, 0.23); } } .MuiOutlinedInput-root.Mui-focused .MuiOutlinedInput-notchedOutline { border-color: #2675a7; border-width: 2px; } .MuiOutlinedInput-root.Mui-error .MuiOutlinedInput-notchedOutline { border-color: #f44336; } .MuiOutlinedInput-root.Mui-disabled .MuiOutlinedInput-notchedOutline { border-color: rgba(0, 0, 0, 0.26); } .MuiOutlinedInput-colorSecondary.Mui-focused .MuiOutlinedInput-notchedOutline { border-color: #db6b1f; } .MuiOutlinedInput-adornedStart { padding-left: 14px; } .MuiOutlinedInput-adornedEnd { padding-right: 14px; } .MuiOutlinedInput-multiline { padding: 18.5px 14px; } .MuiOutlinedInput-multiline.MuiOutlinedInput-marginDense { padding-top: 10.5px; padding-bottom: 10.5px; } .MuiOutlinedInput-notchedOutline { border-color: rgba(0, 0, 0, 0.23); } .MuiOutlinedInput-input { padding: 18.5px 14px; } .MuiOutlinedInput-input:-webkit-autofill { border-radius: inherit; } .MuiOutlinedInput-inputMarginDense { padding-top: 10.5px; padding-bottom: 10.5px; } .MuiOutlinedInput-inputMultiline { padding: 0; } .MuiOutlinedInput-inputAdornedStart { padding-left: 0; } .MuiOutlinedInput-inputAdornedEnd { padding-right: 0; } .MuiTooltip-popper { z-index: 1500; pointer-events: none; } .MuiTooltip-popperInteractive { pointer-events: auto; } .MuiTooltip-popperArrow[x-placement*="bottom"] .MuiTooltip-arrow { top: 0; left: 0; margin-top: -0.71em; margin-left: 4px; margin-right: 4px; } .MuiTooltip-popperArrow[x-placement*="top"] .MuiTooltip-arrow { left: 0; bottom: 0; margin-left: 4px; margin-right: 4px; margin-bottom: -0.71em; } .MuiTooltip-popperArrow[x-placement*="right"] .MuiTooltip-arrow { left: 0; width: 0.71em; height: 1em; margin-top: 4px; margin-left: -0.71em; margin-bottom: 4px; } .MuiTooltip-popperArrow[x-placement*="left"] .MuiTooltip-arrow { right: 0; width: 0.71em; height: 1em; margin-top: 4px; margin-right: -0.71em; margin-bottom: 4px; } .MuiTooltip-popperArrow[x-placement*="left"] .MuiTooltip-arrow::before { transform-origin: 0 0; } .MuiTooltip-popperArrow[x-placement*="right"] .MuiTooltip-arrow::before { transform-origin: 100% 100%; } .MuiTooltip-popperArrow[x-placement*="top"] .MuiTooltip-arrow::before { transform-origin: 100% 0; } .MuiTooltip-popperArrow[x-placement*="bottom"] .MuiTooltip-arrow::before { transform-origin: 0 100%; } .MuiTooltip-tooltip { color: #fff; padding: 4px 8px; font-size: 0.625rem; max-width: 300px; word-wrap: break-word; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 500; line-height: 1.4em; border-radius: 4px; background-color: rgba(97, 97, 97, 0.9); } .MuiTooltip-tooltipArrow { margin: 0; position: relative; } .MuiTooltip-arrow { color: rgba(97, 97, 97, 0.9); width: 1em; height: 0.71em; overflow: hidden; position: absolute; box-sizing: border-box; } .MuiTooltip-arrow::before { width: 100%; height: 100%; margin: auto; content: ""; display: block; transform: rotate(45deg); background-color: currentColor; } .MuiTooltip-touch { padding: 8px 16px; font-size: 0.875rem; font-weight: 400; line-height: 1.14286em; } .MuiTooltip-tooltipPlacementLeft { margin: 0 24px ; transform-origin: right center; } @media (min-width:625px) { .MuiTooltip-tooltipPlacementLeft { margin: 0 14px; } } .MuiTooltip-tooltipPlacementRight { margin: 0 24px; transform-origin: left center; } @media (min-width:625px) { .MuiTooltip-tooltipPlacementRight { margin: 0 14px; } } .MuiTooltip-tooltipPlacementTop { margin: 24px 0; transform-origin: center bottom; } @media (min-width:625px) { .MuiTooltip-tooltipPlacementTop { margin: 14px 0; } } .MuiTooltip-tooltipPlacementBottom { margin: 24px 0; transform-origin: center top; } @media (min-width:625px) { .MuiTooltip-tooltipPlacementBottom { margin: 14px 0; } } .MuiAutocomplete-root.Mui-focused .MuiAutocomplete-clearIndicatorDirty { visibility: visible; } @media (pointer: fine) { .MuiAutocomplete-root:hover .MuiAutocomplete-clearIndicatorDirty { visibility: visible; } } .MuiAutocomplete-fullWidth { width: 100%; } .MuiAutocomplete-tag { margin: 3px; max-width: calc(100% - 6px); } .MuiAutocomplete-tagSizeSmall { margin: 2px; max-width: calc(100% - 4px); } .MuiAutocomplete-inputRoot { flex-wrap: wrap; } .MuiAutocomplete-hasPopupIcon .MuiAutocomplete-inputRoot, .MuiAutocomplete-hasClearIcon .MuiAutocomplete-inputRoot { padding-right: 30px; } .MuiAutocomplete-hasPopupIcon.MuiAutocomplete-hasClearIcon .MuiAutocomplete-inputRoot { padding-right: 56px; } .MuiAutocomplete-inputRoot .MuiAutocomplete-input { width: 0; min-width: 30px; } .MuiAutocomplete-inputRoot[class*="MuiInput-root"] { padding-bottom: 1px; } .MuiAutocomplete-inputRoot[class*="MuiOutlinedInput-root"] { padding: 9px; } .MuiAutocomplete-inputRoot[class*="MuiOutlinedInput-root"][class*="MuiOutlinedInput-marginDense"] { padding: 6px; } .MuiAutocomplete-inputRoot[class*="MuiFilledInput-root"] { padding-top: 19px; padding-left: 8px; } .MuiAutocomplete-inputRoot[class*="MuiFilledInput-root"][class*="MuiFilledInput-marginDense"] { padding-bottom: 1px; } .MuiAutocomplete-inputRoot[class*="MuiFilledInput-root"][class*="MuiFilledInput-marginDense"] .MuiAutocomplete-input { padding: 4.5px 4px; } .MuiAutocomplete-hasPopupIcon .MuiAutocomplete-inputRoot[class*="MuiFilledInput-root"], .MuiAutocomplete-hasClearIcon .MuiAutocomplete-inputRoot[class*="MuiFilledInput-root"] { padding-right: 39px; } .MuiAutocomplete-hasPopupIcon.MuiAutocomplete-hasClearIcon .MuiAutocomplete-inputRoot[class*="MuiFilledInput-root"] { padding-right: 65px; } .MuiAutocomplete-inputRoot[class*="MuiFilledInput-root"] .MuiAutocomplete-input { padding: 9px 4px; } .MuiAutocomplete-inputRoot[class*="MuiFilledInput-root"] .MuiAutocomplete-endAdornment { right: 9px; } .MuiAutocomplete-inputRoot[class*="MuiOutlinedInput-root"][class*="MuiOutlinedInput-marginDense"] .MuiAutocomplete-input { padding: 4.5px 4px; } .MuiAutocomplete-hasPopupIcon .MuiAutocomplete-inputRoot[class*="MuiOutlinedInput-root"], .MuiAutocomplete-hasClearIcon .MuiAutocomplete-inputRoot[class*="MuiOutlinedInput-root"] { padding-right: 39px; } .MuiAutocomplete-hasPopupIcon.MuiAutocomplete-hasClearIcon .MuiAutocomplete-inputRoot[class*="MuiOutlinedInput-root"] { padding-right: 65px; } .MuiAutocomplete-inputRoot[class*="MuiOutlinedInput-root"] .MuiAutocomplete-input { padding: 9.5px 4px; } .MuiAutocomplete-inputRoot[class*="MuiOutlinedInput-root"] .MuiAutocomplete-input:first-child { padding-left: 6px; } .MuiAutocomplete-inputRoot[class*="MuiOutlinedInput-root"] .MuiAutocomplete-endAdornment { right: 9px; } .MuiAutocomplete-inputRoot[class*="MuiInput-root"][class*="MuiInput-marginDense"] .MuiAutocomplete-input { padding: 4px 4px 5px; } .MuiAutocomplete-inputRoot[class*="MuiInput-root"][class*="MuiInput-marginDense"] .MuiAutocomplete-input:first-child { padding: 3px 0 6px; } .MuiAutocomplete-inputRoot[class*="MuiInput-root"] .MuiAutocomplete-input { padding: 4px; } .MuiAutocomplete-inputRoot[class*="MuiInput-root"] .MuiAutocomplete-input:first-child { padding: 6px 0; } .MuiAutocomplete-input { opacity: 0; flex-grow: 1; text-overflow: ellipsis; } .MuiAutocomplete-inputFocused { opacity: 1; } .MuiAutocomplete-endAdornment { top: calc(50% - 14px); right: 0; position: absolute; } .MuiAutocomplete-clearIndicator { padding: 4px; visibility: hidden; margin-right: -2px; } .MuiAutocomplete-popupIndicator { padding: 2px; margin-right: -2px; } .MuiAutocomplete-popupIndicatorOpen { transform: rotate(180deg); } .MuiAutocomplete-popper { z-index: 1300; } .MuiAutocomplete-popperDisablePortal { position: absolute; } .MuiAutocomplete-paper { margin: 4px 0; overflow: hidden; font-size: 1rem; font-family: "Roboto", "Helvetica", "Arial", sans-serif; font-weight: 400; line-height: 1.5; letter-spacing: 0.00938em; } .MuiAutocomplete-listbox { margin: 0; padding: 8px 0; overflow: auto; list-style: none; max-height: 40vh; } .MuiAutocomplete-loading { color: rgba(0, 0, 0, 0.54); padding: 14px 16px; } .MuiAutocomplete-noOptions { color: rgba(0, 0, 0, 0.54); padding: 14px 16px; } .MuiAutocomplete-option { cursor: pointer; display: flex; outline: 0; box-sizing: border-box; min-height: 48px; align-items: center; padding-top: 6px; padding-left: 16px; padding-right: 16px; padding-bottom: 6px; justify-content: flex-start; -webkit-tap-highlight-color: transparent; } @media (min-width:625px) { .MuiAutocomplete-option { min-height: auto; } } .MuiAutocomplete-option[aria-selected="true"] { background-color: rgba(0, 0, 0, 0.08); } .MuiAutocomplete-option[data-focus="true"] { background-color: rgba(0, 0, 0, 0.04); } .MuiAutocomplete-option:active { background-color: rgba(0, 0, 0, 0.08); } .MuiAutocomplete-option[aria-disabled="true"] { opacity: 0.38; pointer-events: none; } .MuiAutocomplete-groupLabel { top: -8px; background-color: #fff; } .MuiAutocomplete-groupUl { padding: 0; } .MuiAutocomplete-groupUl .MuiAutocomplete-option { padding-left: 24px; } .jss3 { width: 100%; bottom: 0; height: 50px; display: flex; z-index: 10000; position: fixed; align-items: center; justify-content: center; } .jss4 { top: 0; width: 100%; height: 50px; display: flex; z-index: 10000; position: fixed; align-items: center; justify-content: center; } .jss5 { font-weight: 600; } .jss1 { max-width: 100vw; } .jss2 { margin-bottom: 48px; } .jss8 { display: flex; padding: 8px; margin-top: -48px; min-height: calc(100vh - 100px); align-items: center; justify-content: center; } @media (max-width:624.95px) { .jss8 { min-height: calc(80vh - 64px); } } @keyframes jss9 { 0% { background-position: 0 0; } 100% { background-position: 0 -3000px; } } .jss10 { color: #eee; width: 100%; height: 80vh; display: flex; position: relative; animation: scrollBG 100s linear infinite; background: url(/hero.webp) repeat-y; align-items: center; margin-left: 80px; border-radius: 10px; animation-name: jss9; background-size: cover; } @media (max-width:624.95px) { .jss10 { height: 65vh; margin-left: 0; flex-direction: column; justify-content: center; } } .jss11 { display: flex; flex-direction: column; justify-content: center; } @media (max-width:624.95px) { .jss11 { padding: 4px; background: #FFFFFF; align-items: center; } } .jss12 { color: #2675a7; width: fit-content; background: #FFFFFF; margin-left: -80px; padding-right: 16px; } @media (max-width:624.95px) { .jss12 { font-size: 1.5rem !important; text-align: center; margin-left: 0; } } .jss13 { color: #2675a7; width: fit-content; background: white; padding-right: 16px; } @media (max-width:624.95px) { .jss13 { padding: 8px; font-size: 2.5rem !important; text-align: center; } } .jss14 { left: -64px; bottom: -40px; position: absolute; } @media (max-width:624.95px) { .jss14 { left: 50%; bottom: -80px; transform: translate(-50%, -50%); } } .jss15 { display: flex; padding: 8px 16px; border-radius: 10px; flex-direction: column; } .jss16 { display: flex; flex-direction: column; } .jss20 { width: 100%; display: flex; margin-top: 40px; align-items: center; flex-direction: column; justify-content: center; } .jss21 { width: 100%; display: grid; grid-template-columns: 1fr 1fr; } @media (max-width:624.95px) { .jss21 { grid-template-columns: 1fr; } } .jss22 { margin-bottom: 16px; } @media (max-width:624.95px) { .jss22 { padding: 8px; } } .jss23 { width: 100%; margin-bottom: 8px; } .jss33 { display: flex; align-items: center; flex-direction: column; justify-content: center; } .jss34 { color: #676767; font-size: small; text-align: center; text-transform: uppercase; } .jss28 { height: 100%; display: flex; padding: 8px; z-index: -100; overflow: hidden; align-items: center; flex-direction: column; justify-content: space-around; } .jss29 { text-align: center; margin-bottom: 16px; } .jss30 { width: 100%; height: 100%; display: grid; max-height: 300px; min-height: 280px; grid-template-columns: 1fr 1fr; } .jss31 { width: 100%; cursor: pointer; display: flex; align-items: flex-end; justify-content: flex-end; } .jss18 { z-index: 10; } .jss19 { height: 100%; z-index: -10; } .jss6 { display: flex; align-items: center; justify-content: center; } @media (max-width:624.95px) { .jss6 { padding-top: 16px; } } .jss7 { width: 100vw; max-width: 1200px; } @media (max-width:624.95px) { .jss7 { width: 100vw; max-width: 100vw; } } .jss43 { width: 500px; } @media (max-width:959.95px) { .jss43 { width: 300px; } } .jss35 { margin-top: 48px; background-color: #2675a7; } .jss36 { display: flex; padding: 48px 0; align-items: center; flex-direction: column; justify-content: center; } .jss37 { color: #FFFFFF; text-align: center; margin-bottom: 16px; } .jss38 { color: #FFFFFF; text-align: center; } .jss39 { max-width: 600px; margin-bottom: 24px; } .jss40 { width: 300px; margin: 24px; } .jss41 { color: #2675a7; background: #FFFFFF; border-radius: 5px; text-decoration: none; } .jss52 { width: 100%; height: 100%; padding: 8px; overflow: hidden; max-width: 300px; background-color: #FFFFFF; } .jss53 { box-shadow: 0 0 1pt 1pt #db6b1f; } .jss54 { box-shadow: 0 0 1pt 1pt #2675a7; } .jss55 { height: 100%; display: flex; align-items: center; flex-direction: column; justify-content: space-between; } .jss56 { display: flex; flex-grow: 1; align-items: center; justify-content: center; } .jss57 { margin-bottom: 32px; } .jss58 { text-align: center; } .jss59 { display: flex; align-items: center; flex-direction: column; justify-content: center; } .jss60 { text-align: center; } .jss44 { width: 100%; max-width: 100vw; margin-top: 64px; } .jss45 { width: 100%; display: flex; overflow: hidden; align-items: center; flex-direction: row; justify-content: center; } .jss46 { width: 100%; height: 100%; display: grid; padding: 8px; grid-gap: 24px; grid-template-columns: 1fr 1fr 1fr; } .jss46 > * { display: flex; align-items: center; justify-content: center; } .jss47 { display: flex; align-items: center; margin-bottom: 32px; justify-content: center; } .jss48 { height: 100%; display: flex; overflow: hidden; align-items: center; justify-content: center; } .jss49 { display: flex; margin-top: 24px; align-items: center; flex-direction: row; justify-content: center; } .jss50 { width: 8px; height: 8px; margin: 4px; display: inline-block; border-radius: 50%; background-color: #bbb; } .jss51 { width: 8px; height: 8px; transition: all .5s; background-color: #2675a7; } .jss75 { max-width: 100vw; margin-top: 48px; background-color: #2675a7; } .jss76 { display: flex; padding: 48px; align-items: center; flex-direction: column; justify-content: center; } @media (max-width:624.95px) { .jss76 { width: 100vw; } } .jss77 { color: #FFFFFF; text-align: center; } .jss78 { color: #FFFFFF; text-align: left; } .jss79 { display: flex; max-width: 600px; align-items: center; margin-bottom: 8px; justify-content: center; } @media (max-width:624.95px) { .jss79 { max-width: 100%; flex-direction: column; } } .jss80 { color: white; text-decoration: none; } .jss81 { margin-bottom: 8px; } .jss82 { width: 100%; display: flex; flex-direction: row; } .jss82 > * { margin: 8px; } .jss83 { color: #FFFFFF !important; } .jss84 { color: #FFFFFF !important; -webkit-box-shadow: none; } .jss84:-webkit-autofill { color: red; } .jss85 { color: #FFFFFF !important; border-color: #FFFFFF !important; } .jss86 { color: #2675a7; background: #FFFFFF; border-radius: 5px; } .jss87 { color: #FFFFFF !important; } .jss88 { font-weight: 600; } .jss89 { color: #FFFFFF; cursor: pointer; text-decoration: underline; } .jss90 { color: #FFFFFF; } .jss91 { display: flex; align-items: center; justify-content: center; } .jss92 { color: #FFFFFF; margin-right: 16px; } .jss61 { max-width: 100vw; margin-top: 48px; background-color: #2675a7; } .jss62 { display: flex; padding: 48px; align-items: center; flex-direction: column; justify-content: center; } @media (max-width:624.95px) { .jss62 { width: 100vw; } } .jss63 { color: #FFFFFF; text-align: center; } .jss64 { color: #FFFFFF; text-align: left; } .jss65 { display: flex; max-width: 600px; align-items: center; margin-bottom: 8px; justify-content: center; } @media (max-width:624.95px) { .jss65 { max-width: 100%; flex-direction: column; } } .jss66 { color: white; text-decoration: none; } .jss67 { margin-bottom: 8px; } .jss68 { width: 100%; display: flex; flex-direction: row; } .jss68 > * { margin: 8px; } .jss69 { color: #FFFFFF !important; } .jss70 { color: #FFFFFF !important; border-color: #FFFFFF !important; } .jss71 { color: #2675a7; background: #FFFFFF; border-radius: 5px; } .jss72 { color: #FFFFFF !important; } .jss73 { font-weight: 600; } .jss74 { color: #FFFFFF; cursor: pointer; text-decoration: underline; } .jss104 { display: flex; align-items: center; justify-content: center; } @media (max-width:624.95px) { .jss104 { width: 100%; display: grid; grid-template-columns: 1fr; } } .jss106 { width: 90px; } .jss97 { display: flex; margin-top: 48px; align-items: center; margin-bottom: 48px; flex-direction: column; justify-content: center; } .jss98 { margin-bottom: 8px; } .jss99 { width: 100%; padding: 48px; } .jss100 { display: flex; align-items: center; justify-content: center; } .jss101 { filter: grayscale(1); display: flex; padding: 16px; align-items: center; justify-content: center; } .jss102 { display: flex; padding: 8px; max-width: 600px; text-align: center; align-items: center; margin-bottom: 8px; justify-content: center; } .jss103 { text-decoration: none; } .jss107 { height: 4px; background-color: #ebebeb; } .jss108 { display: flex; text-align: center; align-items: center; flex-direction: column; justify-content: center; } @media (max-width:1279.95px) { .jss108 { margin: 12px 0 ; } } .jss109 { display: flex; padding: 24px; align-items: center; justify-content: center; } .jss110 { display: flex; align-items: center; margin-bottom: 8px; justify-content: center; } .jss111 { cursor: pointer; margin: 8px; } .jss112 { margin-top: 8px; font-weight: 600; margin-bottom: 8px; text-transform: uppercase; } .jss113 { cursor: pointer; text-decoration: none; } .jss114 { width: 8px; }</style><style data-href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700&display=swap">@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmSU5fBBc-.woff) format('woff')}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOmCnqEu92Fr1Mu4mxM.woff) format('woff')}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmEU9fBBc-.woff) format('woff')}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmWUlfBBc-.woff) format('woff')}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmSU5fCRc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0460-052F,U+1C80-1C88,U+20B4,U+2DE0-2DFF,U+A640-A69F,U+FE2E-FE2F}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmSU5fABc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0301,U+0400-045F,U+0490-0491,U+04B0-04B1,U+2116}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmSU5fCBc4AMP6lbBP.woff2) format('woff2');unicode-range:U+1F00-1FFF}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmSU5fBxc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0370-03FF}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmSU5fCxc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0102-0103,U+0110-0111,U+0128-0129,U+0168-0169,U+01A0-01A1,U+01AF-01B0,U+1EA0-1EF9,U+20AB}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmSU5fChc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0100-024F,U+0259,U+1E00-1EFF,U+2020,U+20A0-20AB,U+20AD-20CF,U+2113,U+2C60-2C7F,U+A720-A7FF}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmSU5fBBc4AMP6lQ.woff2) format('woff2');unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02BB-02BC,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2122,U+2191,U+2193,U+2212,U+2215,U+FEFF,U+FFFD}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOmCnqEu92Fr1Mu72xKKTU1Kvnz.woff2) format('woff2');unicode-range:U+0460-052F,U+1C80-1C88,U+20B4,U+2DE0-2DFF,U+A640-A69F,U+FE2E-FE2F}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOmCnqEu92Fr1Mu5mxKKTU1Kvnz.woff2) format('woff2');unicode-range:U+0301,U+0400-045F,U+0490-0491,U+04B0-04B1,U+2116}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOmCnqEu92Fr1Mu7mxKKTU1Kvnz.woff2) format('woff2');unicode-range:U+1F00-1FFF}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOmCnqEu92Fr1Mu4WxKKTU1Kvnz.woff2) format('woff2');unicode-range:U+0370-03FF}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOmCnqEu92Fr1Mu7WxKKTU1Kvnz.woff2) format('woff2');unicode-range:U+0102-0103,U+0110-0111,U+0128-0129,U+0168-0169,U+01A0-01A1,U+01AF-01B0,U+1EA0-1EF9,U+20AB}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOmCnqEu92Fr1Mu7GxKKTU1Kvnz.woff2) format('woff2');unicode-range:U+0100-024F,U+0259,U+1E00-1EFF,U+2020,U+20A0-20AB,U+20AD-20CF,U+2113,U+2C60-2C7F,U+A720-A7FF}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2) format('woff2');unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02BB-02BC,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2122,U+2191,U+2193,U+2212,U+2215,U+FEFF,U+FFFD}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmEU9fCRc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0460-052F,U+1C80-1C88,U+20B4,U+2DE0-2DFF,U+A640-A69F,U+FE2E-FE2F}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmEU9fABc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0301,U+0400-045F,U+0490-0491,U+04B0-04B1,U+2116}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmEU9fCBc4AMP6lbBP.woff2) format('woff2');unicode-range:U+1F00-1FFF}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmEU9fBxc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0370-03FF}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmEU9fCxc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0102-0103,U+0110-0111,U+0128-0129,U+0168-0169,U+01A0-01A1,U+01AF-01B0,U+1EA0-1EF9,U+20AB}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmEU9fChc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0100-024F,U+0259,U+1E00-1EFF,U+2020,U+20A0-20AB,U+20AD-20CF,U+2113,U+2C60-2C7F,U+A720-A7FF}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmEU9fBBc4AMP6lQ.woff2) format('woff2');unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02BB-02BC,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2122,U+2191,U+2193,U+2212,U+2215,U+FEFF,U+FFFD}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmWUlfCRc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0460-052F,U+1C80-1C88,U+20B4,U+2DE0-2DFF,U+A640-A69F,U+FE2E-FE2F}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmWUlfABc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0301,U+0400-045F,U+0490-0491,U+04B0-04B1,U+2116}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmWUlfCBc4AMP6lbBP.woff2) format('woff2');unicode-range:U+1F00-1FFF}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmWUlfBxc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0370-03FF}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmWUlfCxc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0102-0103,U+0110-0111,U+0128-0129,U+0168-0169,U+01A0-01A1,U+01AF-01B0,U+1EA0-1EF9,U+20AB}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmWUlfChc4AMP6lbBP.woff2) format('woff2');unicode-range:U+0100-024F,U+0259,U+1E00-1EFF,U+2020,U+20A0-20AB,U+20AD-20CF,U+2113,U+2C60-2C7F,U+A720-A7FF}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmWUlfBBc4AMP6lQ.woff2) format('woff2');unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02BB-02BC,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2122,U+2191,U+2193,U+2212,U+2215,U+FEFF,U+FFFD}</style><style data-href="https://fonts.googleapis.com/icon?family=Material+Icons">@font-face{font-family:'Material Icons';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialicons/v135/flUhRq6tzZclQEJ-Vdg-IuiaDsNa.woff) format('woff')}.material-icons{font-family:'Material Icons';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;font-feature-settings:'liga'}@font-face{font-family:'Material Icons';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialicons/v135/flUhRq6tzZclQEJ-Vdg-IuiaDsNcIhQ8tQ.woff2) format('woff2')}.material-icons{font-family:'Material Icons';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;-webkit-font-feature-settings:'liga';-webkit-font-smoothing:antialiased}</style></head><body><div id="__next" data-reactroot=""><section style="opacity:0"><div class="jss1"><div class="jss2"></div><div class="jss6"><div class="jss7"><section class="jss8"><div class="jss10"><div class="jss11" style="opacity:0;transform:translateX(-100px) translateZ(0)"><div class="jss13"><h2 class="MuiTypography-root jss12 MuiTypography-h2">There are</h2></div><div class="jss12"><h1 class="MuiTypography-root jss13 MuiTypography-h1">1 Million+ People with MS</h1></div><div class="jss13"><h2 class="MuiTypography-root jss12 MuiTypography-h2">in Europe</h2></div></div></div></section><section class="jss20"><div class="jss21"><div class="jss22"><div class="jss18"><div class="jss23"><div class="MuiAutocomplete-root MuiAutocomplete-hasPopupIcon" role="combobox" aria-expanded="false"><div class="MuiFormControl-root MuiTextField-root MuiFormControl-fullWidth"><label class="MuiFormLabel-root MuiInputLabel-root MuiInputLabel-formControl MuiInputLabel-animated MuiInputLabel-outlined" data-shrink="false" id="undefined-label">Countries</label><div class="MuiInputBase-root MuiOutlinedInput-root MuiAutocomplete-inputRoot MuiInputBase-fullWidth MuiInputBase-formControl MuiInputBase-adornedEnd MuiOutlinedInput-adornedEnd"><input type="text" aria-invalid="false" autoComplete="off" value="" class="MuiInputBase-input MuiOutlinedInput-input MuiAutocomplete-input MuiAutocomplete-inputFocused MuiInputBase-inputAdornedEnd MuiOutlinedInput-inputAdornedEnd" aria-autocomplete="list" autoCapitalize="none" spellcheck="false"/><div class="MuiAutocomplete-endAdornment"><button class="MuiButtonBase-root MuiIconButton-root MuiAutocomplete-popupIndicator" tabindex="-1" type="button" aria-label="Open" title="Open"><span class="MuiIconButton-label"><svg class="MuiSvgIcon-root" focusable="false" viewBox="0 0 24 24" aria-hidden="true"><path d="M7 10l5 5 5-5z"></path></svg></span></button></div><fieldset aria-hidden="true" class="jss24 MuiOutlinedInput-notchedOutline"><legend class="jss26"><span>Countries</span></legend></fieldset></div></div></div></div><svg viewBox="0 0 800 600" class="rsm-svg " data-tip=""><g class="rsm-geographies "></g></svg></div></div><div class="jss22"><div class="jss19"><div class="jss28" style="opacity:0;transform:translateZ(-10px)"><h4 class="MuiTypography-root jss29 MuiTypography-h4 MuiTypography-colorPrimary">MS in Austria</h4><div><div class="MuiGrid-root MuiGrid-container MuiGrid-direction-xs-column MuiGrid-align-items-xs-center"><div class="MuiGrid-root MuiGrid-item MuiGrid-grid-xs-12"><div role="group" class="MuiButtonGroup-root MuiButtonGroup-disableElevation MuiButtonGroup-contained" aria-label="split button"><button class="MuiButtonBase-root MuiButton-root MuiButton-contained MuiButtonGroup-grouped MuiButtonGroup-groupedHorizontal MuiButtonGroup-groupedContained MuiButtonGroup-groupedContainedHorizontal MuiButtonGroup-groupedContainedPrimary MuiButton-containedPrimary MuiButton-disableElevation" tabindex="0" type="button"><span class="MuiButton-label"><span class="MuiButton-startIcon MuiButton-iconSizeMedium"><svg class="MuiSvgIcon-root" focusable="false" viewBox="0 0 24 24" aria-hidden="true"><path d="M20 2H8c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h12c1.1 0 2-.9 2-2V4c0-1.1-.9-2-2-2zm-8.5 7.5c0 .83-.67 1.5-1.5 1.5H9v2H7.5V7H10c.83 0 1.5.67 1.5 1.5v1zm5 2c0 .83-.67 1.5-1.5 1.5h-2.5V7H15c.83 0 1.5.67 1.5 1.5v3zm4-3H19v1h1.5V11H19v2h-1.5V7h3v1.5zM9 9.5h1v-1H9v1zM4 6H2v14c0 1.1.9 2 2 2h14v-2H4V6zm10 5.5h1v-3h-1v3z"></path></svg></span>Download the 2020 - Austria Factsheet - EN</span></button><button class="MuiButtonBase-root MuiButton-root MuiButton-contained MuiButtonGroup-grouped MuiButtonGroup-groupedHorizontal MuiButtonGroup-groupedContained MuiButtonGroup-groupedContainedHorizontal MuiButtonGroup-groupedContainedPrimary MuiButton-containedPrimary MuiButton-containedSizeSmall MuiButton-sizeSmall MuiButton-disableElevation" tabindex="0" type="button" aria-label="Download report" aria-haspopup="menu"><span class="MuiButton-label"><svg class="MuiSvgIcon-root" focusable="false" viewBox="0 0 24 24" aria-hidden="true"><path d="M7 10l5 5 5-5z"></path></svg></span></button></div></div></div></div><div class="jss30"><div class="jss33"><h6 class="MuiTypography-root jss34 MuiTypography-subtitle2">Population</h6><h4 class="MuiTypography-root MuiTypography-h4 MuiTypography-colorPrimary"></h4></div><div class="jss33"><h6 class="MuiTypography-root jss34 MuiTypography-subtitle2">People with MS</h6><h4 class="MuiTypography-root MuiTypography-h4 MuiTypography-colorPrimary"></h4></div><div class="jss33"><h6 class="MuiTypography-root jss34 MuiTypography-subtitle2">Total score</h6><h4 class="MuiTypography-root MuiTypography-h4 MuiTypography-colorPrimary"></h4></div><div class="jss33"><h6 class="MuiTypography-root jss34 MuiTypography-subtitle2">National scores on MS policy</h6><h4 class="MuiTypography-root MuiTypography-h4 MuiTypography-colorPrimary"></h4></div><div class="jss33"><h6 class="MuiTypography-root jss34 MuiTypography-subtitle2">Scores on care delivery</h6><h4 class="MuiTypography-root MuiTypography-h4 MuiTypography-colorPrimary"></h4></div><div class="jss33"><h6 class="MuiTypography-root jss34 MuiTypography-subtitle2">National score on Employment</h6><h4 class="MuiTypography-root MuiTypography-h4 MuiTypography-colorPrimary"></h4></div></div><div class="jss31"><p class="MuiTypography-root MuiTypography-body1 MuiTypography-colorPrimary">See the detailed report for Austria</p><svg class="MuiSvgIcon-root MuiSvgIcon-colorPrimary" focusable="false" viewBox="0 0 24 24" aria-hidden="true"><path d="M5.88 4.12L13.76 12l-7.88 7.88L8 22l10-10L8 2z"></path></svg></div></div></div></div></div></section></div></div><div class="jss35"><div class="jss6"><div class="jss7"><div class="jss36"><h3 class="MuiTypography-root jss37 MuiTypography-h3">Download the full report</h3><div class="jss43"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:87.46666666666667%"></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fd6a67aa4a02d930b05f475a9cd5eb5f0.png&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fd6a67aa4a02d930b05f475a9cd5eb5f0.png&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fd6a67aa4a02d930b05f475a9cd5eb5f0.png&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fd6a67aa4a02d930b05f475a9cd5eb5f0.png&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fd6a67aa4a02d930b05f475a9cd5eb5f0.png&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fd6a67aa4a02d930b05f475a9cd5eb5f0.png&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fd6a67aa4a02d930b05f475a9cd5eb5f0.png&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fd6a67aa4a02d930b05f475a9cd5eb5f0.png&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fd6a67aa4a02d930b05f475a9cd5eb5f0.png&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div><p class="MuiTypography-root jss38 jss39 MuiTypography-body1">The MS Barometer is a comparative survey collecting key information on Multiple Sclerosis (MS) in 35 countries. It serves as a benchmarking tool to provide an accurate picture of MS management across health and social care systems. We see issues in access to appropriate healthcare, health professionals and social support for people with MS and their carers across the continent. Countries that fail to provide quality care are failing their MS communities.</p><a href="https://barometer.ams3.digitaloceanspaces.com/55ac809262a6e9ad124ecb0dc813d225.pdf" target="_blank" class="jss41"><button class="MuiButtonBase-root MuiButton-root MuiButton-contained jss41 MuiButton-disableElevation" tabindex="0" type="button"><span class="MuiButton-label">Download the report</span></button></a></div></div></div></div><div class="jss6"><div class="jss7"><div class="jss44"><h3 class="MuiTypography-root jss47 MuiTypography-h3 MuiTypography-colorPrimary">Findings</h3><div class="jss45"><div style="overflow-x:hidden;width:100%;height:100%"><div style="-webkit-flex-direction:row;flex-direction:row;-webkit-transition:all 0s ease 0s;transition:transform 0.35s cubic-bezier(0.15, 0.3, 0.25, 1) 0s;direction:ltr;display:flex;will-change:transform" class="react-swipeable-view-container"><div style="width:100%;-webkit-flex-shrink:0;flex-shrink:0;overflow:auto" aria-hidden="false" data-swipeable="true"><div class="jss48"><div class="jss52"><div class="MuiPaper-root MuiCard-root jss52 jss53 jss54 MuiPaper-elevation0 MuiPaper-rounded"><div class="MuiCardContent-root jss55"><div class="MuiGrid-root MuiGrid-container"><div class="MuiGrid-root jss59 MuiGrid-item MuiGrid-grid-xs-12"><p class="MuiTypography-root jss57 MuiTypography-body1 MuiTypography-colorPrimary">Did you know?</p><p class="MuiTypography-root jss58 MuiTypography-body1">Just</p></div></div><h1 class="MuiTypography-root jss60 MuiTypography-h1 MuiTypography-colorPrimary">16</h1><p class="MuiTypography-root jss60 jss56 MuiTypography-body1">countries provide social support specific to carers of children and adolescents with MS.</p></div></div></div></div></div></div></div></div><div class="jss49"><div class="jss50 jss51"></div><div class="jss50 false"></div><div class="jss50 false"></div><div class="jss50 false"></div><div class="jss50 false"></div><div class="jss50 false"></div><div class="jss50 false"></div><div class="jss50 false"></div><div class="jss50 false"></div><div class="jss50 false"></div><div class="jss50 false"></div><div class="jss50 false"></div></div></div></div></div><div class="jss61"><div class="jss6"><div class="jss7"><div class="jss62"><h3 class="MuiTypography-root jss63 jss67 MuiTypography-h3">Subscribe to our newsletter</h3><p class="MuiTypography-root jss63 jss67 MuiTypography-body1">Subscribe to keep informed on EMSP advocacy work and MS Barometer updates</p><form action="" method="post" id="mc-embedded-subscribe-form" name="mc-embedded-subscribe-form" class="validate" target="_blank" novalidate=""><div class="jss79 jss82"><div class="MuiFormControl-root MuiTextField-root jss83 MuiFormControl-fullWidth"><label class="MuiFormLabel-root MuiInputLabel-root jss83 MuiInputLabel-formControl MuiInputLabel-animated MuiInputLabel-outlined" data-shrink="false">Email Address</label><div class="MuiInputBase-root MuiOutlinedInput-root jss84 MuiInputBase-fullWidth MuiInputBase-formControl"><input type="text" aria-invalid="false" value="" class="MuiInputBase-input MuiOutlinedInput-input"/><fieldset aria-hidden="true" class="jss24 MuiOutlinedInput-notchedOutline jss85"><legend class="jss26"><span>Email Address</span></legend></fieldset></div></div></div><div class="jss79 jss82"><div class="MuiFormControl-root MuiTextField-root jss83 MuiFormControl-fullWidth"><label class="MuiFormLabel-root MuiInputLabel-root jss83 MuiInputLabel-formControl MuiInputLabel-animated MuiInputLabel-outlined" data-shrink="false">Name</label><div class="MuiInputBase-root MuiOutlinedInput-root jss84 MuiInputBase-fullWidth MuiInputBase-formControl"><input type="text" aria-invalid="false" value="" class="MuiInputBase-input MuiOutlinedInput-input"/><fieldset aria-hidden="true" class="jss24 MuiOutlinedInput-notchedOutline jss85"><legend class="jss26"><span>Name</span></legend></fieldset></div></div><div class="MuiFormControl-root MuiTextField-root jss83 MuiFormControl-fullWidth"><label class="MuiFormLabel-root MuiInputLabel-root jss83 MuiInputLabel-formControl MuiInputLabel-animated MuiInputLabel-outlined" data-shrink="false">Last Name</label><div class="MuiInputBase-root MuiOutlinedInput-root jss84 MuiInputBase-fullWidth MuiInputBase-formControl"><input type="text" aria-invalid="false" value="" class="MuiInputBase-input MuiOutlinedInput-input"/><fieldset aria-hidden="true" class="jss24 MuiOutlinedInput-notchedOutline jss85"><legend class="jss26"><span>Last Name</span></legend></fieldset></div></div></div><div style="position:absolute;left:-5000px" aria-hidden="true"><input type="text" name="b_5b5ccb101c6036ef052c064d8_bde92ce7d0" tabindex="-1"/></div><div class="jss79 jss82"><span class="MuiButtonBase-root MuiIconButton-root jss93 MuiCheckbox-root MuiCheckbox-colorSecondary jss87 MuiIconButton-colorSecondary" aria-disabled="false"><span class="MuiIconButton-label"><input type="checkbox" class="jss96" value="false" data-indeterminate="false"/><svg class="MuiSvgIcon-root" focusable="false" viewBox="0 0 24 24" aria-hidden="true"><path d="M19 5v14H5V5h14m0-2H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2z"></path></svg></span></span><span class="MuiTypography-root jss78 MuiTypography-caption">European Multiple Sclerosis Platform will use the information you provide on this form to be in touch with you. Please tick the box below if you would like to hear from us. <span class="jss89">Click here for GDPR notice.</span></span></div><div class="jss89"></div><div class="jss79"><button class="MuiButtonBase-root MuiButton-root MuiButton-contained jss86 MuiButton-disableElevation" tabindex="0" type="button"><span class="MuiButton-label">Subscribe</span></button></div></form></div></div></div></div><div class="jss97"><h3 class="MuiTypography-root jss98 MuiTypography-h3 MuiTypography-colorPrimary">Our Sponsors</h3><div class="jss99"><div class="jss6"><div class="jss7"><div class="jss100"><div class="MuiGrid-root jss104 MuiGrid-container"><div class="jss101"><div class="jss106"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:26.122448979591837%"></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F83892c21171cf84d4750fa6c6173a91e.png&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F83892c21171cf84d4750fa6c6173a91e.png&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F83892c21171cf84d4750fa6c6173a91e.png&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F83892c21171cf84d4750fa6c6173a91e.png&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F83892c21171cf84d4750fa6c6173a91e.png&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F83892c21171cf84d4750fa6c6173a91e.png&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F83892c21171cf84d4750fa6c6173a91e.png&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F83892c21171cf84d4750fa6c6173a91e.png&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F83892c21171cf84d4750fa6c6173a91e.png&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div><div class="jss101"><div class="jss106"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:15.918367346938775%"></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F1d9894159b2cd72632666b47cfbb367f.png&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F1d9894159b2cd72632666b47cfbb367f.png&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F1d9894159b2cd72632666b47cfbb367f.png&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F1d9894159b2cd72632666b47cfbb367f.png&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F1d9894159b2cd72632666b47cfbb367f.png&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F1d9894159b2cd72632666b47cfbb367f.png&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F1d9894159b2cd72632666b47cfbb367f.png&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F1d9894159b2cd72632666b47cfbb367f.png&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F1d9894159b2cd72632666b47cfbb367f.png&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div><div class="jss101"><div class="jss106"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:36.734693877551024%"></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F4c4cbfca38f805d774e2aab5f3d56647.png&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F4c4cbfca38f805d774e2aab5f3d56647.png&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F4c4cbfca38f805d774e2aab5f3d56647.png&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F4c4cbfca38f805d774e2aab5f3d56647.png&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F4c4cbfca38f805d774e2aab5f3d56647.png&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F4c4cbfca38f805d774e2aab5f3d56647.png&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F4c4cbfca38f805d774e2aab5f3d56647.png&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F4c4cbfca38f805d774e2aab5f3d56647.png&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F4c4cbfca38f805d774e2aab5f3d56647.png&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div><div class="jss101"><div class="jss106"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:13.877551020408163%"></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fc16d498b0087e7f0ac206ecd3fdac868.webp&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fc16d498b0087e7f0ac206ecd3fdac868.webp&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fc16d498b0087e7f0ac206ecd3fdac868.webp&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fc16d498b0087e7f0ac206ecd3fdac868.webp&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fc16d498b0087e7f0ac206ecd3fdac868.webp&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fc16d498b0087e7f0ac206ecd3fdac868.webp&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fc16d498b0087e7f0ac206ecd3fdac868.webp&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fc16d498b0087e7f0ac206ecd3fdac868.webp&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fc16d498b0087e7f0ac206ecd3fdac868.webp&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div><div class="jss101"><div class="jss106"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:11.83673469387755%"></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F7faf51d74e928b0f05e9f1bd47a383fb.png&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F7faf51d74e928b0f05e9f1bd47a383fb.png&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F7faf51d74e928b0f05e9f1bd47a383fb.png&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F7faf51d74e928b0f05e9f1bd47a383fb.png&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F7faf51d74e928b0f05e9f1bd47a383fb.png&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F7faf51d74e928b0f05e9f1bd47a383fb.png&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F7faf51d74e928b0f05e9f1bd47a383fb.png&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F7faf51d74e928b0f05e9f1bd47a383fb.png&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F7faf51d74e928b0f05e9f1bd47a383fb.png&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div><div class="jss101"><div class="jss106"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:31.020408163265305%"></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fa9ecbafa2f573d43302a20eaad481432.png&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fa9ecbafa2f573d43302a20eaad481432.png&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fa9ecbafa2f573d43302a20eaad481432.png&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fa9ecbafa2f573d43302a20eaad481432.png&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fa9ecbafa2f573d43302a20eaad481432.png&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fa9ecbafa2f573d43302a20eaad481432.png&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fa9ecbafa2f573d43302a20eaad481432.png&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fa9ecbafa2f573d43302a20eaad481432.png&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2Fa9ecbafa2f573d43302a20eaad481432.png&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div><div class="jss101"><div class="jss106"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:42.04081632653061%"></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F6099884b3c0018707432abb44ec93010.png&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F6099884b3c0018707432abb44ec93010.png&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F6099884b3c0018707432abb44ec93010.png&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F6099884b3c0018707432abb44ec93010.png&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F6099884b3c0018707432abb44ec93010.png&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F6099884b3c0018707432abb44ec93010.png&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F6099884b3c0018707432abb44ec93010.png&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F6099884b3c0018707432abb44ec93010.png&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F6099884b3c0018707432abb44ec93010.png&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div><div class="jss101"><div class="jss106"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:29.795918367346943%"></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F5d6b2c4399f25930fd66947ffbf36e2e.webp&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F5d6b2c4399f25930fd66947ffbf36e2e.webp&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F5d6b2c4399f25930fd66947ffbf36e2e.webp&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F5d6b2c4399f25930fd66947ffbf36e2e.webp&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F5d6b2c4399f25930fd66947ffbf36e2e.webp&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F5d6b2c4399f25930fd66947ffbf36e2e.webp&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F5d6b2c4399f25930fd66947ffbf36e2e.webp&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F5d6b2c4399f25930fd66947ffbf36e2e.webp&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F5d6b2c4399f25930fd66947ffbf36e2e.webp&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div><div class="jss101"><div class="jss106"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:33.46938775510204%"></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F23c4f79230117bc63aa2a27c22e0116b.webp&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F23c4f79230117bc63aa2a27c22e0116b.webp&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F23c4f79230117bc63aa2a27c22e0116b.webp&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F23c4f79230117bc63aa2a27c22e0116b.webp&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F23c4f79230117bc63aa2a27c22e0116b.webp&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F23c4f79230117bc63aa2a27c22e0116b.webp&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F23c4f79230117bc63aa2a27c22e0116b.webp&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F23c4f79230117bc63aa2a27c22e0116b.webp&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fbarometer.ams3.digitaloceanspaces.com%2F23c4f79230117bc63aa2a27c22e0116b.webp&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div></div></div></div></div></div><h5 class="MuiTypography-root jss98 MuiTypography-h5 MuiTypography-colorPrimary">Become our sponsor</h5><div class="jss102"><p class="MuiTypography-root MuiTypography-body1">Help us to keep the MS Barometer alive. Send us a gift by clicking on the ‘Donate’ button below or contact our Development and Fundraising Manager via email at <a href="/cdn-cgi/l/email-protection#ee8a8b8c878f80858fc0839b85868b9c848b8bae8b839d9ec0819c89"> <span class="__cf_email__" data-cfemail="debabbbcb7bfb0b5bff0b3abb5b6bbacb4bbbb9ebbb3adaef0b1acb9">[email protected]</span> </a> to learn more about how to become a sponsor of the MS Barometer.</p></div><a href="https://donate.emsp.org/" target="_blank" class="jss103"><button class="MuiButtonBase-root MuiButton-root MuiButton-contained MuiButton-containedPrimary MuiButton-disableElevation" tabindex="0" type="button"><span class="MuiButton-label">Donate</span></button></a></div><div class="jss107"></div><div class="jss6"><div class="jss7"><div class="MuiGrid-root jss109 MuiGrid-container"><div class="MuiGrid-root jss108 MuiGrid-item MuiGrid-grid-md-3"><div class="jss110"><a href="https://www.emsp.org" target="_blank"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%2780%27%20height=%2740%27/%3e"/></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" class="jss111" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img srcSet="/_next/image?url=%2FEMSP.png&w=96&q=75 1x, /_next/image?url=%2FEMSP.png&w=256&q=75 2x" src="/_next/image?url=%2FEMSP.png&w=256&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="jss111" loading="lazy"/></noscript></span></a><div class="jss114"></div><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%2750%27%20height=%2750%27/%3e"/></span><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" class="jss111" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img srcSet="/logo.svg 1x, /logo.svg 2x" src="/logo.svg" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="jss111" loading="lazy"/></noscript></span></div><span class="MuiTypography-root MuiTypography-caption"><button class="MuiButtonBase-root MuiIconButton-root" tabindex="0" type="button" title="Visit EMSP.org"><span class="MuiIconButton-label"><svg class="MuiSvgIcon-root" focusable="false" viewBox="0 0 24 24" aria-hidden="true"><path d="M11.99 2C6.47 2 2 6.48 2 12s4.47 10 9.99 10C17.52 22 22 17.52 22 12S17.52 2 11.99 2zm6.93 6h-2.95c-.32-1.25-.78-2.45-1.38-3.56 1.84.63 3.37 1.91 4.33 3.56zM12 4.04c.83 1.2 1.48 2.53 1.91 3.96h-3.82c.43-1.43 1.08-2.76 1.91-3.96zM4.26 14C4.1 13.36 4 12.69 4 12s.1-1.36.26-2h3.38c-.08.66-.14 1.32-.14 2 0 .68.06 1.34.14 2H4.26zm.82 2h2.95c.32 1.25.78 2.45 1.38 3.56-1.84-.63-3.37-1.9-4.33-3.56zm2.95-8H5.08c.96-1.66 2.49-2.93 4.33-3.56C8.81 5.55 8.35 6.75 8.03 8zM12 19.96c-.83-1.2-1.48-2.53-1.91-3.96h3.82c-.43 1.43-1.08 2.76-1.91 3.96zM14.34 14H9.66c-.09-.66-.16-1.32-.16-2 0-.68.07-1.35.16-2h4.68c.09.65.16 1.32.16 2 0 .68-.07 1.34-.16 2zm.25 5.56c.6-1.11 1.06-2.31 1.38-3.56h2.95c-.96 1.65-2.49 2.93-4.33 3.56zM16.36 14c.08-.66.14-1.32.14-2 0-.68-.06-1.34-.14-2h3.38c.16.64.26 1.31.26 2s-.1 1.36-.26 2h-3.38z"></path></svg></span></button><button class="MuiButtonBase-root MuiIconButton-root" tabindex="0" type="button" title="EMSP on Facebook"><span class="MuiIconButton-label"><svg class="MuiSvgIcon-root" focusable="false" viewBox="0 0 24 24" aria-hidden="true"><path d="M5 3h14a2 2 0 0 1 2 2v14a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V5a2 2 0 0 1 2-2m13 2h-2.5A3.5 3.5 0 0 0 12 8.5V11h-2v3h2v7h3v-7h3v-3h-3V9a1 1 0 0 1 1-1h2V5z"></path></svg></span></button><button class="MuiButtonBase-root MuiIconButton-root" tabindex="0" type="button" title="EMSP on Youtube"><span class="MuiIconButton-label"><svg class="MuiSvgIcon-root" focusable="false" viewBox="0 0 24 24" aria-hidden="true"><path d="M10 15l5.19-3L10 9v6m11.56-7.83c.13.47.22 1.1.28 1.9.07.8.1 1.49.1 2.09L22 12c0 2.19-.16 3.8-.44 4.83-.25.9-.83 1.48-1.73 1.73-.47.13-1.33.22-2.65.28-1.3.07-2.49.1-3.59.1L12 19c-4.19 0-6.8-.16-7.83-.44-.9-.25-1.48-.83-1.73-1.73-.13-.47-.22-1.1-.28-1.9-.07-.8-.1-1.49-.1-2.09L2 12c0-2.19.16-3.8.44-4.83.25-.9.83-1.48 1.73-1.73.47-.13 1.33-.22 2.65-.28 1.3-.07 2.49-.1 3.59-.1L12 5c4.19 0 6.8.16 7.83.44.9.25 1.48.83 1.73 1.73z"></path></svg></span></button><button class="MuiButtonBase-root MuiIconButton-root" tabindex="0" type="button" title="EMSP on Instagram"><span class="MuiIconButton-label"><svg class="MuiSvgIcon-root" focusable="false" viewBox="0 0 24 24" aria-hidden="true"><path d="M7.8 2h8.4C19.4 2 22 4.6 22 7.8v8.4a5.8 5.8 0 0 1-5.8 5.8H7.8C4.6 22 2 19.4 2 16.2V7.8A5.8 5.8 0 0 1 7.8 2m-.2 2A3.6 3.6 0 0 0 4 7.6v8.8C4 18.39 5.61 20 7.6 20h8.8a3.6 3.6 0 0 0 3.6-3.6V7.6C20 5.61 18.39 4 16.4 4H7.6m9.65 1.5a1.25 1.25 0 0 1 1.25 1.25A1.25 1.25 0 0 1 17.25 8 1.25 1.25 0 0 1 16 6.75a1.25 1.25 0 0 1 1.25-1.25M12 7a5 5 0 0 1 5 5 5 5 0 0 1-5 5 5 5 0 0 1-5-5 5 5 0 0 1 5-5m0 2a3 3 0 0 0-3 3 3 3 0 0 0 3 3 3 3 0 0 0 3-3 3 3 0 0 0-3-3z"></path></svg></span></button><button class="MuiButtonBase-root MuiIconButton-root" tabindex="0" type="button" title="EMSP on Twitter"><span class="MuiIconButton-label"><svg class="MuiSvgIcon-root" focusable="false" viewBox="0 0 24 24" aria-hidden="true"><path d="M22.46 6c-.77.35-1.6.58-2.46.69.88-.53 1.56-1.37 1.88-2.38-.83.5-1.75.85-2.72 1.05C18.37 4.5 17.26 4 16 4c-2.35 0-4.27 1.92-4.27 4.29 0 .34.04.67.11.98C8.28 9.09 5.11 7.38 3 4.79c-.37.63-.58 1.37-.58 2.15 0 1.49.75 2.81 1.91 3.56-.71 0-1.37-.2-1.95-.5v.03c0 2.08 1.48 3.82 3.44 4.21a4.22 4.22 0 0 1-1.93.07 4.28 4.28 0 0 0 4 2.98 8.521 8.521 0 0 1-5.33 1.84c-.34 0-.68-.02-1.02-.06C3.44 20.29 5.7 21 8.12 21 16 21 20.33 14.46 20.33 8.79c0-.19 0-.37-.01-.56.84-.6 1.56-1.36 2.14-2.23z"></path></svg></span></button><button class="MuiButtonBase-root MuiIconButton-root" tabindex="0" type="button" title="EMSP on LinkedIn"><span class="MuiIconButton-label"><svg class="MuiSvgIcon-root" focusable="false" viewBox="0 0 24 24" aria-hidden="true"><path d="M19 3a2 2 0 0 1 2 2v14a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V5a2 2 0 0 1 2-2h14m-.5 15.5v-5.3a3.26 3.26 0 0 0-3.26-3.26c-.85 0-1.84.52-2.32 1.3v-1.11h-2.79v8.37h2.79v-4.93c0-.77.62-1.4 1.39-1.4a1.4 1.4 0 0 1 1.4 1.4v4.93h2.79M6.88 8.56a1.68 1.68 0 0 0 1.68-1.68c0-.93-.75-1.69-1.68-1.69a1.69 1.69 0 0 0-1.69 1.69c0 .93.76 1.68 1.69 1.68m1.39 9.94v-8.37H5.5v8.37h2.77z"></path></svg></span></button></span></div><div class="MuiGrid-root jss108 MuiGrid-item MuiGrid-grid-xs-12 MuiGrid-grid-md-3"><span color="primary" class="jss112">ADDRESS</span>Rue Auguste Lambiotte 144/8 <br/> 1030 Brussels | Belgium<span color="primary" class="jss112">EMAIL</span><a href="/cdn-cgi/l/email-protection#60130503120514011209011420050d13104e0f1207"><p class="MuiTypography-root MuiTypography-body2 MuiTypography-colorPrimary"><span class="__cf_email__" data-cfemail="b1c2d4d2c3d4c5d0c3d8d0c5f1d4dcc2c19fdec3d6">[email protected]</span></p></a></div><div class="MuiGrid-root jss108 MuiGrid-item MuiGrid-grid-xs-6 MuiGrid-grid-md-3"><span color="primary" class="jss112">Site</span><p class="MuiTypography-root jss113 MuiTypography-body1 MuiTypography-colorPrimary">Findings</p><p class="MuiTypography-root jss113 MuiTypography-body1 MuiTypography-colorPrimary">Comparison</p><p class="MuiTypography-root jss113 MuiTypography-body1 MuiTypography-colorPrimary">Country Data</p><p class="MuiTypography-root jss113 MuiTypography-body1 MuiTypography-colorPrimary">Advocacy Toolkit</p><p class="MuiTypography-root jss113 MuiTypography-body1 MuiTypography-colorPrimary">FAQ</p></div></div></div></div><div class="jss107"></div></div></section></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script id="__NEXT_DATA__" type="application/json">{"props":{"props":{},"__N_SSG":true,"pageProps":{"barometer":{"id":3,"index":{"id":4,"title":"","content":"","created_at":"2021-06-02T08:39:53.543Z","updated_at":"2021-06-14T19:37:04.158Z"},"year":"2020","slug":null,"newsletter":null,"report":{"id":3,"description":"The MS Barometer is a comparative survey collecting key information on Multiple Sclerosis (MS) in 35 countries. \n\nIt serves as a benchmarking tool to provide an accurate picture of MS management across health and social care systems. \n\nWe see issues in access to appropriate healthcare, health professionals and social support for people with MS and their carers across the continent. \n\nCountries that fail to provide quality care are failing their MS communities.","created_at":"2021-06-14T15:46:45.218Z","updated_at":"2021-06-14T19:36:50.758Z","mockup":{"id":212,"name":"mockup_small.png","alternativeText":null,"caption":null,"width":834,"height":730,"formats":{"small":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/11bc0c9597b727c909033a4cbd23b40e.png","hash":"11bc0c9597b727c909033a4cbd23b40e","mime":"image/png","name":"small_mockup_small.png","path":null,"size":251.26,"width":500,"height":438},"medium":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/d6a67aa4a02d930b05f475a9cd5eb5f0.png","hash":"d6a67aa4a02d930b05f475a9cd5eb5f0","mime":"image/png","name":"medium_mockup_small.png","path":null,"size":521.9,"width":750,"height":656},"thumbnail":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/78a9dd680d25fcbdaa40b50091153ec2.png","hash":"78a9dd680d25fcbdaa40b50091153ec2","mime":"image/png","name":"thumbnail_mockup_small.png","path":null,"size":41.89,"width":178,"height":156}},"hash":"40b2878f9345e1f497463cd65ee946fb","ext":".png","mime":"image/png","size":118.07,"url":"https://barometer.ams3.digitaloceanspaces.com/40b2878f9345e1f497463cd65ee946fb.png","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-14T15:46:42.969Z","updated_at":"2021-06-14T15:46:42.969Z"},"PDF":{"id":211,"name":"MSBarometer2020Web.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"55ac809262a6e9ad124ecb0dc813d225","ext":".pdf","mime":"application/pdf","size":2089.85,"url":"https://barometer.ams3.digitaloceanspaces.com/55ac809262a6e9ad124ecb0dc813d225.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-14T15:46:30.237Z","updated_at":"2021-06-14T15:46:30.237Z"}},"article":null,"donate":null,"cta":null,"countryStructure":{"id":3,"created_at":"2021-05-28T18:15:52.984Z","updated_at":"2021-05-28T18:15:52.984Z","items":[{"id":32,"displayName":"Employed","excelName":"EMP_CHART_EMP","description":null,"dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-06-03T08:51:53.469Z","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z"},"visible":false,"highlight":null,"order":1},{"id":33,"displayName":"Part-time employed","excelName":"EMP_CHART_PART","description":null,"dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-06-03T08:51:53.469Z","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z"},"visible":null,"highlight":null,"order":2},{"id":34,"displayName":"Full-time employed","excelName":"EMP_CHART_FULL","description":null,"dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-06-03T08:51:53.469Z","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z"},"visible":null,"highlight":null,"order":3},{"id":31,"displayName":"People with MS","excelName":"GEN_PEOPMS","description":null,"dataset":{"id":27,"name":"General","units":"People","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:48:31.798Z","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z"},"visible":true,"highlight":true,"order":5},{"id":35,"displayName":"Total score","excelName":"TOT_TOT","description":null,"dataset":{"id":29,"name":"Total score","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-06-09T11:18:04.745Z","created_at":"2021-06-09T11:18:04.763Z","updated_at":"2021-06-09T11:18:04.763Z"},"visible":true,"highlight":true,"order":6},{"id":7,"displayName":"Disease-modifying drugs","excelName":"TOT_DMD","description":null,"dataset":{"id":8,"name":"F1 Total scores","units":null,"possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T18:13:32.827Z","created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z"},"visible":false,"highlight":false,"order":7},{"id":8,"displayName":"Research","excelName":"TOT_RES","description":null,"dataset":{"id":8,"name":"F1 Total scores","units":null,"possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T18:13:32.827Z","created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z"},"visible":false,"highlight":null,"order":8},{"id":10,"displayName":"Policy","excelName":"TOT_POL","description":null,"dataset":{"id":8,"name":"F1 Total scores","units":null,"possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T18:13:32.827Z","created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z"},"visible":null,"highlight":null,"order":9},{"id":12,"displayName":"Optimal care delivery","excelName":"TOT_OCD","description":null,"dataset":{"id":8,"name":"F1 Total scores","units":null,"possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T18:13:32.827Z","created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z"},"visible":null,"highlight":null,"order":10},{"id":13,"displayName":"Employment and social support","excelName":"TOT_EMP","description":null,"dataset":{"id":8,"name":"F1 Total scores","units":null,"possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T18:13:32.827Z","created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z"},"visible":null,"highlight":null,"order":11},{"id":15,"displayName":"Rehabilitation","excelName":"TOT_REH","description":null,"dataset":{"id":8,"name":"F1 Total scores","units":null,"possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T18:13:32.827Z","created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z"},"visible":null,"highlight":null,"order":12},{"id":14,"displayName":"Paediatric MS","excelName":"TOT_PAED","description":null,"dataset":{"id":8,"name":"F1 Total scores","units":null,"possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T18:13:32.827Z","created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z"},"visible":false,"highlight":false,"order":13},{"id":16,"displayName":"Symptomatic treatments","excelName":"TOT_SYTR","description":null,"dataset":{"id":8,"name":"F1 Total scores","units":null,"possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T18:13:32.827Z","created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z"},"visible":null,"highlight":null,"order":14},{"id":11,"displayName":"National scores on MS policy","excelName":"POLICY_SCR","description":null,"dataset":{"id":9,"name":"F2 Policy scores","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T19:39:27.147Z","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z"},"visible":true,"highlight":true,"order":15},{"id":17,"displayName":"Chronic disease policy","excelName":"DISEASE_POL","description":" Existence reported for a chronic disease policy or neurological disease policy that includes MS","dataset":{"id":10,"name":"F3 Disease policy","units":null,"possibleValues":"string","datasetType":"country","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"],"published_at":"2021-05-28T19:47:00.923Z","created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z"},"visible":true,"highlight":null,"order":16},{"id":18,"displayName":"MS in policy consultation","excelName":"CON_MS","description":null,"dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","possibleValues":"string","datasetType":"country","possibleAnswers":["Does include","Does not include"],"published_at":"2021-05-29T09:06:48.342Z","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z"},"visible":true,"highlight":false,"order":17},{"id":19,"displayName":"Scores on care delivery","excelName":"SCR_CARED","description":null,"dataset":{"id":13,"name":"F5 Care delivery","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:08:47.232Z","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z"},"visible":true,"highlight":true,"order":18},{"id":20,"displayName":"National score on DMD","excelName":"NAT_DMD","description":null,"dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:20:58.740Z","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z"},"visible":true,"highlight":false,"order":19},{"id":21,"displayName":"National score on symptomatic treatments","excelName":"NAT_SYMT","description":null,"dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:26:34.089Z","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z"},"visible":true,"highlight":null,"order":20},{"id":22,"displayName":"Availability of palliative care","excelName":"PAL_CARE","description":null,"dataset":{"id":18,"name":"F 11 Pallative care","units":null,"possibleValues":"string","datasetType":"country","possibleAnswers":["yes","no"],"published_at":"2021-05-29T09:27:53.858Z","created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z"},"visible":true,"highlight":null,"order":21},{"id":23,"displayName":"National score on rehabilitaton","excelName":"NAT_REHAB","description":null,"dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:40:27.840Z","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z"},"visible":true,"highlight":null,"order":22},{"id":28,"displayName":"National score on research","excelName":"NAT_RES","description":null,"dataset":{"id":24,"name":"F17 Nat Research","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:23:25.369Z","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z"},"visible":true,"highlight":null,"order":23},{"id":29,"displayName":"Diease registry","excelName":"DIS_REG","description":null,"dataset":{"id":25,"name":"F18 Disease registry ","units":null,"possibleValues":"string","datasetType":"country","possibleAnswers":["National","Local or regional ","None"],"published_at":"2021-05-30T10:25:40.789Z","created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z"},"visible":true,"highlight":null,"order":24},{"id":24,"displayName":"National score on Employment","excelName":"NAT_EMPSOC","description":null,"dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:19:04.534Z","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z"},"visible":true,"highlight":true,"order":25},{"id":27,"displayName":"Employment","excelName":"EMP_EMP","description":null,"dataset":{"id":23,"name":"F16 Employment","units":"%","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:22:38.176Z","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z"},"visible":true,"highlight":false,"order":26},{"id":25,"displayName":"Full-time employment","excelName":"EMP_FULL","description":null,"dataset":{"id":23,"name":"F16 Employment","units":"%","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:22:38.176Z","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z"},"visible":true,"highlight":null,"order":27},{"id":26,"displayName":"Part-time employment","excelName":"EMP_PART","description":null,"dataset":{"id":23,"name":"F16 Employment","units":"%","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:22:38.176Z","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z"},"visible":true,"highlight":null,"order":28},{"id":30,"displayName":"Population","excelName":"GEN_POP","description":null,"dataset":{"id":27,"name":"General","units":"People","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:48:31.798Z","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z"},"visible":true,"highlight":true,"order":4}]},"public":true,"published_at":"2021-05-27T21:50:27.221Z","created_at":"2021-05-27T21:50:27.225Z","updated_at":"2021-06-14T15:46:45.559Z","sponsors":[{"id":27,"description":null,"title":"Novartis","created_at":"2021-06-09T10:37:23.841Z","updated_at":"2021-06-09T10:37:23.841Z","logo":{"id":195,"name":"Novartis Pharmaceuticals.png","alternativeText":null,"caption":null,"width":3171,"height":826,"formats":{"large":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/015cba54708c55f3f0e9b2fd9d96b89e.png","hash":"015cba54708c55f3f0e9b2fd9d96b89e","mime":"image/png","name":"large_Novartis Pharmaceuticals.png","path":null,"size":140.06,"width":1000,"height":260},"small":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/fc3cf0ad376beaa984f231d7b0ee8b4a.png","hash":"fc3cf0ad376beaa984f231d7b0ee8b4a","mime":"image/png","name":"small_Novartis Pharmaceuticals.png","path":null,"size":56.82,"width":500,"height":130},"medium":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/f8b0a411d8150c9b295ab2b4888beec1.png","hash":"f8b0a411d8150c9b295ab2b4888beec1","mime":"image/png","name":"medium_Novartis Pharmaceuticals.png","path":null,"size":97.25,"width":750,"height":195},"thumbnail":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/83892c21171cf84d4750fa6c6173a91e.png","hash":"83892c21171cf84d4750fa6c6173a91e","mime":"image/png","name":"thumbnail_Novartis Pharmaceuticals.png","path":null,"size":21.13,"width":245,"height":64}},"hash":"fe84a00b1615185f6c70bcab43cab79f","ext":".png","mime":"image/png","size":127.1,"url":"https://barometer.ams3.digitaloceanspaces.com/fe84a00b1615185f6c70bcab43cab79f.png","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-09T10:37:27.466Z","updated_at":"2021-06-09T10:37:27.466Z"}},{"id":25,"description":null,"title":"Merck","created_at":"2021-06-09T10:35:51.531Z","updated_at":"2021-06-09T10:35:51.531Z","logo":{"id":193,"name":"Logo_Merck_KGaA_2015.png","alternativeText":null,"caption":null,"width":2223,"height":356,"formats":{"large":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/daa49d3036e44cd17214f33554f7e5f8.png","hash":"daa49d3036e44cd17214f33554f7e5f8","mime":"image/png","name":"large_Logo_Merck_KGaA_2015.png","path":null,"size":30.02,"width":1000,"height":160},"small":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/07f1bc3c3541b485875bad5119792052.png","hash":"07f1bc3c3541b485875bad5119792052","mime":"image/png","name":"small_Logo_Merck_KGaA_2015.png","path":null,"size":14.41,"width":500,"height":80},"medium":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/3f674f5a5f594ae3243837c9698b8cc8.png","hash":"3f674f5a5f594ae3243837c9698b8cc8","mime":"image/png","name":"medium_Logo_Merck_KGaA_2015.png","path":null,"size":21.7,"width":750,"height":120},"thumbnail":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/1d9894159b2cd72632666b47cfbb367f.png","hash":"1d9894159b2cd72632666b47cfbb367f","mime":"image/png","name":"thumbnail_Logo_Merck_KGaA_2015.png","path":null,"size":6.8,"width":245,"height":39}},"hash":"0881ae2cee71337ef95d532a8b862cc4","ext":".png","mime":"image/png","size":21.69,"url":"https://barometer.ams3.digitaloceanspaces.com/0881ae2cee71337ef95d532a8b862cc4.png","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-09T10:35:53.507Z","updated_at":"2021-06-09T10:35:53.507Z"}},{"id":24,"description":null,"title":"Med Day","created_at":"2021-06-09T10:35:00.805Z","updated_at":"2021-06-09T10:35:00.805Z","logo":{"id":192,"name":"logo-medday.png","alternativeText":null,"caption":null,"width":3559,"height":1314,"formats":{"large":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/0aa4d8ac94eb4a712542022dd45f7d33.png","hash":"0aa4d8ac94eb4a712542022dd45f7d33","mime":"image/png","name":"large_logo-medday.png","path":null,"size":55.24,"width":1000,"height":369},"small":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/4322154a310c96176d24bbfd9ac69b80.png","hash":"4322154a310c96176d24bbfd9ac69b80","mime":"image/png","name":"small_logo-medday.png","path":null,"size":22.75,"width":500,"height":185},"medium":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/8da29a555eb86d96b8d15a8123caa051.png","hash":"8da29a555eb86d96b8d15a8123caa051","mime":"image/png","name":"medium_logo-medday.png","path":null,"size":38.58,"width":750,"height":277},"thumbnail":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/4c4cbfca38f805d774e2aab5f3d56647.png","hash":"4c4cbfca38f805d774e2aab5f3d56647","mime":"image/png","name":"thumbnail_logo-medday.png","path":null,"size":9.4,"width":245,"height":90}},"hash":"fabc5a1a0b17e676ad5619978cb03a60","ext":".png","mime":"image/png","size":40.03,"url":"https://barometer.ams3.digitaloceanspaces.com/fabc5a1a0b17e676ad5619978cb03a60.png","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-09T10:35:05.950Z","updated_at":"2021-06-09T10:35:05.950Z"}},{"id":22,"description":null,"title":"BMS","created_at":"2021-06-09T10:32:33.737Z","updated_at":"2021-06-09T10:32:33.737Z","logo":{"id":190,"name":"LOGO_BMS.webp","alternativeText":null,"caption":null,"width":1502,"height":208,"formats":{"large":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/44ebaf6368aac6b577a2150ad93fb3ca.webp","hash":"44ebaf6368aac6b577a2150ad93fb3ca","mime":"image/webp","name":"large_LOGO_BMS.webp","path":null,"size":18.23,"width":1000,"height":138},"small":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/ef9982b049a1410f8d3fdf005d612d4f.webp","hash":"ef9982b049a1410f8d3fdf005d612d4f","mime":"image/webp","name":"small_LOGO_BMS.webp","path":null,"size":7.91,"width":500,"height":69},"medium":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/ff9bb1455409f3b629a93230dab120c3.webp","hash":"ff9bb1455409f3b629a93230dab120c3","mime":"image/webp","name":"medium_LOGO_BMS.webp","path":null,"size":11,"width":750,"height":104},"thumbnail":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/c16d498b0087e7f0ac206ecd3fdac868.webp","hash":"c16d498b0087e7f0ac206ecd3fdac868","mime":"image/webp","name":"thumbnail_LOGO_BMS.webp","path":null,"size":3.78,"width":245,"height":34}},"hash":"ac7471ecaf114c42f814a3521d9ac1c9","ext":".webp","mime":"image/webp","size":14.55,"url":"https://barometer.ams3.digitaloceanspaces.com/ac7471ecaf114c42f814a3521d9ac1c9.webp","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-09T10:32:35.022Z","updated_at":"2021-06-09T10:32:35.022Z"}},{"id":30,"description":null,"title":"Sanofi genzyme","created_at":"2021-06-09T10:40:34.876Z","updated_at":"2021-06-09T10:40:34.876Z","logo":{"id":198,"name":"Sanofi-Genzyme-RGB-Colors.png","alternativeText":null,"caption":null,"width":969,"height":113,"formats":{"small":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/4870f9ef7c08a6b9a126d9f62d4db7f5.png","hash":"4870f9ef7c08a6b9a126d9f62d4db7f5","mime":"image/png","name":"small_Sanofi-Genzyme-RGB-Colors.png","path":null,"size":15,"width":500,"height":58},"medium":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/05c05b68626ebd7e8d18fdfdcceeedc5.png","hash":"05c05b68626ebd7e8d18fdfdcceeedc5","mime":"image/png","name":"medium_Sanofi-Genzyme-RGB-Colors.png","path":null,"size":24.4,"width":750,"height":87},"thumbnail":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/7faf51d74e928b0f05e9f1bd47a383fb.png","hash":"7faf51d74e928b0f05e9f1bd47a383fb","mime":"image/png","name":"thumbnail_Sanofi-Genzyme-RGB-Colors.png","path":null,"size":6.69,"width":245,"height":29}},"hash":"8b30a03fb445e82b6ec31b56af81e5eb","ext":".png","mime":"image/png","size":8.07,"url":"https://barometer.ams3.digitaloceanspaces.com/8b30a03fb445e82b6ec31b56af81e5eb.png","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-09T10:40:35.623Z","updated_at":"2021-06-09T10:40:35.623Z"}},{"id":20,"description":null,"title":"almirall","created_at":"2021-06-09T10:31:17.892Z","updated_at":"2021-06-09T10:31:17.892Z","logo":{"id":188,"name":"ALM_AW_LOGO_MV_Positive_RGB.png","alternativeText":null,"caption":null,"width":533,"height":166,"formats":{"small":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/d00fcbd099c6096148cd875fae2c12de.png","hash":"d00fcbd099c6096148cd875fae2c12de","mime":"image/png","name":"small_ALM_AW_LOGO_MV_Positive_RGB.png","path":null,"size":17.52,"width":500,"height":156},"thumbnail":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/a9ecbafa2f573d43302a20eaad481432.png","hash":"a9ecbafa2f573d43302a20eaad481432","mime":"image/png","name":"thumbnail_ALM_AW_LOGO_MV_Positive_RGB.png","path":null,"size":7.96,"width":245,"height":76}},"hash":"d53a7f6b1be53f3b1e6302e31840a10a","ext":".png","mime":"image/png","size":4.82,"url":"https://barometer.ams3.digitaloceanspaces.com/d53a7f6b1be53f3b1e6302e31840a10a.png","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-09T10:31:18.544Z","updated_at":"2021-06-09T10:31:18.544Z"}},{"id":29,"description":null,"title":"Roche","created_at":"2021-06-09T10:39:36.788Z","updated_at":"2021-06-09T10:39:36.788Z","logo":{"id":197,"name":"Roche_Logo.png","alternativeText":null,"caption":null,"width":2360,"height":990,"formats":{"large":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/96fbf6b8f7ae92c6c4c9a1025c92301a.png","hash":"96fbf6b8f7ae92c6c4c9a1025c92301a","mime":"image/png","name":"large_Roche_Logo.png","path":null,"size":54.78,"width":1000,"height":419},"small":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/59cc810240346aa15afc7859f83caae6.png","hash":"59cc810240346aa15afc7859f83caae6","mime":"image/png","name":"small_Roche_Logo.png","path":null,"size":23.84,"width":500,"height":210},"medium":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/290425aad95d2dbad7438bf72343e8e2.png","hash":"290425aad95d2dbad7438bf72343e8e2","mime":"image/png","name":"medium_Roche_Logo.png","path":null,"size":38.64,"width":750,"height":315},"thumbnail":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/6099884b3c0018707432abb44ec93010.png","hash":"6099884b3c0018707432abb44ec93010","mime":"image/png","name":"thumbnail_Roche_Logo.png","path":null,"size":9.63,"width":245,"height":103}},"hash":"c8861e4222059ba6d72fc753f9cea12f","ext":".png","mime":"image/png","size":26.78,"url":"https://barometer.ams3.digitaloceanspaces.com/c8861e4222059ba6d72fc753f9cea12f.png","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-09T10:39:40.913Z","updated_at":"2021-06-09T10:39:40.913Z"}},{"id":26,"description":null,"title":"Mylan","created_at":"2021-06-09T10:36:55.083Z","updated_at":"2021-06-09T10:36:55.083Z","logo":{"id":194,"name":"2000px-Mylan_Logo.svg.webp","alternativeText":null,"caption":null,"width":2000,"height":592,"formats":{"large":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/9d0c392f6daf364616d04985ae85c501.webp","hash":"9d0c392f6daf364616d04985ae85c501","mime":"image/webp","name":"large_2000px-Mylan_Logo.svg.webp","path":null,"size":14.34,"width":1000,"height":296},"small":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/b0d434fdf4d075fbae2126f482aba4f9.webp","hash":"b0d434fdf4d075fbae2126f482aba4f9","mime":"image/webp","name":"small_2000px-Mylan_Logo.svg.webp","path":null,"size":7.23,"width":500,"height":148},"medium":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/b2a244e2922997eecc78105b95b6c66a.webp","hash":"b2a244e2922997eecc78105b95b6c66a","mime":"image/webp","name":"medium_2000px-Mylan_Logo.svg.webp","path":null,"size":10.69,"width":750,"height":222},"thumbnail":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/5d6b2c4399f25930fd66947ffbf36e2e.webp","hash":"5d6b2c4399f25930fd66947ffbf36e2e","mime":"image/webp","name":"thumbnail_2000px-Mylan_Logo.svg.webp","path":null,"size":3.88,"width":245,"height":73}},"hash":"2944a6bdb488fb0bf289aa4e486e9ce3","ext":".webp","mime":"image/webp","size":17,"url":"https://barometer.ams3.digitaloceanspaces.com/2944a6bdb488fb0bf289aa4e486e9ce3.webp","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-09T10:36:57.746Z","updated_at":"2021-06-09T10:36:57.746Z"}},{"id":21,"description":null,"title":"Biogen","created_at":"2021-06-09T10:31:56.495Z","updated_at":"2021-06-09T10:31:56.495Z","logo":{"id":189,"name":"biogen.webp","alternativeText":null,"caption":null,"width":3053,"height":1019,"formats":{"large":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/8d604b6fcd3e2e48811942bcb357818b.webp","hash":"8d604b6fcd3e2e48811942bcb357818b","mime":"image/webp","name":"large_biogen.webp","path":null,"size":27.09,"width":1000,"height":334},"small":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/a9a44db340ff971a564a1efc68691243.webp","hash":"a9a44db340ff971a564a1efc68691243","mime":"image/webp","name":"small_biogen.webp","path":null,"size":13.81,"width":500,"height":167},"medium":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/59481a3db3000126b977a12f97ee51f8.webp","hash":"59481a3db3000126b977a12f97ee51f8","mime":"image/webp","name":"medium_biogen.webp","path":null,"size":21.47,"width":750,"height":250},"thumbnail":{"ext":".webp","url":"https://barometer.ams3.digitaloceanspaces.com/23c4f79230117bc63aa2a27c22e0116b.webp","hash":"23c4f79230117bc63aa2a27c22e0116b","mime":"image/webp","name":"thumbnail_biogen.webp","path":null,"size":7.1,"width":245,"height":82}},"hash":"a9fb7d1265cd53cd8cfa585f11491596","ext":".webp","mime":"image/webp","size":31.19,"url":"https://barometer.ams3.digitaloceanspaces.com/a9fb7d1265cd53cd8cfa585f11491596.webp","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-09T10:31:59.688Z","updated_at":"2021-06-09T10:31:59.688Z"}}],"advocacies":[],"countries":[{"id":45,"added":true,"country":{"id":10,"countryName":"Denmark","alpha2":"DK","alpha3":"DNK","created_at":"2021-05-27T21:09:15.986Z","updated_at":"2021-05-27T21:09:15.986Z"},"values":[{"value":"13.2","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"13.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"5.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"83","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"9.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"5.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"15.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"8.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"76","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"78","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"71","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"89","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"5.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"82","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"39","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_FULL","description":null,"displayName":"Full-time employment"},{"value":"13","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_PART","description":null,"displayName":"Part-time employment"},{"value":"49","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"5700000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"16500","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"52","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"Chronic only","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"13","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_PART","description":null,"displayName":"Part-time employed"},{"value":"39","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_FULL","description":null,"displayName":"Full-time employed"},{"value":"76.7","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"The national plan for MS treatment and rehabilitation was developed\nin 2019 and will be implemented in 2020 and 2021, to ensure\nthat each person with MS receives annual access to a neurologist\nand MS nurse. The Danish MS registry provides a strong platform\nfor assessing access to and quality of care. However, gaps in MS\nmanagement remain:","countryContext":"In Denmark, citizens have good healthcare\ncoverage from a public insurance system;\nspending on health is higher than the\nEuropean Union average but lower than in\nother Nordic countries.(1)\nIndividual spending on out-of-pocket payments for medicines\nand physiotherapy is generally low. However, as service\nprovision and public health are organised at the regional\nand municipal levels, availability of services may\ndepend on where a person lives.","created_at":"2021-05-27T21:09:15.986Z","updated_at":"2021-05-27T21:09:15.986Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Denmark: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":59,"title":"2020 - Denmark Factsheet - EN","published":null,"published_at":"2021-05-28T16:28:37.869Z","created_at":"2021-05-28T16:28:37.882Z","updated_at":"2021-05-28T16:28:37.882Z","document":{"id":113,"name":"MS Barometer 2020_Country Factsheet_Denmark_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"a700dc1ee88a06927914512319fa6157","ext":".pdf","mime":"application/pdf","size":249.34,"url":"https://barometer.ams3.digitaloceanspaces.com/a700dc1ee88a06927914512319fa6157.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:28:38.168Z","updated_at":"2021-05-28T16:28:38.168Z"}},{"id":60,"title":"2020 - Denmark Factsheet - DA","published":null,"published_at":"2021-05-28T16:29:06.010Z","created_at":"2021-05-28T16:29:06.012Z","updated_at":"2021-05-28T16:29:06.012Z","document":{"id":114,"name":"MS Barometer 2020_Country Factsheet_Denmark_DA.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"edda14e2862ee9d519a638f5cdd120d0","ext":".pdf","mime":"application/pdf","size":253.67,"url":"https://barometer.ams3.digitaloceanspaces.com/edda14e2862ee9d519a638f5cdd120d0.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:29:06.143Z","updated_at":"2021-05-28T16:29:06.143Z"}}],"findings":[{"id":45,"title":"Only","description":"of people with MS\nreceive disease-modifying\ndrugs (DMDs) in Denmark,\nthe majority of whom have\nrelapsing-remitting MS.","highlightText":"48%","isHighlighted":true,"created_at":"2021-05-28T11:22:40.268Z","updated_at":"2021-05-28T11:22:40.268Z"},{"id":46,"title":"","description":"of people with\nprogressive MS see a\nneurology specialist less\nthan once a year.","highlightText":"60%","isHighlighted":true,"created_at":"2021-05-28T11:22:54.286Z","updated_at":"2021-05-28T11:22:54.286Z"},{"id":47,"title":"There are","description":"data available on the number\nof people with access to\ncognitive, psychological or\noccupational rehabilitation.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:23:44.431Z","updated_at":"2021-05-28T11:26:30.270Z"}],"recoms":[{"id":48,"title":"","description":"Ensure that all people with MS have annual\nappointments with a neurologist and the option to\nuse any approved DMD, without restrictions on age or\ntype of MS.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:23:59.194Z","updated_at":"2021-05-28T11:23:59.194Z"},{"id":49,"title":"","description":"Develop national guidelines for palliative care specific for\nMS with a cross-disciplinary group including representatives\nfrom the Danish Neurology Society, Danish MS nurses,\nDanish MS Hospitals and the Danish Knowledge Centre for\nRehabilitation and Palliative Care (Rehpa).","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:24:08.788Z","updated_at":"2021-05-28T11:24:08.788Z"},{"id":50,"title":"","description":"Dedicate funding for expanding outpatient\nrehabilitation services to include fully reimbursed\ncognitive, psychological and occupational support,\nand reduce any geographical inequalities in access to\nthese programmes.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:24:20.798Z","updated_at":"2021-05-28T11:24:20.798Z"}],"countryName":"Denmark","alpha2":"DK","alpha3":"DNK"},{"id":66,"added":true,"country":{"id":30,"countryName":"Serbia","alpha2":"RS","alpha3":"SRB","created_at":"2021-05-27T21:18:52.537Z","updated_at":"2021-05-27T21:18:52.537Z"},"values":[{"value":"8.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"11.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"4.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"67","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"10.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"1.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"12.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"7.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"87","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"52","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"64","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"71","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"1.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"66","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"13","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"8800000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"9000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"Local or regional ","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"57.8","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"In late 2019, Serbia approved reimbursement of almost all MS\ndisease-modifying drugs (DMDs), greatly improving access to these\nessential therapies. However, barriers to availability of DMDs, care and\nsupport persist:","countryContext":"Serbia has social health insurance providing near-universal\ncoverage.(1) However, this is supplemented\nby significant out-of-pocket spending, and unmet\nneeds persist as a result of geographical disparities\nbetween urban and rural regions, as well as a\nshortage of health specialists.","created_at":"2021-05-27T21:18:52.537Z","updated_at":"2021-05-27T21:18:52.537Z","references":"(1) European Observatory on Health Systems and Policies. 2019. Serbia: Health system review. WHO Europe","factsheets":[{"id":121,"title":"2020 - Serbia Factsheet - EN","published":null,"published_at":"2021-07-22T10:49:04.972Z","created_at":"2021-07-22T10:49:04.986Z","updated_at":"2021-07-22T10:49:04.986Z","document":{"id":310,"name":"MS Barometer 2020_Country Factsheet_Serbia_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"c3f9c783456f146bbc968cffd1953b89","ext":".pdf","mime":"application/pdf","size":635.11,"url":"https://barometer.ams3.digitaloceanspaces.com/c3f9c783456f146bbc968cffd1953b89.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-07-22T10:49:05.223Z","updated_at":"2021-07-22T10:49:05.223Z"}},{"id":122,"title":"2020 - Serbia Factsheet - SR","published":null,"published_at":"2021-07-22T10:49:22.818Z","created_at":"2021-07-22T10:49:22.823Z","updated_at":"2021-07-22T10:49:22.823Z","document":{"id":311,"name":"MS Barometer 2020_Country Factsheet_Serbia_SR.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"466e04b67d004effd585a81ab7b2ec6b","ext":".pdf","mime":"application/pdf","size":639.52,"url":"https://barometer.ams3.digitaloceanspaces.com/466e04b67d004effd585a81ab7b2ec6b.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-07-22T10:49:23.224Z","updated_at":"2021-07-22T10:49:23.224Z"}}],"findings":[{"id":171,"title":"Only an estimated","description":"of\npeople with MS are eligible\nfor DMDs.","highlightText":"30%","isHighlighted":true,"created_at":"2021-05-28T17:35:28.291Z","updated_at":"2021-05-28T17:35:28.291Z"},{"id":172,"title":"There is","description":"reimbursement\nfor therapies for key\nsymptoms, such as fatigue\nand pain.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T17:35:46.042Z","updated_at":"2021-05-28T17:35:46.042Z"},{"id":173,"title":"Serbia has","description":"legal provisions\nto protect people with MS\nagainst dismissal from\nemployment due to their\ncondition.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T17:36:03.091Z","updated_at":"2021-05-28T17:36:03.091Z"}],"recoms":[{"id":174,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:36:15.933Z","updated_at":"2021-05-28T17:36:15.933Z"},{"id":175,"title":"","description":"Increase awareness of the needs of people with\ndisabilities throughout the employment and education\nsystems, and establish legal protection against\ndismissal from employment due to disability.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:36:24.774Z","updated_at":"2021-05-28T17:36:24.774Z"},{"id":176,"title":"","description":"Revise reimbursement criteria to ensure all\npeople with MS can access approved DMDs and\nsymptomatic therapies at the point of diagnosis.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:36:56.770Z","updated_at":"2021-05-28T17:36:56.770Z"}],"countryName":"Serbia","alpha2":"RS","alpha3":"SRB"},{"id":73,"added":true,"country":{"id":3,"countryName":"United Kingdom","alpha2":"GB","alpha3":"GBR","created_at":"2021-05-19T11:40:59.769Z","updated_at":"2021-05-19T11:40:59.769Z"},"values":[{"value":"11.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"9.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"50","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"9.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"4.2","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"3.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"81","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"67","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"81","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"18","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"5.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"58","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"16","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_FULL","description":null,"displayName":"Full-time employment"},{"value":"14","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_PART","description":null,"displayName":"Part-time employment"},{"value":"36","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"67800000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"130000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"30","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"14","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_PART","description":null,"displayName":"Part-time employed"},{"value":"16","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_FULL","description":null,"displayName":"Full-time employed"},{"value":"56.6","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"The UK’s response to MS includes a strong research environment and\nalmost no out-of-pocket costs for approved disease-modifying drugs\n(DMDs) or symptomatic treatments. However, there is still room for\nimprovement in important areas of care:","countryContext":"The UK’s National Health Service provides\nhealthcare free at the point of access.(1)\nHealthcare is managed by the four\ndevolved nations, with many elements\nfurther devolved to health trusts, health and social care trusts,\nhealth boards and clinical commissioning groups. This\ncan lead to distinct differences in care depending on\nwhere a person lives. There are also critical issues\nwith access to care due to delayed diagnosis, along\nwith workforce and funding challenges. Healthcare\nspending in the UK is significantly lower than in\nother European countries with similar wealth.","created_at":"2021-05-19T11:40:59.769Z","updated_at":"2021-05-19T11:40:59.769Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. United Kingdom: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":120,"title":"2020 - United Kingdom Factsheet - EN","published":null,"published_at":"2021-05-28T18:08:59.505Z","created_at":"2021-05-28T18:08:59.509Z","updated_at":"2021-05-28T18:08:59.509Z","document":{"id":174,"name":"MS Barometer 2020_Country Factsheet_UK_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"441eeaec3ac208a1d46cbb8cfbbdffcd","ext":".pdf","mime":"application/pdf","size":280.88,"url":"https://barometer.ams3.digitaloceanspaces.com/441eeaec3ac208a1d46cbb8cfbbdffcd.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T18:08:59.739Z","updated_at":"2021-05-28T18:08:59.739Z"}}],"findings":[{"id":213,"title":"Under","description":"of people with\nMS have access to physical\nrehabilitation services, and\naccess to other types of\nrehabilitation is not known.","highlightText":"50%","isHighlighted":true,"created_at":"2021-05-28T18:10:09.390Z","updated_at":"2021-05-28T18:10:09.390Z"},{"id":214,"title":"There are","description":"practising\nneurologists in the UK –\none for every 148 people\nwith MS.","highlightText":"880","isHighlighted":true,"created_at":"2021-05-28T18:10:28.119Z","updated_at":"2021-05-28T18:10:28.119Z"},{"id":215,"title":"Only","description":"of people\nwith MS received DMD\ntreatment in 2019.","highlightText":"38%","isHighlighted":true,"created_at":"2021-05-28T18:10:44.127Z","updated_at":"2021-05-28T18:10:44.127Z"}],"recoms":[{"id":216,"title":"","description":"Ensure each of the devolved nations has a\nneurological disease plan with an adequate\nbudget and workforce for implementation, which\nincludes a comprehensive approach to MS and\naims to reduce unwarranted variations in care.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T18:10:55.942Z","updated_at":"2021-05-28T18:10:55.942Z"},{"id":217,"title":"","description":"Increase provision of general and specialist rehabilitation\nsupport across the UK, reducing regional disparities in\nthe provision of therapies and rehabilitation services and\nensuring that every person with MS has a personalised\nrehabilitation plan and continuous team rehabilitation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T18:11:04.598Z","updated_at":"2021-05-28T18:11:04.598Z"},{"id":218,"title":"","description":"Improve financial and employment\nsupport to help people with MS find\nand maintain employment and financial\nsecurity.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T18:11:14.886Z","updated_at":"2021-05-28T18:11:14.886Z"}],"countryName":"United Kingdom","alpha2":"GB","alpha3":"GBR"},{"id":41,"added":true,"country":{"id":6,"countryName":"Belgium","alpha2":"BE","alpha3":"BEL","created_at":"2021-05-27T21:06:53.815Z","updated_at":"2021-05-27T21:06:53.815Z"},"values":[{"value":"13.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"8.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"4.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"67","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"11.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"6.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"10.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"95","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"80","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"80","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"61","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"3.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"51","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"36","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_FULL","description":null,"displayName":"Full-time employment"},{"value":"24","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_PART","description":null,"displayName":"Part-time employment"},{"value":"51","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"11500000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"12000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"yes","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"Local or regional ","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"60","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"Chronic only","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"24","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_PART","description":null,"displayName":"Part-time employed"},{"value":"36","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_FULL","description":null,"displayName":"Full-time employed"},{"value":"66.9","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Recent improvements in MS care in Belgium include a greater focus\non the needs of young people and paediatric MS, as well as the\nestablishment of the BELTRIMS treatment registry. However, some\nchallenges persist:","countryContext":"Health and social care services in Belgium\nare organised at the federal and regional\nlevels. These two levels of government\nsubsidise part of the social security\nand healthcare,(1) and this can result in\ngeographic disparities in the delivery of care and services.\nIn addition, there are co-payments and user\ncharges for services such as general practitioner\nand specialist consultations, inpatient hospital\nstays, physiotherapy and pharmaceuticals.\nAllowances provide financial support to the most\ndisadvantaged groups of people.","created_at":"2021-05-27T21:06:53.815Z","updated_at":"2021-05-27T21:06:53.815Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Belgium: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":50,"title":"2020 - Belgium Factsheet - FR","published":null,"published_at":"2021-05-28T16:16:34.573Z","created_at":"2021-05-28T16:16:34.578Z","updated_at":"2021-05-28T16:16:34.578Z","document":{"id":104,"name":"MS Barometer 2020_Country Factsheet_Belgium_FR.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"697aa2b149702fbe9f9964901a701146","ext":".pdf","mime":"application/pdf","size":250.8,"url":"https://barometer.ams3.digitaloceanspaces.com/697aa2b149702fbe9f9964901a701146.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:16:34.781Z","updated_at":"2021-05-28T16:16:34.781Z"}},{"id":51,"title":"2020 - Belgium Factsheet - FL","published":null,"published_at":"2021-05-28T16:16:47.436Z","created_at":"2021-05-28T16:16:47.444Z","updated_at":"2021-05-28T16:16:47.444Z","document":{"id":105,"name":"MS Barometer 2020_Country Factsheet_Belgium_FL.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"4f73b8e8fe7710a10a1f3185bbac7e35","ext":".pdf","mime":"application/pdf","size":247.85,"url":"https://barometer.ams3.digitaloceanspaces.com/4f73b8e8fe7710a10a1f3185bbac7e35.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:16:47.587Z","updated_at":"2021-05-28T16:16:47.587Z"}},{"id":52,"title":"2020 - Belgium Factsheet - EN","published":null,"published_at":"2021-05-28T16:17:01.053Z","created_at":"2021-05-28T16:17:01.056Z","updated_at":"2021-05-28T16:17:01.056Z","document":{"id":106,"name":"MS Barometer 2020_Country Factsheet_Belgium_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"ec02fb89bd999e7e3b9fe8c39357f14f","ext":".pdf","mime":"application/pdf","size":274.23,"url":"https://barometer.ams3.digitaloceanspaces.com/ec02fb89bd999e7e3b9fe8c39357f14f.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:17:01.333Z","updated_at":"2021-05-28T16:17:01.333Z"}}],"findings":[{"id":9,"title":"Just","description":"of the MS population\nare in full-time employment.","highlightText":"36%","isHighlighted":true,"created_at":"2021-05-28T07:25:04.965Z","updated_at":"2021-05-28T07:25:04.965Z"},{"id":10,"title":"Only","description":"of the MS population\nare in part-time employment.","highlightText":"24%","isHighlighted":true,"created_at":"2021-05-28T07:25:39.821Z","updated_at":"2021-05-28T07:25:39.821Z"},{"id":11,"title":"","description":"number of people\nwith MS are receiving physical,\noccupational, cognitive or\npsychological rehabilitation.","highlightText":"Unknown","isHighlighted":true,"created_at":"2021-05-28T07:28:59.559Z","updated_at":"2021-05-28T07:29:40.416Z"}],"recoms":[{"id":12,"title":"","description":"Establish a mandatory national disease registry which\ncollects epidemiological, therapeutic, rehabilitation\nand patient-reported data.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T07:30:03.113Z","updated_at":"2021-05-28T07:30:03.113Z"},{"id":13,"title":"","description":"Reduce delays between European\nMedicines Agency approval of new\ntherapies and national reimbursement.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T07:30:11.868Z","updated_at":"2021-05-28T07:30:11.868Z"},{"id":14,"title":"","description":"Provide MS-specific financial support to help people\nwith MS to complete their education and find and\nmaintain employment.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T07:30:24.102Z","updated_at":"2021-05-28T07:30:24.102Z"}],"countryName":"Belgium","alpha2":"BE","alpha3":"BEL"},{"id":70,"added":true,"country":{"id":34,"countryName":"The Netherlands","alpha2":"NL","alpha3":"NLD","created_at":"2021-05-27T21:20:52.462Z","updated_at":"2021-05-27T21:20:52.462Z"},"values":[{"value":"10.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"9.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"50","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"9.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"2.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"3.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"2.2","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"79","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"63","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"19","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"22","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"1.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"59","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"18","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"17100000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"25000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"42.4","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"The Netherlands has made progress on improving reimbursement for\ndisease-modifying drugs (DMDs). There are 17 MS centres across the\ncountry, and MS specialist certifications are available for neurologists,\nnurses, physiotherapists and counsellors. However, important gaps\nremain:","countryContext":"The Netherlands provides universal health coverage\nthrough three central government-regulated health\ninsurance schemes, which include coverage for\ncurative, long-term and social care.(1)\nThe Netherlands spends more on healthcare than the\nEuropean Union average, both in terms of percentage of\nGDP (10% vs 8.3%) and per capita spending (€3,679 PPP\nvs €2,572 PPP), and out-of-pocket expenses are low.(2)\nA number of integrated care programmes for people\nwith multiple chronic diseases are being trialled in\nan effort to streamline care.","created_at":"2021-05-27T21:20:52.462Z","updated_at":"2021-05-27T21:20:52.462Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. The Netherlands: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels\n(2) European Commission. 2020. Health at a Glance: Europe 2020. Brussels: EU","factsheets":[{"id":116,"title":"2020 - The Netherlands Factsheet - EN","published":null,"published_at":"2021-05-28T17:53:59.956Z","created_at":"2021-05-28T17:53:59.961Z","updated_at":"2021-05-28T17:53:59.961Z","document":{"id":170,"name":"MS Barometer 2020_Country Factsheet_TheNetherlands_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"7fb2ad4af02786fdd22df94826f032ad","ext":".pdf","mime":"application/pdf","size":266.3,"url":"https://barometer.ams3.digitaloceanspaces.com/7fb2ad4af02786fdd22df94826f032ad.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:54:00.246Z","updated_at":"2021-05-28T17:54:00.246Z"}},{"id":117,"title":"2020 - The Netherlands Factsheet - NL","published":null,"published_at":"2021-05-28T17:54:15.214Z","created_at":"2021-05-28T17:54:15.217Z","updated_at":"2021-05-28T17:54:15.217Z","document":{"id":171,"name":"MS Barometer 2020_Country Factsheet_TheNetherlands_NL.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"4c93ed55dd0b8976c7967d782c7e42e4","ext":".pdf","mime":"application/pdf","size":268.24,"url":"https://barometer.ams3.digitaloceanspaces.com/4c93ed55dd0b8976c7967d782c7e42e4.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:54:15.465Z","updated_at":"2021-05-28T17:54:15.465Z"}}],"findings":[{"id":201,"title":"The Netherlands has","description":" any national MS,\nneurological or chronic\ndisease plans.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T17:55:42.958Z","updated_at":"2021-05-28T17:55:59.319Z"},{"id":202,"title":"Despite availability of a range of rehabilitation specialties, it is","description":"what services people with\nMS are actually able to\naccess.","highlightText":"unknown","isHighlighted":true,"created_at":"2021-05-28T17:56:21.820Z","updated_at":"2021-05-28T17:56:21.820Z"},{"id":203,"title":"It is","description":" how many\npeople with MS are being\ntreated with DMDs.","highlightText":"unknown","isHighlighted":true,"created_at":"2021-05-28T17:58:45.451Z","updated_at":"2021-05-28T17:58:45.451Z"}],"recoms":[{"id":204,"title":"","description":"Strengthen reimbursement policies for evidence-based\nMS therapies, and expand uptake of available\nresearch on different treatments.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:59:03.299Z","updated_at":"2021-05-28T17:59:16.043Z"},{"id":205,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS, with\nan adequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:59:26.500Z","updated_at":"2021-05-28T17:59:26.500Z"},{"id":206,"title":"","description":"Increase the use of the national MS registry\nto include all people with MS, and collect\nadditional data on clinical, occupational and\npatient-reported indicators.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:59:42.210Z","updated_at":"2021-05-28T17:59:42.210Z"}],"countryName":"The Netherlands","alpha2":"NL","alpha3":"NLD"},{"id":61,"added":true,"country":{"id":25,"countryName":"Norway","alpha2":"NO","alpha3":"NOR","created_at":"2021-05-27T21:16:19.116Z","updated_at":"2021-05-27T21:16:19.116Z"},"values":[{"value":"12.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"12.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"2.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"33","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"7.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"5.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"7.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"8.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"65","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"71","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"67","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"43","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"2.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"75","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"42","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"5420000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"13000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"Neurological only","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"57.0","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"The adoption of a national brain health strategy in 2017 was an\nimportant achievement to help improve MS care in Norway. However,\nsignificant gaps remain:","countryContext":"Norway’s healthcare system is partly centralised,\nwith the state managing specialised care while\nmunicipalities organise primary, long-term and\nsocial care.(1)\nHealthcare spending is higher than the European Union average\nand in line with neighbouring Scandinavian countries. Health\ncoverage is universal, although there are co-payments\nfor services and out-of-pocket payments for outpatient\npharmaceuticals.","created_at":"2021-05-27T21:16:19.116Z","updated_at":"2021-05-27T21:16:19.116Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Norway: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":94,"title":"2020 - Norway Factsheet - EN","published":null,"published_at":"2021-05-28T17:17:12.937Z","created_at":"2021-05-28T17:17:12.941Z","updated_at":"2021-05-28T17:17:12.941Z","document":{"id":148,"name":"MS Barometer 2020_Country Factsheet_Norway_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"c7d5bba809e2ca3e9e3ab2c020cca069","ext":".pdf","mime":"application/pdf","size":275.91,"url":"https://barometer.ams3.digitaloceanspaces.com/c7d5bba809e2ca3e9e3ab2c020cca069.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:17:13.112Z","updated_at":"2021-05-28T17:17:13.112Z"}},{"id":95,"title":"2020 - Norway Factsheet - NO","published":null,"published_at":"2021-05-28T17:17:23.259Z","created_at":"2021-05-28T17:17:23.263Z","updated_at":"2021-05-28T17:17:23.263Z","document":{"id":149,"name":"MS Barometer 2020_Country Factsheet_Norway_NO.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"b49e3ff591a93097dcfb836b0025c480","ext":".pdf","mime":"application/pdf","size":158.08,"url":"https://barometer.ams3.digitaloceanspaces.com/b49e3ff591a93097dcfb836b0025c480.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:17:23.394Z","updated_at":"2021-05-28T17:17:23.394Z"}}],"findings":[{"id":122,"title":"The national registry only covers ","description":"of people\nwith MS.","highlightText":"50-59%","isHighlighted":true,"created_at":"2021-05-28T15:47:21.848Z","updated_at":"2021-05-28T15:47:21.848Z"},{"id":123,"title":"","description":"of people with MS\nhave access to physical\nrehabilitation services, and\naccess to specialised MS\nrehabilitation is poor.","highlightText":"50-59%","isHighlighted":true,"created_at":"2021-05-28T15:48:34.752Z","updated_at":"2021-05-28T15:48:34.752Z"},{"id":124,"title":"In Norway there is","description":"specialist clinic or clinical\ntreatment guidelines for\npaediatric MS.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T15:50:18.020Z","updated_at":"2021-05-28T15:50:18.020Z"}],"recoms":[{"id":125,"title":"","description":"Mandate inclusion of all people\nwith MS in the national MS registry.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T15:50:33.242Z","updated_at":"2021-05-28T15:50:33.242Z"},{"id":126,"title":"","description":"Ensure that every person with MS has a personalised\nrehabilitation plan and consistent access to specialised MS\nrehabilitation, including psychological and social support.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T15:50:55.068Z","updated_at":"2021-05-28T15:50:55.068Z"},{"id":127,"title":"","description":"Improve professional awareness for paediatric\nMS and increase access to specialist paediatric\nneurologists to reduce diagnostic delays for\nthis rare disease.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T15:51:06.201Z","updated_at":"2021-05-28T15:51:06.201Z"}],"countryName":"Norway","alpha2":"NO","alpha3":"NOR"},{"id":40,"added":true,"country":{"id":5,"countryName":"Belarus","alpha2":"BY","alpha3":"BLR","created_at":"2021-05-27T21:06:31.427Z","updated_at":"2021-05-27T21:06:31.427Z"},"values":[{"value":"5.2","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"0","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"0.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"28","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"31","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"0","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"0","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"1.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"0","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"6","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"9500000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"4600","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"None","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"20","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"20","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_EMP","description":null,"displayName":"Employed"},{"value":"10.6","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Access to disease-modifying drugs (DMDs) has recently improved\nthanks to changes within the Belarus Health Ministry. However, there\nare areas for improvement in the care for people with MS:","countryContext":"Access to health services in Belarus is\nuniversal through the state-run healthcare\nsystem; however, significant co-payments\nare required for pharmaceuticals and\noptician and dental services.(1)\nHistorically, there has been low prioritisation of social,\nlong-term and mental health care, as well as noted\nchallenges in access to trained medical staff and\nlong waiting times for services.","created_at":"2021-05-27T21:06:31.427Z","updated_at":"2021-05-27T21:06:31.427Z","references":"(1) Richardson E, Malakhova I, Novik I, et al. 2013. Health Syst Transit 15(5): 1-118","factsheets":[{"id":48,"title":"2020 - Belarus Factsheet - EN","published":null,"published_at":"2021-05-28T16:15:38.994Z","created_at":"2021-05-28T16:15:39.004Z","updated_at":"2021-05-28T16:15:39.004Z","document":{"id":102,"name":"MS Barometer 2020_Country Factsheet_Belarus_EN.indd.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"646864dc8606f2580a879fbf32275512","ext":".pdf","mime":"application/pdf","size":191.3,"url":"https://barometer.ams3.digitaloceanspaces.com/646864dc8606f2580a879fbf32275512.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:15:39.156Z","updated_at":"2021-05-28T16:15:39.156Z"}},{"id":49,"title":"2020 - Belarus Factsheet - BE","published":null,"published_at":"2021-05-28T16:15:56.304Z","created_at":"2021-05-28T16:15:56.307Z","updated_at":"2021-05-28T16:15:56.307Z","document":{"id":103,"name":"MS Barometer 2020_Country Factsheet_Belarus_BE.indd.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"e4c8c99dc3ea848874e66b46d14eb5c8","ext":".pdf","mime":"application/pdf","size":250.69,"url":"https://barometer.ams3.digitaloceanspaces.com/e4c8c99dc3ea848874e66b46d14eb5c8.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:15:56.501Z","updated_at":"2021-05-28T16:15:56.501Z"}}],"findings":[{"id":21,"title":"Only","description":"DMDs\nsurveyed are available.","highlightText":"4/12","isHighlighted":true,"created_at":"2021-05-28T07:43:00.443Z","updated_at":"2021-05-28T07:43:00.443Z"},{"id":22,"title":"","description":"paid symptomatic therapies are available.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T07:45:30.325Z","updated_at":"2021-05-28T07:45:30.325Z"},{"id":23,"title":"There is ","description":"publicly funded\nrehabilitation available.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T07:45:56.619Z","updated_at":"2021-05-28T07:45:56.619Z"}],"recoms":[{"id":24,"title":"","description":"Increase understanding of symptomatic therapies and\nDMDs among decision-makers and policymakers to\nsupport the approval and reimbursement process.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T07:46:20.729Z","updated_at":"2021-05-28T07:46:20.729Z"},{"id":25,"title":"","description":"Establish an outpatient rehabilitation\nservice for people with MS that includes\nphysiotherapy and psychological support.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T07:46:31.089Z","updated_at":"2021-05-28T07:46:31.089Z"},{"id":26,"title":"","description":"Increase awareness of the needs of people with\ndisabilities throughout health, social and education\nsystems, as part of Belarus’s commitments to the\nUnited Nations Sustainable Development Goals.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T07:46:44.051Z","updated_at":"2021-05-28T07:46:44.051Z"}],"countryName":"Belarus","alpha2":"BY","alpha3":"BLR"},{"id":48,"added":true,"country":{"id":13,"countryName":"France","alpha2":"FR","alpha3":"FRA","created_at":"2021-05-27T21:10:35.011Z","updated_at":"2021-05-27T21:10:35.011Z"},"values":[{"value":"12.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"11.2","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"5.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"83","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"8.2","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"6.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"3.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"69","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"76","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"81","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"22","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"3.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"66","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"53","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"65200000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"115000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"Neurological only","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"61.4","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Recent political efforts in France have seen the creation of a national\nplan for neurodegenerative diseases, expansion of benefits for carers\nand the creation of an MS parliamentary interest group. Furthermore,\n23 MS specialist centres have been established inside universities to\nimprove research and management of MS. However, gaps remain:","countryContext":"The state plays a strong role in healthcare\nprovision in France; however, in recent\nyears, regional health agencies have\ndeveloped a growing role in local\nhealthcare delivery.(1)\nHealthcare funding is based on a model of social health\ninsurance, and people with chronic diseases are\nexempt from almost all co-payments.","created_at":"2021-05-27T21:10:35.011Z","updated_at":"2021-05-27T21:10:35.011Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. France: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":65,"title":"2020 - France Factsheet - EN","published":null,"published_at":"2021-05-28T16:33:27.416Z","created_at":"2021-05-28T16:33:27.420Z","updated_at":"2021-05-28T16:33:27.420Z","document":{"id":119,"name":"MS Barometer 2020_Country Factsheet_France_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"14b5c7ecb021efed4e4f80fabdbc0ec8","ext":".pdf","mime":"application/pdf","size":274.19,"url":"https://barometer.ams3.digitaloceanspaces.com/14b5c7ecb021efed4e4f80fabdbc0ec8.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:33:27.656Z","updated_at":"2021-05-28T16:33:27.656Z"}},{"id":66,"title":"2020 - France Factsheet - FR","published":null,"published_at":"2021-05-28T16:33:47.002Z","created_at":"2021-05-28T16:33:47.004Z","updated_at":"2021-05-28T16:33:47.004Z","document":{"id":120,"name":"MS Barometer 2020_Country Factsheet_France_FR.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"52a6749f7edbdbd3254561b6fee31244","ext":".pdf","mime":"application/pdf","size":252.82,"url":"https://barometer.ams3.digitaloceanspaces.com/52a6749f7edbdbd3254561b6fee31244.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:33:47.120Z","updated_at":"2021-05-28T16:33:47.120Z"}}],"findings":[{"id":134,"title":"There are","description":"data available on\nthe number of people with MS\naccessing physical, psychological,\ncognitive or occupational\nrehabilitation.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T16:43:03.454Z","updated_at":"2021-05-28T16:43:03.454Z"},{"id":135,"title":"There are only","description":"neurologists specialising in\nMS, meaning each neurologist\nmay manage approximately\n575 people with MS.","highlightText":"200","isHighlighted":true,"created_at":"2021-05-28T16:43:23.766Z","updated_at":"2021-05-28T16:43:23.766Z"},{"id":136,"title":"There is","description":"early palliative care\nfor symptomatic treatment of MS,\neven though palliative care may\nbe initiated at any stage of chronic\nneurodegenerative illnesses such\nas MS in order to manage pain\nand other symptoms.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T16:43:41.275Z","updated_at":"2021-05-28T16:44:32.542Z"}],"recoms":[{"id":137,"title":"","description":"Ensure that all people with MS have a personalised rehabilitation\nplan including physical therapy and cognitive, psychological and\noccupational support, with a needs assessment each year.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T16:43:55.432Z","updated_at":"2021-05-28T16:43:55.432Z"},{"id":138,"title":"","description":"Encourage neurologists to include all people with MS in the MS patient\nregistry, educate people with MS on the value of sharing data with disease\nregistries and expand data collection to include use of rehabilitation\nservices, employment rates and patient-reported outcomes.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T16:44:06.792Z","updated_at":"2021-05-28T16:44:06.792Z"},{"id":139,"title":"","description":"Provide psychological support to people newly diagnosed\nwith MS through the Social Health Insurance, including\nimproving training of neurologists in psychology, scheduling\nconsultations with trained nurses immediately after\nMore information can be found at diagnosis and offering peer support without delay.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T16:44:20.810Z","updated_at":"2021-05-28T16:44:20.810Z"}],"countryName":"France","alpha2":"FR","alpha3":"FRA"},{"id":64,"added":true,"country":{"id":28,"countryName":"Romania","alpha2":"RO","alpha3":"ROU","created_at":"2021-05-27T21:18:02.434Z","updated_at":"2021-05-27T21:18:02.434Z"},"values":[{"value":"11.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"5.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"0","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"6.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"5.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"0.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"4.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"56","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"65","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"35","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"5","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"4.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"33","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"42","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"19200000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"9000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"37.7","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Romania has made some improvements to MS care in recent years,\nincluding doubling the number of paediatric patients receiving\ndisease-modifying drugs (DMDs). However, significant gaps persist:","countryContext":"Romania has a centralised health system,\ngoverned by the Ministry of Health and\nadministered and regulated by the national\nhealth insurance.(1)\nRomania has the lowest health spending per capita in the\nEuropean Union, less than half the average, as well as the\nlowest health spending as a share of GDP. As a result,\nout-of-pocket payments for health and social care\nare substantial.","created_at":"2021-05-27T21:18:02.434Z","updated_at":"2021-05-27T21:18:02.434Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Romania: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":100,"title":"2020 - Romania Factsheet - EN","published":null,"published_at":"2021-05-28T17:24:12.196Z","created_at":"2021-05-28T17:24:12.208Z","updated_at":"2021-05-28T17:24:12.208Z","document":{"id":154,"name":"MS Barometer 2020_Country Factsheet_Romanial_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"f563714737d176b9feb75e73cd3cd336","ext":".pdf","mime":"application/pdf","size":287.38,"url":"https://barometer.ams3.digitaloceanspaces.com/f563714737d176b9feb75e73cd3cd336.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:24:12.457Z","updated_at":"2021-05-28T17:24:12.457Z"}},{"id":101,"title":"2020 - Romania Factsheet - RO","published":null,"published_at":"2021-05-28T17:24:26.559Z","created_at":"2021-05-28T17:24:26.566Z","updated_at":"2021-05-28T17:24:26.566Z","document":{"id":155,"name":"MS Barometer 2020_Country Factsheet_Romanial_RO.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"5df2a5d9cb3e4c39c1bcaaa2213fcaef","ext":".pdf","mime":"application/pdf","size":273.67,"url":"https://barometer.ams3.digitaloceanspaces.com/5df2a5d9cb3e4c39c1bcaaa2213fcaef.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:24:26.818Z","updated_at":"2021-05-28T17:24:26.818Z"}}],"findings":[{"id":159,"title":"There is","description":"access to\nmultidisciplinary teams or\ndedicated MS centres.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T17:25:36.733Z","updated_at":"2021-05-28T17:25:36.733Z"},{"id":160,"title":"There is","description":"access to\nrehabilitation, with very\nlimited physiotherapy, no\naccess to occupational or\ncognitive rehabilitation and\nno reimbursement for\npsychological rehabilitation.","highlightText":"limited ","isHighlighted":true,"created_at":"2021-05-28T17:26:04.823Z","updated_at":"2021-05-28T17:26:04.823Z"},{"id":161,"title":"There may be more than","description":"years long delays between European\nMedicines Agency and\nnational approval for new\ntherapies","highlightText":"4","isHighlighted":true,"created_at":"2021-05-28T17:27:46.040Z","updated_at":"2021-05-28T17:27:46.040Z"}],"recoms":[{"id":162,"title":"","description":"Establish a national MS registry with mandatory data\ncollection encompassing clinical, occupational and\npatient-reported data.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:28:05.559Z","updated_at":"2021-05-28T17:28:05.559Z"},{"id":163,"title":"","description":"Increase the number of dedicated MS centres\nand create multidisciplinary teams incorporating a\nneurologist, nurse and rehabilitation specialists.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:28:15.835Z","updated_at":"2021-05-28T17:28:15.835Z"},{"id":164,"title":"","description":"Increase reimbursement for specialised\nrehabilitation including physiotherapy,\nand psychological, cognitive and\nMore information can be found at occupational rehabilitation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:28:24.902Z","updated_at":"2021-05-28T17:28:24.902Z"}],"countryName":"Romania","alpha2":"RO","alpha3":"ROU"},{"id":49,"added":true,"country":{"id":12,"countryName":"Finland","alpha2":"FI","alpha3":"FIN","created_at":"2021-05-27T21:10:13.368Z","updated_at":"2021-05-27T21:10:13.368Z"},"values":[{"value":"12.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"12.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"2.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"33","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"9.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"6.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"13.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"10.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"82","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"71","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"90","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"79","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"3.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"76","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"35","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_FULL","description":null,"displayName":"Full-time employment"},{"value":"15","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_PART","description":null,"displayName":"Part-time employment"},{"value":"55","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"5500000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"12080","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"yes","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"50","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"15","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_PART","description":null,"displayName":"Part-time employed"},{"value":"35","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_FULL","description":null,"displayName":"Full-time employed"},{"value":"71.2","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"The recently established national MS registry covers 90–99% of the\nFinnish MS population, and has greatly improved the accuracy of\nresearch. There are nearly 200 nurses with certifications in MS, and\nwidespread access to multidisciplinary care teams. However, there are\nstill areas for improvement:","countryContext":"Healthcare organisation in Finland is\ncomplex as many actors are involved in\nhealthcare decision-making at the national\nand local level.(1)\nSpending as a share of GDP and per capita health spending are\nlower than in neighbouring Nordic countries but similar to\nthe European Union average.\nHealth coverage is universal and financed primarily\nthrough general taxation. However, out-of-pocket\npayments for outpatient and long-term care are\nhigh, resulting in a growing uptake of private health\ninsurance.(1)","created_at":"2021-05-27T21:10:13.368Z","updated_at":"2021-05-27T21:10:13.368Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Finland: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":63,"title":"2020 - Finland Factsheet - EN","published":null,"published_at":"2021-05-28T16:31:41.553Z","created_at":"2021-05-28T16:31:41.567Z","updated_at":"2021-05-28T16:31:41.567Z","document":{"id":117,"name":"MS Barometer 2020_Country Factsheet_Finland_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"d3b4b763f95e5c3bf3e7b70b276e63eb","ext":".pdf","mime":"application/pdf","size":276.51,"url":"https://barometer.ams3.digitaloceanspaces.com/d3b4b763f95e5c3bf3e7b70b276e63eb.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:31:41.933Z","updated_at":"2021-05-28T16:31:41.933Z"}},{"id":64,"title":"2020 - Finland Factsheet - FI ","published":null,"published_at":"2021-05-28T16:32:14.115Z","created_at":"2021-05-28T16:32:14.123Z","updated_at":"2021-05-28T16:32:14.123Z","document":{"id":118,"name":"MS Barometer 2020_Country Factsheet_Finland_FI.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"963f8a0c0941efb291c5e860aed95528","ext":".pdf","mime":"application/pdf","size":251.2,"url":"https://barometer.ams3.digitaloceanspaces.com/963f8a0c0941efb291c5e860aed95528.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:32:14.477Z","updated_at":"2021-05-28T16:32:14.477Z"}}],"findings":[{"id":57,"title":"Only","description":"of people with\nMS are receiving diseasemodifying\ndrugs.","highlightText":"43%","isHighlighted":true,"created_at":"2021-05-28T11:34:01.903Z","updated_at":"2021-05-28T11:34:01.903Z"},{"id":58,"title":"Under","description":"of people with\nMS have access to physical\nrehabilitation services.","highlightText":"50%","isHighlighted":true,"created_at":"2021-05-28T11:34:20.652Z","updated_at":"2021-05-28T11:34:20.652Z"},{"id":59,"title":"Only","description":"of people\nwith MS are in full-time\nemployment, and just 15%\nin part-time employment.","highlightText":"35%","isHighlighted":true,"created_at":"2021-05-28T11:34:38.427Z","updated_at":"2021-05-28T11:34:38.427Z"}],"recoms":[{"id":60,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS, with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:35:01.873Z","updated_at":"2021-05-28T11:35:01.873Z"},{"id":61,"title":"","description":"Ensure that all people with MS have publicly\nfunded rehabilitation programmes spanning\ncognitive, psychological and occupational support.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:35:10.226Z","updated_at":"2021-05-28T11:35:10.226Z"},{"id":62,"title":"","description":"Develop nationally specific treatment\nguidelines for paediatric MS.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:35:19.537Z","updated_at":"2021-05-28T11:35:19.537Z"}],"countryName":"Finland","alpha2":"FI","alpha3":"FIN"},{"id":39,"added":true,"country":{"id":4,"countryName":"Austria","alpha2":"AT","alpha3":"AUT","created_at":"2021-05-27T21:06:03.051Z","updated_at":"2021-05-27T21:06:03.051Z"},"values":[{"value":"9.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"0","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"10.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"5.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"16.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"90","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"75","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"81","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"100","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"5.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"53","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"17","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_FULL","description":null,"displayName":"Full-time employment"},{"value":"29","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_PART","description":null,"displayName":"Part-time employment"},{"value":"47","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"9000000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"13500","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"Local or regional ","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"46","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"12.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"29","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_PART","description":null,"displayName":"Part-time employed"},{"value":"17","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_FULL","description":null,"displayName":"Full-time employed"},{"value":"69.9","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Austria has a well organised system for managing MS, with good\naccess and reimbursement for disease-modifying drugs (DMDs) and\nsymptomatic therapies. A new MS treatment registry has recently\nbeen established to support quality improvements and clinical\nresearch, and new outpatient centres for paediatric MS have been set\nup across the country. However, there are areas for improvement:","countryContext":"Healthcare organisation in Austria is\ncomplex as many actors are involved in\nhealthcare decision-making at the federal\nand state level, including municipalities,\ncommissioning bodies and the social health\ninsurance provider.(1)\nSpending on healthcare in Austria is above the European\nUnion (EU) average. Although out-of-pocket payments\nfor medicines and long-term care are higher\nthan the EU average, there are exemptions for\nvulnerable groups and people with low incomes.","created_at":"2021-05-27T21:06:03.051Z","updated_at":"2021-05-27T21:06:03.051Z","references":"(1). OECD/European Observatory on Health Systems Policies. 2019. Austria: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":46,"title":"2020 - Austria Factsheet - EN","published":null,"published_at":"2021-05-28T16:14:00.386Z","created_at":"2021-05-28T16:14:00.391Z","updated_at":"2021-05-28T16:14:00.391Z","document":{"id":100,"name":"MS Barometer 2020_Country Factsheet_Austria_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"00ffc4da26e7e0d6c53ea07e903b1d13","ext":".pdf","mime":"application/pdf","size":153.81,"url":"https://barometer.ams3.digitaloceanspaces.com/00ffc4da26e7e0d6c53ea07e903b1d13.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:14:00.544Z","updated_at":"2021-05-28T16:14:00.544Z"}},{"id":47,"title":"2020 - Austria Factsheet - DE","published":null,"published_at":"2021-05-28T16:14:15.775Z","created_at":"2021-05-28T16:14:15.778Z","updated_at":"2021-05-28T16:14:15.778Z","document":{"id":101,"name":"MS Barometer 2020_Country Factsheet_Austria_DE.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"03f7ae8c7605a6bdec38432969c9291f","ext":".pdf","mime":"application/pdf","size":259.37,"url":"https://barometer.ams3.digitaloceanspaces.com/03f7ae8c7605a6bdec38432969c9291f.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:14:15.941Z","updated_at":"2021-05-28T16:14:15.941Z"}}],"findings":[{"id":15,"title":"Only","description":"of people with MS\nare in full-time employment\nand 29% in part-time\nemployment.","highlightText":"17%","isHighlighted":true,"created_at":"2021-05-28T07:37:08.070Z","updated_at":"2021-05-28T07:37:08.070Z"},{"id":16,"title":"Approximately","description":"of\npeople with MS have\naccess to outpatient\nrehabilitation.","highlightText":"10%","isHighlighted":true,"created_at":"2021-05-28T07:37:36.648Z","updated_at":"2021-05-28T07:37:36.648Z"},{"id":17,"title":"Fewer than","description":"of people\nwith MS received inpatient\nrehabilitation in the past\nyear.","highlightText":"20%","isHighlighted":true,"created_at":"2021-05-28T07:37:57.265Z","updated_at":"2021-05-28T07:37:57.265Z"}],"recoms":[{"id":18,"title":"","description":"Expand the outpatient rehabilitation services available\nfor MS to improve consistency and flexibility of\nsupport for people with MS.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T07:38:36.387Z","updated_at":"2021-05-28T07:38:36.387Z"},{"id":19,"title":"","description":"Provide MS-specific financial and practical\nsupport to help people with MS complete their\n€ education, and find and maintain employment.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T07:38:46.377Z","updated_at":"2021-05-28T07:38:46.377Z"},{"id":20,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS, with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T07:38:55.674Z","updated_at":"2021-05-28T07:38:55.674Z"}],"countryName":"Austria","alpha2":"AT","alpha3":"AUT"},{"id":54,"added":true,"country":{"id":19,"countryName":"Latvia","alpha2":"LV","alpha3":"LVA","created_at":"2021-05-27T21:12:44.910Z","updated_at":"2021-05-27T21:12:44.910Z"},"values":[{"value":"10.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"1.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"17","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"7.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"2.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"9.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"5.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"64","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"61","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"48","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"55","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"0","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"22","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"1800000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"2035","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"None","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"36.8","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Recent updates to the Latvian MS guidelines have been helpful in\nimproving MS care and there is good availability of many diseasemodifying\ndrugs (DMDs). However, several unmet needs persist:","countryContext":"Latvia’s national health service provides\nuniversal health coverage through\ncompulsory health insurance.(1)\nHealth spending per capita is the second\nlowest in the European Union (EU) and out-of-pocket spending\non healthcare is the third highest in the EU – accounting\nfor more than 40% of spending. This significantly\nimpacts access to care for low-income households.","created_at":"2021-05-27T21:12:44.910Z","updated_at":"2021-05-27T21:12:44.910Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Latvia: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":80,"title":"2020 - Latvia Factsheet - LV","published":null,"published_at":"2021-05-28T17:05:41.062Z","created_at":"2021-05-28T17:05:41.071Z","updated_at":"2021-05-28T17:05:41.071Z","document":{"id":134,"name":"MS Barometer 2020_Country Factsheet_Latvia_LV.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"e2df78031e89f93290c2ee1a1e65526f","ext":".pdf","mime":"application/pdf","size":231.6,"url":"https://barometer.ams3.digitaloceanspaces.com/e2df78031e89f93290c2ee1a1e65526f.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:05:41.285Z","updated_at":"2021-05-28T17:05:41.285Z"}},{"id":81,"title":"2020 - Latvia Factsheet - EN","published":null,"published_at":"2021-05-28T17:05:54.318Z","created_at":"2021-05-28T17:05:54.321Z","updated_at":"2021-05-28T17:05:54.321Z","document":{"id":135,"name":"MS Barometer 2020_Country Factsheet_Latvia_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"d4fd16c8dd39d3b440468dfc79e3a9ab","ext":".pdf","mime":"application/pdf","size":235.62,"url":"https://barometer.ams3.digitaloceanspaces.com/d4fd16c8dd39d3b440468dfc79e3a9ab.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:05:54.543Z","updated_at":"2021-05-28T17:05:54.543Z"}}],"findings":[{"id":92,"title":"There are ","description":"data on\naccess to rehabilitation\nservices including physical,\noccupational, psychological\nor cognitive rehabilitation.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:59:24.383Z","updated_at":"2021-05-28T11:59:24.383Z"},{"id":93,"title":"There are","description":"employment\nprotections against dismissal\nfor people with disabilities\nor MS, no flexible working\npractice legislation and no\ndata on employment of\npeople with MS.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:59:41.830Z","updated_at":"2021-05-28T11:59:41.830Z"},{"id":94,"title":"There is","description":"reimbursement\nfor several DMDs and\nsymptomatic treatments.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:59:56.226Z","updated_at":"2021-05-28T11:59:56.226Z"}],"recoms":[{"id":95,"title":"","description":"Develop a national neurological disease plan which\nincludes a comprehensive approach to MS with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:00:08.869Z","updated_at":"2021-05-28T12:00:08.869Z"},{"id":96,"title":"","description":"Ensure all approved DMDs and symptomatic\ntherapies are fully reimbursed by the\nnational health insurance system.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:00:17.395Z","updated_at":"2021-05-28T12:00:17.395Z"},{"id":97,"title":"","description":"Establish a national MS registry with mandatory\ndata collection encompassing epidemiological,\nclinical and rehabilitation data.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:00:25.649Z","updated_at":"2021-05-28T12:00:25.649Z"}],"countryName":"Latvia","alpha2":"LV","alpha3":"LVA"},{"id":53,"added":true,"country":{"id":17,"countryName":"Ireland","alpha2":"IE","alpha3":"IRL","created_at":"2021-05-27T21:11:57.050Z","updated_at":"2021-05-27T21:11:57.050Z"},"values":[{"value":"3.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"4.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"13.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"1.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"11.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"67","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"10.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"4.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"84","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"70","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"81","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"82","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"20","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"29","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_FULL","description":null,"displayName":"Full-time employment"},{"value":"19","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_PART","description":null,"displayName":"Part-time employment"},{"value":"38","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"4900000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"9000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"None","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"48","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"Chronic and neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"19","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_PART","description":null,"displayName":"Part-time employed"},{"value":"29","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_FULL","description":null,"displayName":"Full-time employed"},{"value":"59.0","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"A nationally ring-fenced budget for infused MS therapies and an\nMS Clinical Advisory Group within the Irish National Clinical Care\nProgramme have been noted successes in recent years. However,\nthere are still areas for improvement:","countryContext":"Healthcare in Ireland is managed by\nmany governmental bodies including the\nDepartment of Health and the Health\nService Executive.(1)\nHealthcare spending is one fifth higher than the European\nUnion average and there is a high rate of voluntary private\nhealth insurance.\nDespite this, out-of-pocket spending and copayments\nremain significant, though some people\nwith long-term health conditions are exempt from\nsome of these additional payments.","created_at":"2021-05-27T21:11:57.050Z","updated_at":"2021-05-27T21:11:57.050Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Ireland: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":76,"title":"2020 - Ireland Factsheet - EN","published":null,"published_at":"2021-05-28T17:00:22.994Z","created_at":"2021-05-28T17:00:22.999Z","updated_at":"2021-05-28T17:00:22.999Z","document":{"id":130,"name":"MS Barometer 2020_Country Factsheet_Ireland_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"a3c82d5cfa4f57f31c7137f0581d1044","ext":".pdf","mime":"application/pdf","size":281.72,"url":"https://barometer.ams3.digitaloceanspaces.com/a3c82d5cfa4f57f31c7137f0581d1044.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:00:23.214Z","updated_at":"2021-05-28T17:00:23.214Z"}},{"id":77,"title":"2020 - Ireland Factsheet - GA","published":null,"published_at":"2021-05-28T17:00:47.314Z","created_at":"2021-05-28T17:00:47.316Z","updated_at":"2021-05-28T17:00:47.316Z","document":{"id":131,"name":"MS Barometer 2020_Country Factsheet_Ireland_GA.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"5671e0756279e3fc9c1f81073de026c5","ext":".pdf","mime":"application/pdf","size":272.52,"url":"https://barometer.ams3.digitaloceanspaces.com/5671e0756279e3fc9c1f81073de026c5.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:00:47.495Z","updated_at":"2021-05-28T17:00:47.495Z"}}],"findings":[{"id":80,"title":"There are fewer than","description":"practising neurologists in\nIreland, one of the lowest per\ncapita numbers in Europe.","highlightText":"35","isHighlighted":true,"created_at":"2021-05-28T11:50:53.049Z","updated_at":"2021-05-28T11:50:53.049Z"},{"id":81,"title":"Under","description":"of people with\nMS receive occupational\nrehabilitation, and\nfewer than 20% receive\npsychological and\ncognitive rehabilitation.","highlightText":"30%","isHighlighted":true,"created_at":"2021-05-28T11:51:25.850Z","updated_at":"2021-05-28T11:51:25.850Z"},{"id":82,"title":"There is only","description":"dedicated\nMS care centre – focusing\non respite care.","highlightText":"1","isHighlighted":true,"created_at":"2021-05-28T11:51:42.842Z","updated_at":"2021-05-28T11:51:42.842Z"}],"recoms":[{"id":83,"title":"","description":"Establish and provide secure funding for local,\ncommunity-based multidisciplinary MS teams across the\ncountry that include clinical and rehabilitation specialists.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:51:56.881Z","updated_at":"2021-05-28T11:51:56.881Z"},{"id":84,"title":"","description":"Dedicate funding to the Neurological Rehabilitation\nStrategy 2019–2021 to ensure that all people with MS\nhave publicly funded rehabilitation programmes spanning psychological, cognitive and occupational support.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:52:24.249Z","updated_at":"2021-05-28T11:52:24.249Z"},{"id":85,"title":"","description":"Establish a national MS registry with mandatory data\ncollection encompassing clinical, occupational and\npatient-reported data.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:52:33.022Z","updated_at":"2021-05-28T11:52:33.022Z"}],"countryName":"Ireland","alpha2":"IE","alpha3":"IRL"},{"id":51,"added":true,"country":{"id":1,"countryName":"Hungary","alpha2":"HU","alpha3":"HUN","created_at":"2021-05-13T12:30:14.623Z","updated_at":"2021-05-13T12:30:14.623Z"},"values":[{"value":"12.2","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"5.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"1.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"17","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"9.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"3.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"9.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"7.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"83","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"72","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"62","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"55","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"1.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"35","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"30","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"9700000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"8500","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"Local or regional ","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"50.8","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Significant progress has been made in availability of disease-modifying\ndrugs (DMDs) in Hungary, with all DMDs approved by the European\nMedicines Agency available at the national level and covered by the\nhealth insurance. A new emphasis on neurorehabilitation has been\nmade to support wider efforts in access to rehabilitation, but deficits\nremain:","countryContext":"Hungary provides healthcare coverage to\nalmost all citizens through a centralised\nhealth insurance fund.(1)\nHowever, a limited benefits package results\nin considerable out-of-pocket payments – double the European\nUnion (EU) average. Government spending on health can be\nunstable and is below the EU average.\nThe healthcare system focuses mostly on hospitalbased\ncare, with primary and preventive care\ncomparatively underdeveloped.","created_at":"2021-05-13T12:30:14.623Z","updated_at":"2021-05-13T12:30:14.623Z","references":"(1) OECD, Systems EOoH, Policies. 2019. Hungary: Country Health Profile 2019","factsheets":[{"id":72,"title":"2020 - Hungary Factsheet - HU","published":null,"published_at":"2021-05-28T16:51:48.938Z","created_at":"2021-05-28T16:51:48.941Z","updated_at":"2021-05-28T16:51:48.941Z","document":{"id":126,"name":"MS Barometer 2020_Country Factsheet_Hungary_HU.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"00015419f522fc96f51481cbb5e126fb","ext":".pdf","mime":"application/pdf","size":263.63,"url":"https://barometer.ams3.digitaloceanspaces.com/00015419f522fc96f51481cbb5e126fb.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:51:49.133Z","updated_at":"2021-05-28T16:51:49.133Z"}},{"id":73,"title":"2020 - Hungary Factsheet - EN","published":null,"published_at":"2021-05-28T16:52:05.484Z","created_at":"2021-05-28T16:52:05.490Z","updated_at":"2021-05-28T16:52:05.490Z","document":{"id":127,"name":"MS Barometer 2020_Country Factsheet_Hungary_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"38a2c5ce40609c3cbcf26c2159bbf078","ext":".pdf","mime":"application/pdf","size":265.21,"url":"https://barometer.ams3.digitaloceanspaces.com/38a2c5ce40609c3cbcf26c2159bbf078.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:52:05.648Z","updated_at":"2021-05-28T16:52:05.648Z"}}],"findings":[{"id":74,"title":"Only","description":"of people with MS\nreceive treatment with DMDs.","highlightText":"54%","isHighlighted":true,"created_at":"2021-05-28T11:46:52.571Z","updated_at":"2021-05-28T11:46:52.571Z"},{"id":75,"title":"There are ","description":"symptomatic\ntherapies that are 100%\nreimbursed for people\nwith MS.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:47:12.270Z","updated_at":"2021-05-28T11:47:12.270Z"},{"id":76,"title":"Under","description":"of people\nwith MS receive cognitive\nrehabilitation support.","highlightText":"40%","isHighlighted":true,"created_at":"2021-05-28T11:47:28.840Z","updated_at":"2021-05-28T11:47:28.840Z"}],"recoms":[{"id":77,"title":"","description":"Develop a national neurological disease plan\nthat includes holistic treatment and care for MS\nwith an adequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:47:41.846Z","updated_at":"2021-05-28T11:47:41.846Z"},{"id":78,"title":"","description":"Develop nationally specific treatment\nguidelines for paediatric MS.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:47:51.381Z","updated_at":"2021-05-28T11:47:51.381Z"},{"id":79,"title":"","description":"Mandate electronic data recording\nand expansion of the Szegedi Sclerosis\nMultiplex Regiszter.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:48:07.299Z","updated_at":"2021-05-28T11:48:07.299Z"}],"countryName":"Hungary","alpha2":"HU","alpha3":"HUN"},{"id":68,"added":true,"country":{"id":32,"countryName":"Sweden","alpha2":"SE","alpha3":"SWE","created_at":"2021-05-27T21:19:49.434Z","updated_at":"2021-05-27T21:19:49.434Z"},"values":[{"value":"12.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"14.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"4.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"67","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"6.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"4.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"4.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"58","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"71","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"81","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"25","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"83","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"34","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"10000000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"21500","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"Neurological only","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"59.0","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Sweden has good access and high reimbursement for disease-modifying\ndrugs (DMDs) and symptomatic therapies. The research environment in\nSweden is strong: the Swedish MS Disease Registry includes 80% of the\npopulation and people with MS can access an online portal at any time\nto submit information. However, deficits persist:","countryContext":"Sweden has a well-funded healthcare system with universal\ncoverage.(1) However, care is funded, organised and\ndelivered at the county level, leading to regional disparities\nin funding priorities and services offered across the 21\ncounties.","created_at":"2021-05-27T21:19:49.434Z","updated_at":"2021-05-27T21:19:49.434Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Sweden: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":110,"title":"2020 - Sweden Factsheet - EN","published":null,"published_at":"2021-05-28T17:46:07.697Z","created_at":"2021-05-28T17:46:07.701Z","updated_at":"2021-05-28T17:46:07.701Z","document":{"id":164,"name":"MS Barometer 2020_Country Factsheet_Sweden_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"2396682bcae2794525af043fc14ed315","ext":".pdf","mime":"application/pdf","size":288.83,"url":"https://barometer.ams3.digitaloceanspaces.com/2396682bcae2794525af043fc14ed315.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:46:07.995Z","updated_at":"2021-05-28T17:46:07.995Z"}},{"id":111,"title":"2020 - Sweden Factsheet - SV","published":null,"published_at":"2021-05-28T17:46:26.236Z","created_at":"2021-05-28T17:46:26.239Z","updated_at":"2021-05-28T17:46:26.239Z","document":{"id":165,"name":"MS Barometer 2020_Country Factsheet_Sweden_SV.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"006fa3b8d14f6336d50b10e87b2a780f","ext":".pdf","mime":"application/pdf","size":252.95,"url":"https://barometer.ams3.digitaloceanspaces.com/006fa3b8d14f6336d50b10e87b2a780f.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:46:26.378Z","updated_at":"2021-05-28T17:46:26.378Z"}}],"findings":[{"id":189,"title":"Sweden has","description":"neurologists –\nless than 1 per 22,000 people.","highlightText":"450","isHighlighted":true,"created_at":"2021-05-28T17:47:43.899Z","updated_at":"2021-05-28T17:47:43.899Z"},{"id":190,"title":"Under","description":"of people\nwith MS have access to\nphysical rehabilitation.","highlightText":"10%","isHighlighted":true,"created_at":"2021-05-28T17:48:01.210Z","updated_at":"2021-05-28T17:48:01.210Z"},{"id":191,"title":"There is","description":"clear data on\nthe levels of employment\nof people with MS in\nSweden.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T17:48:16.412Z","updated_at":"2021-05-28T17:48:16.412Z"}],"recoms":[{"id":192,"title":"","description":"Increase the number of practising neurologists\nto ensure every person with MS has access to a\nneurologist at least once a year, as stated in the\nSwedish guidelines for MS care.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:48:29.307Z","updated_at":"2021-05-28T17:48:29.307Z"},{"id":193,"title":"","description":"Reduce regional disparities in the provision of therapies\nand rehabilitation services, ensuring that every person\nwith MS has a personalised rehabilitation plan and\naccess to a multidisciplinary rehabilitation team.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:48:38.054Z","updated_at":"2021-05-28T17:48:38.054Z"},{"id":194,"title":"","description":"Raise awareness of paediatric MS as a\nrare disease and increase the number of\nspecialist paediatric neurologists.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:48:47.685Z","updated_at":"2021-05-28T17:48:47.685Z"}],"countryName":"Sweden","alpha2":"SE","alpha3":"SWE"},{"id":58,"added":true,"country":{"id":23,"countryName":"Moldova","alpha2":"MD","alpha3":"MDA","created_at":"2021-05-27T21:14:21.458Z","updated_at":"2021-05-27T21:14:21.458Z"},"values":[{"value":"4.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"1.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"17","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"7.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"2.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"5.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"61","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"27","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"78","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"32","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"0","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"22","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"4000000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"1500","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"yes","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"None","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"30.4","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"The number of people receiving disease-modifying drugs (DMDs)\nrose in 2018 from 17 to 60 people, and may now be as high as 100.\nHowever, most people are still unable to access DMDs, and other gaps\nin care persist:","countryContext":"Healthcare in Moldova is complex as many\nactors are involved in healthcare provision,\nregulation and financing, including central\ngovernment agencies, local authorities, and\npublic and private medical providers.(1)\nThere is mandatory health insurance, but out-of-pocket costs\nmay reach up to 44% of total spending.(2) Following reforms\nin 2004, focus has shifted from a hospital-centric system\nto one with strong primary care, but significant\ngeographical disparities persist and, overall,\nprovisions for long-term and rehabilitation care\nremain weak.","created_at":"2021-05-27T21:14:21.458Z","updated_at":"2021-05-27T21:14:21.458Z","references":"(1) European Observatory on Health Systems Policies. 2012. Republic of Moldova: Health systems in review. Copenhagen, Denmark\n(2) World Bank. Out of pocket expenditure - Moldova. Available from: https://data.worldbank.org/indicator/SH.XPD.OOPC.CH.ZS?locations=MD","factsheets":[{"id":92,"title":"2020 - Moldova Factsheet - MD","published":null,"published_at":"2021-05-28T17:16:14.978Z","created_at":"2021-05-28T17:16:14.982Z","updated_at":"2021-05-28T17:16:14.982Z","document":{"id":146,"name":"MS Barometer 2020_Country Factsheet_Moldova_MD.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"9628334e83f42c27c9723369727adc29","ext":".pdf","mime":"application/pdf","size":323.15,"url":"https://barometer.ams3.digitaloceanspaces.com/9628334e83f42c27c9723369727adc29.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:16:15.196Z","updated_at":"2021-05-28T17:16:15.196Z"}},{"id":93,"title":"2020 - Moldova Factsheet - EN","published":null,"published_at":"2021-05-28T17:16:28.934Z","created_at":"2021-05-28T17:16:28.937Z","updated_at":"2021-05-28T17:16:28.937Z","document":{"id":147,"name":"MS Barometer 2020_Country Factsheet_Moldova_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"6704489e95ded0f07fb0a167de1c9331","ext":".pdf","mime":"application/pdf","size":318.52,"url":"https://barometer.ams3.digitaloceanspaces.com/6704489e95ded0f07fb0a167de1c9331.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:16:29.235Z","updated_at":"2021-05-28T17:16:29.235Z"}}],"findings":[{"id":110,"title":"Only","description":"DMD is available and\nreimbursed, and just 6% of\npeople with MS receive this\nDMD.","highlightText":"1","isHighlighted":true,"created_at":"2021-05-28T12:16:49.774Z","updated_at":"2021-05-28T12:16:49.774Z"},{"id":111,"title":"There is","description":"reimbursement\nfor symptomatic therapies\nused outside of the hospital\nsetting for people with MS.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T12:17:15.722Z","updated_at":"2021-05-28T12:17:15.722Z"},{"id":112,"title":"","description":"publicly available\nrehabilitation is inpatient\nrehabilitation –which up\nto 30% of people with MS\nreceive each year.","highlightText":"The only","isHighlighted":true,"created_at":"2021-05-28T12:17:48.012Z","updated_at":"2021-05-28T12:17:48.012Z"}],"recoms":[{"id":113,"title":"","description":"Improve understanding of DMDs and symptomatic\ntherapies among decision-makers and policymakers\nto increase the number of approved and reimbursed\ntreatments, and ensure adequate budgets are secured to\nfund them.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:18:10.873Z","updated_at":"2021-05-28T12:18:10.873Z"},{"id":114,"title":"","description":"Establish an MS centre of excellence with\na multidisciplinary team incorporating a\nneurologist, nurse and rehabilitation specialists.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:18:27.702Z","updated_at":"2021-05-28T12:18:27.702Z"},{"id":115,"title":"","description":"Establish a publicly funded outpatient rehabilitation\nservice that allows all people with MS to receive a\npersonalised rehabilitation plan and access to a\nmultidisciplinary rehabilitation team.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:18:48.947Z","updated_at":"2021-05-28T12:18:48.947Z"}],"countryName":"Moldova","alpha2":"MD","alpha3":"MDA"},{"id":56,"added":true,"country":{"id":20,"countryName":"Lithuania","alpha2":"LT","alpha3":"LTU","created_at":"2021-05-27T21:13:05.599Z","updated_at":"2021-05-27T21:13:05.599Z"},"values":[{"value":"12.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"8.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"50","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"11.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"5.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"12.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"8.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"93","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"76","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"71","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"75","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"49","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"45","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"2800000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"3000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"65.4","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Lithuania aligned national reimbursement of disease modifying drugs\n(DMDs) with recommendations from the European Medicines Agency.\nAs a result, DMD access has improved significantly. Yet, important\nchallenges to MS care remain.","countryContext":"The Lithuanian healthcare system provides\nuniversal health coverage, primarily\nthrough its health insurance fund.(1)\nHowever, spending on health is lower than\nthe EU average, with particular deficits in long-term care. Outof-\npocket spending can be significant, driving inequalities\nin care.","created_at":"2021-05-27T21:13:05.599Z","updated_at":"2021-05-27T21:13:05.599Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Lithuania: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":82,"title":"2020 - Lithuania Factsheet - EN","published":null,"published_at":"2021-05-28T17:06:25.354Z","created_at":"2021-05-28T17:06:25.356Z","updated_at":"2021-05-28T17:06:25.356Z","document":{"id":136,"name":"MS Barometer 2020_Country Factsheet_Lithuania_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"028c1f0327f900f5359bbb97c303b6e0","ext":".pdf","mime":"application/pdf","size":242.76,"url":"https://barometer.ams3.digitaloceanspaces.com/028c1f0327f900f5359bbb97c303b6e0.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:06:25.541Z","updated_at":"2021-05-28T17:06:25.541Z"}},{"id":83,"title":"2020 - Lithuania Factsheet - LT","published":null,"published_at":"2021-05-28T17:06:39.717Z","created_at":"2021-05-28T17:06:39.720Z","updated_at":"2021-05-28T17:06:39.720Z","document":{"id":137,"name":"MS Barometer 2020_Country Factsheet_Lithuania_LT.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"3b96c8528e9b0a300b80541b92037ad8","ext":".pdf","mime":"application/pdf","size":255.05,"url":"https://barometer.ams3.digitaloceanspaces.com/3b96c8528e9b0a300b80541b92037ad8.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:06:39.841Z","updated_at":"2021-05-28T17:06:39.841Z"}}],"findings":[{"id":98,"title":"On average, it still takes over","description":"months for a therapy\napproved by the EMA to be\navailable nationally.","highlightText":"15","isHighlighted":true,"created_at":"2021-05-28T12:03:04.208Z","updated_at":"2021-05-28T12:03:04.208Z"},{"id":99,"title":"The annual entitlement is","description":"for in-patient\nrehabilitation or 14 days for\nout-patient rehabilitation,\nthough implementation and\nservice delivery may vary.","highlightText":"20 days","isHighlighted":true,"created_at":"2021-05-28T12:03:27.383Z","updated_at":"2021-05-28T12:03:27.383Z"},{"id":100,"title":"People with MS and their carers","description":"social support,\nincluding financial support\nfor carers of people with MS.","highlightText":"lack","isHighlighted":true,"created_at":"2021-05-28T12:03:50.131Z","updated_at":"2021-05-28T12:03:50.131Z"}],"recoms":[{"id":101,"title":"","description":"Develop a national neurological disease plan which\nincludes a comprehensive approach to MS with an\nadequate budget for implementation and funding\nfor MS research.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:04:01.397Z","updated_at":"2021-05-28T12:04:01.397Z"},{"id":102,"title":"","description":"Increase social support for people with MS and their\ncarers, including providing funding for informal carers\nand improving workplace support to help people with\nMS and their carers to find and keep employment.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:04:12.515Z","updated_at":"2021-05-28T12:04:12.515Z"},{"id":103,"title":"","description":"Include the Lithuanian Multiple Sclerosis Union (LISS)\nand people with MS in the government’s consultation\n group on MS-related policies and matters.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:04:23.989Z","updated_at":"2021-05-28T12:04:49.784Z"}],"countryName":"Lithuania","alpha2":"LT","alpha3":"LTU"},{"id":67,"added":true,"country":{"id":31,"countryName":"Slovenia","alpha2":"SI","alpha3":"SVN","created_at":"2021-05-27T21:19:28.414Z","updated_at":"2021-05-27T21:19:28.414Z"},"values":[{"value":"11.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"1.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"17","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"7.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"0.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"6.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"59","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"67","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"78","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"40","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"1.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"0","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"4","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"2000000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"3500","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"None","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"37.3","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Access to treatments is good and all therapies are reimbursed by the\nnational health insurance system. However, gaps in care persist:","countryContext":"Spending on health in Slovenia has\nincreased over the past decade, resulting in\nalmost universal healthcare coverage and\nsome of the lowest out-of-pocket spending\non health in the European Union.(1)\nThe focus is now on strengthening the long-term and\nprimary care systems to better support people with\nchronic conditions.","created_at":"2021-05-27T21:19:28.414Z","updated_at":"2021-05-27T21:19:28.414Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Slovenia: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":106,"title":"2020 - Slovenia Factsheet - EN","published":null,"published_at":"2021-05-28T17:38:11.502Z","created_at":"2021-05-28T17:38:11.515Z","updated_at":"2021-05-28T17:38:11.515Z","document":{"id":160,"name":"MS Barometer 2020_Country Factsheet_Slovenia_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"2c12303bbcae4743c11bbc96aa520184","ext":".pdf","mime":"application/pdf","size":284.24,"url":"https://barometer.ams3.digitaloceanspaces.com/2c12303bbcae4743c11bbc96aa520184.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:38:11.676Z","updated_at":"2021-05-28T17:38:11.676Z"}},{"id":107,"title":"2020 - Slovenia Factsheet - SL","published":null,"published_at":"2021-05-28T17:38:25.887Z","created_at":"2021-05-28T17:38:25.891Z","updated_at":"2021-05-28T17:38:25.891Z","document":{"id":161,"name":"MS Barometer 2020_Country Factsheet_Slovenia_SL.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"26523c7f8717de27f83ee6060d37e0b2","ext":".pdf","mime":"application/pdf","size":279.6,"url":"https://barometer.ams3.digitaloceanspaces.com/26523c7f8717de27f83ee6060d37e0b2.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:38:26.140Z","updated_at":"2021-05-28T17:38:26.140Z"}}],"findings":[{"id":177,"title":"There are just","description":"neurologists\nwho specialise in MS.","highlightText":"15","isHighlighted":true,"created_at":"2021-05-28T17:40:05.329Z","updated_at":"2021-05-28T17:40:05.329Z"},{"id":178,"title":"There are just","description":"nurses\nwho specialise in caring\nfor people with MS.","highlightText":"8","isHighlighted":true,"created_at":"2021-05-28T17:40:23.278Z","updated_at":"2021-05-28T17:40:23.278Z"},{"id":179,"title":"Under","description":"of people\nwith MS receive physical\nrehabilitation.","highlightText":"50%","isHighlighted":true,"created_at":"2021-05-28T17:40:39.076Z","updated_at":"2021-05-28T17:40:39.076Z"}],"recoms":[{"id":180,"title":"","description":"Establish certified training courses in MS to increase\naccess to specialist neurologists, nurses and\nrehabilitation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:40:50.990Z","updated_at":"2021-05-28T17:40:50.990Z"},{"id":181,"title":"","description":"Ensure each person with MS receives\npersonalised rehabilitation with an annual\nneeds assessment.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:41:00.987Z","updated_at":"2021-05-28T17:41:00.987Z"},{"id":182,"title":"","description":"Establish a national MS registry with mandatory data\ncollection encompassing clinical, occupational and\npatient-reported data.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:41:20.628Z","updated_at":"2021-05-28T17:41:20.628Z"}],"countryName":"Slovenia","alpha2":"SI","alpha3":"SVN"},{"id":60,"added":true,"country":{"id":24,"countryName":"North Macedonia","alpha2":"MK","alpha3":"MKD","created_at":"2021-05-27T21:15:50.150Z","updated_at":"2021-05-27T21:15:50.150Z"},"values":[{"value":"6.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"6.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"1.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"17","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"5.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"2.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"7.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"45","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"40","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"42","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"45","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"0.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"39","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"24","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"2100000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"1500","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"5.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"35.9","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"North Macedonia has made recent progress in access to and use of\ndisease-modifying drugs (DMDs) and the establishment of a national\nMS patient registry. Collaboration with healthcare authorities and\nthe Ministry of Health has been an important facilitator to these\nimprovements. However, deficits persist:","countryContext":"The North Macedonian social insurance\nsystem provides citizens with a broad\npackage of benefits, covering most\ntreatments and rehabilitation services.(1)\nHowever, the public hospitals often lack adequate funding,\nleading to substantial co-payments, direct payments and\ninefficient service provision.","created_at":"2021-05-27T21:15:50.150Z","updated_at":"2021-05-27T21:15:50.150Z","references":"(1) Milevska Kostova N, Chichevalieva S, Ponce NA, et al. 2017. Health Syst Transit 19(3): 1-160","factsheets":[{"id":90,"title":"2020 - North Macedonia Factsheet - MK","published":null,"published_at":"2021-05-28T17:15:31.705Z","created_at":"2021-05-28T17:15:31.707Z","updated_at":"2021-05-28T17:15:31.707Z","document":{"id":144,"name":"MS Barometer 2020_Country Factsheet_NorthMacedonia_MK.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"71fbcc5e30e031348dfa0102f9d6afff","ext":".pdf","mime":"application/pdf","size":248.22,"url":"https://barometer.ams3.digitaloceanspaces.com/71fbcc5e30e031348dfa0102f9d6afff.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:15:31.929Z","updated_at":"2021-05-28T17:15:31.929Z"}},{"id":91,"title":"2020 - North Macedonia Factsheet - EN","published":null,"published_at":"2021-05-28T17:15:44.385Z","created_at":"2021-05-28T17:15:44.393Z","updated_at":"2021-05-28T17:15:44.393Z","document":{"id":145,"name":"MS Barometer 2020_Country Factsheet_NorthMacedonia_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"4d96c55f99733c4257eb1d01f025ced9","ext":".pdf","mime":"application/pdf","size":267.79,"url":"https://barometer.ams3.digitaloceanspaces.com/4d96c55f99733c4257eb1d01f025ced9.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:15:44.585Z","updated_at":"2021-05-28T17:15:44.585Z"}}],"findings":[{"id":116,"title":"Up to","description":"of people with\nMS are on a waiting list to\nstart or switch their DMDs.","highlightText":"20%","isHighlighted":true,"created_at":"2021-05-28T12:21:47.085Z","updated_at":"2021-05-28T12:21:47.085Z"},{"id":117,"title":"There is ","description":"reimbursement\nfor most symptomatic\ntherapies.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T12:22:13.611Z","updated_at":"2021-05-28T12:22:13.611Z"},{"id":118,"title":"There is ","description":"specialist\nrehabilitation available to\npeople with MS.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T15:42:31.389Z","updated_at":"2021-05-28T15:42:31.389Z"}],"recoms":[{"id":119,"title":"","description":"Increase funding for DMDs and symptomatic therapies\nthrough the National Health Insurance Fund’s\ndedicated fund for MS treatment.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T15:42:44.201Z","updated_at":"2021-05-28T15:42:44.201Z"},{"id":120,"title":"","description":"Expand rehabilitation services for\npeople with MS to include cognitive,\npsychological and occupational support.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T15:42:53.834Z","updated_at":"2021-05-28T15:42:53.834Z"},{"id":121,"title":"","description":"Mandate inclusion of all people with MS in the\nMS patient registry.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T15:43:04.804Z","updated_at":"2021-05-28T15:43:04.804Z"}],"countryName":"North Macedonia","alpha2":"MK","alpha3":"MKD"},{"id":52,"added":true,"country":{"id":16,"countryName":"Iceland","alpha2":"IS","alpha3":"ISL","created_at":"2021-05-27T21:11:39.845Z","updated_at":"2021-05-27T21:11:39.845Z"},"values":[{"value":"11.2","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"1.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"17","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"9.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"5.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"16.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"7.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"79","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"66","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"63","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"100","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"2.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"0","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"341250","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"720","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"None","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"49","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"54.2","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"MS care in Iceland is improving, driven by recent capacity expansions\nof the MS Centre and significant efforts to improve awareness\nof paediatric MS. In addition, physical rehabilitation is now fully\nreimbursed regardless of disability status. However, there is still room\nfor progress:","countryContext":"Iceland has a centralised healthcare\nsystem providing universal health coverage\nsupplemented by limited out-of-pocket\npayments.(1)\nHealthcare spending per capita is higher than the European\nUnion average, but there is a relatively small budget\nfor preventive care and limited access to general\npractitioners.","created_at":"2021-05-27T21:11:39.845Z","updated_at":"2021-05-27T21:11:39.845Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Iceland: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":74,"title":"2020 - Iceland Factsheet - IS","published":null,"published_at":"2021-05-28T16:56:03.227Z","created_at":"2021-05-28T16:56:03.244Z","updated_at":"2021-05-28T16:56:03.244Z","document":{"id":128,"name":"MS Barometer 2020_Country Factsheet_Iceland_IS.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"100ec490070e17f21c74837d06cf5c4b","ext":".pdf","mime":"application/pdf","size":245.84,"url":"https://barometer.ams3.digitaloceanspaces.com/100ec490070e17f21c74837d06cf5c4b.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:56:03.447Z","updated_at":"2021-05-28T16:56:03.447Z"}},{"id":75,"title":"2020 - Iceland Factsheet - EN","published":null,"published_at":"2021-05-28T16:56:18.824Z","created_at":"2021-05-28T16:56:18.829Z","updated_at":"2021-05-28T16:56:18.829Z","document":{"id":129,"name":"MS Barometer 2020_Country Factsheet_Iceland_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"0ec7d3bcd2fb2ab3f7104c983673087a","ext":".pdf","mime":"application/pdf","size":267.8,"url":"https://barometer.ams3.digitaloceanspaces.com/0ec7d3bcd2fb2ab3f7104c983673087a.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:56:19.023Z","updated_at":"2021-05-28T16:56:19.023Z"}}],"findings":[{"id":140,"title":"There is","description":"disease plan for\nMS or neurological conditions\nmore broadly.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T16:57:30.706Z","updated_at":"2021-05-28T16:57:30.706Z"},{"id":141,"title":"There are only","description":"practising neurologists in\nthe whole country, with\nonly 6 focusing on MS.","highlightText":"24","isHighlighted":true,"created_at":"2021-05-28T16:57:50.729Z","updated_at":"2021-05-28T16:57:50.729Z"},{"id":142,"title":"There is ","description":"national registry\nfor MS or neurological\ndiseases more broadly.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T16:58:45.210Z","updated_at":"2021-05-28T16:58:45.210Z"}],"recoms":[{"id":143,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T16:58:58.095Z","updated_at":"2021-05-28T16:58:58.095Z"},{"id":144,"title":"","description":"Establish a national neurological disease registry\nwith mandatory data collection encompassing\nclinical, occupational and patient-reported data.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T16:59:07.972Z","updated_at":"2021-05-28T16:59:07.972Z"},{"id":145,"title":"","description":"Increase the number of practising neurologists and\nMS specialist nurses to ensure every person with\nMS has timely access to specialist care.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T16:59:18.744Z","updated_at":"2021-05-28T16:59:18.744Z"}],"countryName":"Iceland","alpha2":"IS","alpha3":"ISL"},{"id":71,"added":true,"country":{"id":33,"countryName":"Switzerland","alpha2":"CH","alpha3":"CHE","created_at":"2021-05-27T21:20:10.104Z","updated_at":"2021-05-27T21:20:10.104Z"},"values":[{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"15.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"13.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"5.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"11.2","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"7.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"16.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"7.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"6.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"Chronic and neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"83","dataset":{"id":9,"name":"F2 Policy scores","units":"%","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-29T09:07:55.122Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"94","dataset":{"id":13,"name":"F5 Care delivery","units":"%","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-29T09:08:47.245Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"94","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"63","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"100","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"80","dataset":{"id":24,"name":"F17 Nat Research","units":"%","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T10:23:25.375Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"65","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"59","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"%","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T10:19:04.576Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"8600000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"15000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"yes","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"65","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_EMP","description":null,"displayName":"Employed"},{"value":"84.4","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"The launch of the Swiss MS Registry in 2016 was a significant\nachievement to improve MS management in Switzerland, and a\npaediatric MS registry is now being set up. The majority of people\nwith MS (90%) receive disease-modifying drugs (DMDs) and all\nsurveyed symptomatic treatments are available. However, some\ngaps in care remain:","countryContext":"Healthcare organisation in Switzerland is\ncomplex with many actors involved, including\nregional and municipal decision-makers,\nnational health insurers, healthcare providers\nand civil society organisations.(1) Switzerland\nhas mandatory health insurance, which is subsidised for people\nwith low incomes. This, together with government schemes,\nconstitutes 64% of total health spending, which is nearly\ntwice the Organisation for Economic Co-operation\nand Development (OECD) average for per capita\nhealth spending.(2) While this ensures universal health\ncoverage for all citizens, health insurance premiums\nand out-of-pocket payments are also higher than the\nOECD average, which may result in health inequities.","created_at":"2021-05-27T21:20:10.104Z","updated_at":"2021-05-27T21:20:10.104Z","references":"(1) European Observatory on Health Systems Policies. 2015. Switzerland: Health systems review. Copenhagen, Denmark\n(2) Organisation for Economic Co-operation and Development. 2017. Health at a Glance 2017: OECD Indicators - How does Switzerland compare? Paris: OECD","factsheets":[{"id":112,"title":"2020 - Switzerland Factsheet - EN","published":null,"published_at":"2021-05-28T17:49:41.302Z","created_at":"2021-05-28T17:49:41.313Z","updated_at":"2021-05-28T17:49:41.313Z","document":{"id":166,"name":"MS Barometer 2020_Country Factsheet_Switzerland_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"7fcaa79e799958a9a1ebf2742da53fc7","ext":".pdf","mime":"application/pdf","size":281.48,"url":"https://barometer.ams3.digitaloceanspaces.com/7fcaa79e799958a9a1ebf2742da53fc7.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:49:41.602Z","updated_at":"2021-05-28T17:49:41.602Z"}},{"id":113,"title":"2020 - Switzerland Factsheet - DE","published":null,"published_at":"2021-05-28T17:49:54.698Z","created_at":"2021-05-28T17:49:54.701Z","updated_at":"2021-05-28T17:49:54.701Z","document":{"id":167,"name":"MS Barometer 2020_Country Factsheet_Switzerland_DE.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"5965513748d6d2219061beedb700765c","ext":".pdf","mime":"application/pdf","size":250.8,"url":"https://barometer.ams3.digitaloceanspaces.com/5965513748d6d2219061beedb700765c.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:49:54.917Z","updated_at":"2021-05-28T17:49:54.917Z"}},{"id":114,"title":"2020 - Switzerland Factsheet - FR","published":null,"published_at":"2021-05-28T17:50:08.218Z","created_at":"2021-05-28T17:50:08.221Z","updated_at":"2021-05-28T17:50:08.221Z","document":{"id":168,"name":"MS Barometer 2020_Country Factsheet_Switzerland_FR.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"7f58d0a4dcc38f6105ca7fdedecca0b0","ext":".pdf","mime":"application/pdf","size":285.02,"url":"https://barometer.ams3.digitaloceanspaces.com/7f58d0a4dcc38f6105ca7fdedecca0b0.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:50:08.415Z","updated_at":"2021-05-28T17:50:08.415Z"}},{"id":115,"title":"2020 - Switzerland Factsheet - IT","published":null,"published_at":"2021-05-28T17:50:24.678Z","created_at":"2021-05-28T17:50:24.683Z","updated_at":"2021-05-28T17:50:24.683Z","document":{"id":169,"name":"MS Barometer 2020_Country Factsheet_Switzerland_IT.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"3ad7b583cd4354f9d08bea04e52db45d","ext":".pdf","mime":"application/pdf","size":280.69,"url":"https://barometer.ams3.digitaloceanspaces.com/3ad7b583cd4354f9d08bea04e52db45d.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:50:24.877Z","updated_at":"2021-05-28T17:50:24.877Z"}}],"findings":[{"id":195,"title":"It is","description":"how many\nMS specialists there are in\nSwitzerland.","highlightText":"unclear","isHighlighted":true,"created_at":"2021-05-28T17:51:55.382Z","updated_at":"2021-05-28T17:51:55.382Z"},{"id":196,"title":"","description":"people with MS\nmay have access to\nreimbursed psychological\nrehabilitation, though the\nnumber of people with\nMS living with depression\nis significant.","highlightText":"Not all","isHighlighted":true,"created_at":"2021-05-28T17:52:15.181Z","updated_at":"2021-05-28T17:52:15.181Z"},{"id":197,"title":"Under","description":"of people with\nMS are recorded in the\nnational MS registry.","highlightText":"30%","isHighlighted":true,"created_at":"2021-05-28T17:52:32.515Z","updated_at":"2021-05-28T17:52:32.515Z"}],"recoms":[{"id":198,"title":"","description":"Develop formal MS specialist certifications in\npartnership with the national MS society and relevant\nprofessional societies in order to identify and\nformally recognise neurologists and other healthcare\nprofessionals with MS expertise.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:52:46.361Z","updated_at":"2021-05-28T17:52:46.361Z"},{"id":199,"title":"","description":"Change evaluation processes for benefit claims for\npeople with MS to ensure that those with cognitive and\ninvisible impairments can access the support they need.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:52:55.427Z","updated_at":"2021-05-28T17:52:55.427Z"},{"id":200,"title":"","description":"Strengthen reimbursement protocols to ensure all\npeople with MS have full access to therapies and\nspecialist rehabilitation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:53:03.922Z","updated_at":"2021-05-28T17:53:03.922Z"}],"countryName":"Switzerland","alpha2":"CH","alpha3":"CHE"},{"id":42,"added":true,"country":{"id":7,"countryName":"Bosnia and Herzegovina","alpha2":"BA","alpha3":"BIH","created_at":"2021-05-27T21:07:38.320Z","updated_at":"2021-05-27T21:07:38.320Z"},"values":[{"value":"9.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"4.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"67","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"10.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"3.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"8.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"87","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"56","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"68","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"18","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"1.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"0","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"0","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"3280000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"3557","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"None","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"36.9","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Access to certain disease-modifying drugs (DMDs) has improved\nrecently, thanks to advocacy efforts by physicians who were in\nconstant contact with government and regulatory authorities, as well\nas increases in funding for MS treatments. National society members\nalso featured on television to promote treatment for all people with\nMS for World MS Day 2020. However, there remain many areas for\nimprovement requiring attention:","countryContext":"Healthcare in Bosnia and Herzegovina is\nmanaged differently by the two separate\ngoverning entities: in the Federation of\nBosnia and Herzegovina, healthcare is\ndecentralised to the 10 cantons which\nmanage and finance healthcare; in the Republika Srpska, care\nis delivered by the city, municipality and employers,\nwith financing provided through obligatory health\ninsurance.(1)\nRegardless of location, there are limited provisions\nfor long-term care, placing significant strain on\npeople with complex conditions and disabilities.","created_at":"2021-05-27T21:07:38.320Z","updated_at":"2021-05-27T21:07:38.320Z","references":"(1) World Health Organization Regional Office for Europe. 2020. Bosnia and Herzegovina: assessing health systems capacity to manage large influx of refugees and migrants. Copenhagen, Denmark","factsheets":[{"id":53,"title":"2020 - Bosnia and Harzegovina Factsheet - EN","published":null,"published_at":"2021-05-28T16:18:00.237Z","created_at":"2021-05-28T16:18:00.251Z","updated_at":"2021-05-28T16:18:00.251Z","document":{"id":107,"name":"MS Barometer 2020_Country Factsheet_BosniaHerzegovina_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"98f90e78c9aad739c5795d36572c7219","ext":".pdf","mime":"application/pdf","size":282.6,"url":"https://barometer.ams3.digitaloceanspaces.com/98f90e78c9aad739c5795d36572c7219.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:18:00.478Z","updated_at":"2021-05-28T16:18:00.478Z"}},{"id":54,"title":"2020 - Bosnia and Harzegovina Factsheet - BO","published":null,"published_at":"2021-05-28T16:18:17.770Z","created_at":"2021-05-28T16:18:17.775Z","updated_at":"2021-05-28T16:18:17.775Z","document":{"id":108,"name":"MS Barometer 2020_Country Factsheet_BosniaHerzegovina_BO.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"7fb3d339e49efbdc55eaec8a3bc525ec","ext":".pdf","mime":"application/pdf","size":254.13,"url":"https://barometer.ams3.digitaloceanspaces.com/7fb3d339e49efbdc55eaec8a3bc525ec.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:18:17.906Z","updated_at":"2021-05-28T16:18:17.906Z"}}],"findings":[{"id":27,"title":"Just","description":"Just 10% of people with MS\nreceive DMDs; only 5 of the 12\nDMDs surveyed are available\nand reimbursed, and they are\nsubject to significant waiting\nlists and costs.","highlightText":"10%","isHighlighted":true,"created_at":"2021-05-28T11:04:48.981Z","updated_at":"2021-05-28T11:04:48.981Z"},{"id":28,"title":"Up to","description":"of people receive\nphysical rehabilitation,\nwith only 4 outpatient\nphysiotherapy sessions\naccessible annually, and there\nis no access to psychological\nor cognitive rehabilitation.","highlightText":"20%","isHighlighted":true,"created_at":"2021-05-28T11:05:16.103Z","updated_at":"2021-05-28T11:05:16.103Z"},{"id":29,"title":"There are","description":"social\nprotections or support\nprogrammes to help\npeople with MS to\nmaintain employment.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:05:39.496Z","updated_at":"2021-05-28T11:05:39.496Z"}],"recoms":[{"id":30,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS, with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:05:56.271Z","updated_at":"2021-05-28T11:05:56.271Z"},{"id":31,"title":"","description":"Ensure that all DMDs and symptomatic therapies\napproved by the European Medicines Agency are fully\nreimbursed and available to patients in a timely manner.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:06:06.300Z","updated_at":"2021-05-28T11:06:06.300Z"},{"id":32,"title":"","description":"Ensure that all people with MS have better\nreimbursement for rehabilitation programmes and\npublicly- funded options spanning physical therapy\nand cognitive, psychological and occupational support.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:06:15.448Z","updated_at":"2021-05-28T11:06:15.448Z"}],"countryName":"Bosnia and Herzegovina","alpha2":"BA","alpha3":"BIH"},{"id":46,"added":true,"country":{"id":14,"countryName":"Germany","alpha2":"DE","alpha3":"DEU","created_at":"2021-05-27T21:10:53.059Z","updated_at":"2021-05-27T21:10:53.059Z"},"values":[{"value":"12.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"4.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"10.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"5.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"13.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"67","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"10.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"5.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"86","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"80","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"81","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"61","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"74","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"37","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_FULL","description":null,"displayName":"Full-time employment"},{"value":"19","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_PART","description":null,"displayName":"Part-time employment"},{"value":"47","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"83700000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"250000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"56","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"19","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_PART","description":null,"displayName":"Part-time employed"},{"value":"37","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_FULL","description":null,"displayName":"Full-time employed"},{"value":"71.6","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Aiming to improve access to specialised care and support, Germany\nhas established new MS centres and a Master in MS Management.\nFurthermore, the MS Society has supported the development\nof new patient empowerment programmes to better support people\nwith MS. However, there are still areas for improvement:","countryContext":"Healthcare in Germany is organised by\nvarious bodies at the federal, regional and\nstate levels.(1)\nHealthcare spending is higher than the\nEuropean Union (EU) average and the country has the highest per\ncapita spend on healthcare in the EU.\nGermany has near universal health coverage through\ncompulsory health insurance that is primarily based\non a public insurance scheme, with low out-of-pocket\nspending. However, care is noted to be fragmented\nand uncoordinated due to lack of digitisation.","created_at":"2021-05-27T21:10:53.059Z","updated_at":"2021-05-27T21:10:53.059Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Germany: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":68,"title":"2020 - Germany Factsheet - EN","published":null,"published_at":"2021-05-28T16:49:35.266Z","created_at":"2021-05-28T16:49:35.270Z","updated_at":"2021-05-28T16:49:35.270Z","document":{"id":122,"name":"MS Barometer 2020_Country Factsheet_Germany_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"e0b6b792169047c6f0965820b2570823","ext":".pdf","mime":"application/pdf","size":269.87,"url":"https://barometer.ams3.digitaloceanspaces.com/e0b6b792169047c6f0965820b2570823.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:49:35.531Z","updated_at":"2021-05-28T16:49:35.531Z"}},{"id":69,"title":"2020 - Germany Factsheet - DE","published":null,"published_at":"2021-05-28T16:49:49.148Z","created_at":"2021-05-28T16:49:49.151Z","updated_at":"2021-05-28T16:49:49.151Z","document":{"id":123,"name":"MS Barometer 2020_Country Factsheet_Germany_DE.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"33e3d9727ba70e424525adf3ef266a50","ext":".pdf","mime":"application/pdf","size":253.89,"url":"https://barometer.ams3.digitaloceanspaces.com/33e3d9727ba70e424525adf3ef266a50.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:49:49.349Z","updated_at":"2021-05-28T16:49:49.349Z"}}],"findings":[{"id":63,"title":"Only","description":"of people\nwith MS are recorded in the\nnational MS registry.","highlightText":"15-25%","isHighlighted":true,"created_at":"2021-05-28T11:38:47.789Z","updated_at":"2021-05-28T11:38:47.789Z"},{"id":64,"title":"There are","description":"available\nstatistics for the numbers\nof people with MS receiving\nphysical, psychological,\ncognitive or occupational\nrehabilitation.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:39:06.134Z","updated_at":"2021-05-28T11:39:06.134Z"},{"id":65,"title":"There is","description":"accredited\nprogramme for MSspecialist\nnurses.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:39:27.193Z","updated_at":"2021-05-28T11:39:27.193Z"}],"recoms":[{"id":66,"title":"","description":"Strengthen management of MS care by\nproviding accredited training for MS-specialist\nnurses and ensuring that these roles are\ndirectly reimbursed by insurance providers.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:39:39.800Z","updated_at":"2021-05-28T11:39:39.800Z"},{"id":67,"title":"","description":"Mandate inclusion of all people with MS into the\nMS patient registry and record data on use of\nrehabilitation services.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:39:49.049Z","updated_at":"2021-05-28T11:39:49.049Z"}],"countryName":"Germany","alpha2":"DE","alpha3":"DEU"},{"id":47,"added":true,"country":{"id":11,"countryName":"Estonia","alpha2":"EE","alpha3":"EST","created_at":"2021-05-27T21:09:39.223Z","updated_at":"2021-05-27T21:09:39.223Z"},"values":[{"value":"12.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"4.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"67","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"7.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"5.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"12.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"8.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"67","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"74","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"72","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"71","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"3.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"0","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"44","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"1300000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"1000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"None","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"53.9","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"People with MS have good access to disease-modifying drugs,\nand neurologists are able to see their patients very frequently for\nassessments and to modify treatment plans. In addition, access to\nmultidisciplinary care is good. However, deficits persist:","countryContext":"Healthcare in Estonia is organised and\ndelivered by the Ministry of Social Affairs\nand a national health insurance fund.(1)\nHealth spending as a proportion of GDP is\nconsiderably lower than the European Union (EU) average, and\nalmost one quarter of spending on healthcare is in the\nform of out-of-pocket payments for medicine.\nEstonia has the highest unmet need for healthcare\nin the EU, mainly as a result of long waiting times\nfor care.","created_at":"2021-05-27T21:09:39.223Z","updated_at":"2021-05-27T21:09:39.223Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Estonia: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":61,"title":"2020 - Estonia Factsheet - EN","published":null,"published_at":"2021-05-28T16:30:16.172Z","created_at":"2021-05-28T16:30:16.175Z","updated_at":"2021-05-28T16:30:16.175Z","document":{"id":115,"name":"MS Barometer 2020_Country Factsheet_Estonia_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"4084fd3de999c6512f9fb36136a5dcbe","ext":".pdf","mime":"application/pdf","size":268.12,"url":"https://barometer.ams3.digitaloceanspaces.com/4084fd3de999c6512f9fb36136a5dcbe.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:30:16.360Z","updated_at":"2021-05-28T16:30:16.360Z"}},{"id":62,"title":"2020 - Estonia Factsheet - ET","published":null,"published_at":"2021-05-28T16:30:32.100Z","created_at":"2021-05-28T16:30:32.103Z","updated_at":"2021-05-28T16:30:32.103Z","document":{"id":116,"name":"MS Barometer 2020_Country Factsheet_Estonia_ET.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"7dfa7a10d9b8266d9f7fed39002d7a81","ext":".pdf","mime":"application/pdf","size":233.61,"url":"https://barometer.ams3.digitaloceanspaces.com/7dfa7a10d9b8266d9f7fed39002d7a81.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:30:32.297Z","updated_at":"2021-05-28T16:30:32.297Z"}}],"findings":[{"id":51,"title":"Only","description":"of symptomatic therapies are reimbursed.","highlightText":"50%","isHighlighted":true,"created_at":"2021-05-28T11:29:09.949Z","updated_at":"2021-05-28T11:29:09.949Z"},{"id":52,"title":"There is","description":"national MS\ndisease registry.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:29:28.454Z","updated_at":"2021-05-28T11:29:28.454Z"},{"id":53,"title":"There are only","description":"practising neurologists\nin the country, or one for\nevery 50 people with MS.","highlightText":"20","isHighlighted":true,"created_at":"2021-05-28T11:30:00.735Z","updated_at":"2021-05-28T11:30:00.735Z"}],"recoms":[{"id":54,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS, with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:30:18.912Z","updated_at":"2021-05-28T11:30:18.912Z"},{"id":55,"title":"","description":"Increase reimbursement of symptomatic\ntherapies to 100% and ensure that there\nare no limits on duration.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:30:29.064Z","updated_at":"2021-05-28T11:30:29.064Z"},{"id":56,"title":"","description":"Establish a national MS registry with mandatory data\ncollection encompassing clinical, occupational and\npatient-reported data.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:30:39.737Z","updated_at":"2021-05-28T11:30:39.737Z"}],"countryName":"Estonia","alpha2":"EE","alpha3":"EST"},{"id":57,"added":true,"country":{"id":22,"countryName":"Malta","alpha2":"MT","alpha3":"MLT","created_at":"2021-05-27T21:13:50.970Z","updated_at":"2021-05-27T21:13:50.970Z"},"values":[{"value":"11.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"6.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"2.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"33","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"9.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"2.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"10.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"11.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"81","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"68","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"100","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"61","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"1.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"39","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"16","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"442000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"400","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"yes","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"55.2","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"The national MS registry has excellent inclusion, covering more than\n90% of people with MS in Malta. There is good reimbursement of\nand access to rehabilitation and symptomatic treatments, but this is\nnot the case with all disease-modifying drugs (DMDs). However, gaps\nremain:","countryContext":"Healthcare in Malta is highly centralised\nand managed primarily by the Ministry of\nHealth.(1)\nThe country provides near universal health\ncoverage and per person expenditure has increased more than\n60% since 2007, yet remains below the European Union (EU)\naverage.\nThe out-of-pocket spending rate is among the\nhighest in the EU, including significant expenses for\nmedicines; however, people with certain chronic\nconditions are exempt, including people with MS.","created_at":"2021-05-27T21:13:50.970Z","updated_at":"2021-05-27T21:13:50.970Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Malta: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":88,"title":"2020 - Malta Factsheet - EN","published":null,"published_at":"2021-05-28T17:13:53.335Z","created_at":"2021-05-28T17:13:53.339Z","updated_at":"2021-05-28T17:13:53.339Z","document":{"id":142,"name":"MS Barometer 2020_Country Factsheet_Malta_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"56c4b79ef1b79dd6e5e2dec11f0774f1","ext":".pdf","mime":"application/pdf","size":337.42,"url":"https://barometer.ams3.digitaloceanspaces.com/56c4b79ef1b79dd6e5e2dec11f0774f1.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:13:53.660Z","updated_at":"2021-05-28T17:13:53.660Z"}},{"id":89,"title":"2020 - Malta Factsheet - MT","published":null,"published_at":"2021-05-28T17:14:05.687Z","created_at":"2021-05-28T17:14:05.693Z","updated_at":"2021-05-28T17:14:05.693Z","document":{"id":143,"name":"MS Barometer 2020_Country Factsheet_Malta_MT.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"6390d92af08447f1ee0e0f185ea428fb","ext":".pdf","mime":"application/pdf","size":309.92,"url":"https://barometer.ams3.digitaloceanspaces.com/6390d92af08447f1ee0e0f185ea428fb.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:14:05.820Z","updated_at":"2021-05-28T17:14:05.820Z"}}],"findings":[{"id":104,"title":"It takes","description":"months for drugs\napproved by the European Medicines\nAgency (EMA) to be approved and\nreimbursed, meaning many EMAapproved\nDMDs are not yet available\nto people with MS in Malta.","highlightText":"12-14","isHighlighted":true,"created_at":"2021-05-28T12:09:01.317Z","updated_at":"2021-05-28T12:09:01.317Z"},{"id":105,"title":"There are only","description":"practising\nneurologists in Malta – one for\nevery 57 people with MS.","highlightText":"7","isHighlighted":true,"created_at":"2021-05-28T12:11:23.712Z","updated_at":"2021-05-28T12:11:23.712Z"},{"id":106,"title":"It is","description":"how many people\nwith MS are in full- or part-time\nemployment, and it is unclear\nwhether they receive any support\nto complete their education or\nfind and retain work.","highlightText":"not known","isHighlighted":true,"created_at":"2021-05-28T12:12:04.127Z","updated_at":"2021-05-28T12:12:04.127Z"}],"recoms":[{"id":107,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS, with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:12:16.980Z","updated_at":"2021-05-28T12:12:16.980Z"},{"id":108,"title":"","description":"Increase the number of practising\nneurologists to ensure every person with MS\nhas access to a neurologist at least once a\nyear to provide timely and personalised care.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:12:26.701Z","updated_at":"2021-05-28T12:12:26.701Z"},{"id":109,"title":"","description":"Reduce delays between EMA approval of new\ntherapies and national reimbursement.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T12:12:36.899Z","updated_at":"2021-05-28T12:12:36.899Z"}],"countryName":"Malta","alpha2":"MT","alpha3":"MLT"},{"id":72,"added":true,"country":{"id":35,"countryName":"Turkey","alpha2":"TR","alpha3":"TUR","created_at":"2021-05-27T21:21:11.706Z","updated_at":"2021-05-27T21:21:11.706Z"},"values":[{"value":"12.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"10.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"50","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"10.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"4.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"6.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"84","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"74","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"81","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"38","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"2.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"64","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"40","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_FULL","description":null,"displayName":"Full-time employment"},{"value":"25","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_PART","description":null,"displayName":"Part-time employment"},{"value":"35","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"88300000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"70000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"Local or regional ","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"65","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"25","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_PART","description":null,"displayName":"Part-time employed"},{"value":"40","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_FULL","description":null,"displayName":"Full-time employed"},{"value":"59.5","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Turkey has recently increased the number of treatment and\nrehabilitation options available to people with MS. There has also\nbeen an increase in the number of MS specialists. However, there are\nstill gaps that need to be addressed:","countryContext":"Healthcare in Turkey is organised and delivered by the\nMinistry of Health through a range of public and private\nproviders, with financing provided by the Social Security\nInstitution.(1) Turkey provides universal healthcare through a\ngeneral health insurance scheme.","created_at":"2021-05-27T21:21:11.706Z","updated_at":"2021-05-27T21:21:11.706Z","references":"(1) European Observatory on Health Systems Policies. 2011. Turkey: Health systems in review. Copenhagen, Denmark","factsheets":[{"id":118,"title":"2020 - Turkey Factsheet - EN","published":null,"published_at":"2021-05-28T18:00:34.050Z","created_at":"2021-05-28T18:00:34.054Z","updated_at":"2021-05-28T18:00:34.054Z","document":{"id":172,"name":"MS Barometer 2020_Country Factsheet_Turkey_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"433225c9f18d59daf911aecc813fa35c","ext":".pdf","mime":"application/pdf","size":277.73,"url":"https://barometer.ams3.digitaloceanspaces.com/433225c9f18d59daf911aecc813fa35c.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T18:00:34.289Z","updated_at":"2021-05-28T18:00:34.289Z"}},{"id":119,"title":"2020 - Turkey Factsheet - TR","published":null,"published_at":"2021-05-28T18:00:48.080Z","created_at":"2021-05-28T18:00:48.084Z","updated_at":"2021-05-28T18:00:48.084Z","document":{"id":173,"name":"MS Barometer 2020_Country Factsheet_Turkey_TR.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"62ae43a4ee5f30fe8be756b745320bab","ext":".pdf","mime":"application/pdf","size":268.97,"url":"https://barometer.ams3.digitaloceanspaces.com/62ae43a4ee5f30fe8be756b745320bab.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T18:00:48.203Z","updated_at":"2021-05-28T18:00:48.203Z"}}],"findings":[{"id":207,"title":"There are delays of","description":"months to approving\nnew disease-modifying\ndrugs (DMDs) for use and\nreimbursement.","highlightText":"9-18","isHighlighted":true,"created_at":"2021-05-28T18:02:28.104Z","updated_at":"2021-05-28T18:02:28.104Z"},{"id":208,"title":"There are just 3,000 practising neurologists in the country and only","description":"MS specialist neurologists\n– one for every 467\npeople with MS.","highlightText":"150","isHighlighted":true,"created_at":"2021-05-28T18:06:04.207Z","updated_at":"2021-05-28T18:06:04.207Z"},{"id":209,"title":"Under","description":"of people\nwith MS with higher\ndisabilities have access to\noccupational or cognitive\nrehabilitation.","highlightText":"25%","isHighlighted":true,"created_at":"2021-05-28T18:06:24.707Z","updated_at":"2021-05-28T18:06:24.707Z"}],"recoms":[{"id":210,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS, with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T18:06:43.260Z","updated_at":"2021-05-28T18:06:43.260Z"},{"id":211,"title":"","description":"Increase the number of neurologists, including MS specialist\nneurologists, and reduce delays to national approval of MS\ntherapies to ensure that every person with MS has timely\naccess to specialist care and appropriate treatments.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T18:07:43.124Z","updated_at":"2021-05-28T18:07:43.124Z"},{"id":212,"title":"","description":"Expand the number of rehabilitation centres and\navailability of unlimited therapy without restrictions.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T18:07:55.612Z","updated_at":"2021-05-28T18:07:55.612Z"}],"countryName":"Turkey","alpha2":"TR","alpha3":"TUR"},{"id":55,"added":true,"country":{"id":18,"countryName":"Italy","alpha2":"IT","alpha3":"ITA","created_at":"2021-05-27T21:12:17.171Z","updated_at":"2021-05-27T21:12:17.171Z"},"values":[{"value":"12.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"13.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"5.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"83","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"10.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"6.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"12.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"11.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"88","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"75","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"100","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"75","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"6.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"80","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"55","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"Chronic only","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"60400000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"126000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"48","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"yes","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"48","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_EMP","description":null,"displayName":"Employed"},{"value":"80.3","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Italy offers a network of more than 200 specialist MS centres and has\nmade significant progress developing since 1996 a dedicated national\ncare pathway to secure an integrated diagnostic, therapeutic and\ncare pathway across all regions. The Italian MS Society Foundation\n(Fondazione Italiana Sclerosi Multipla; FISM) is a significant supporter\nof MS research, investing between €5 million and €6 million annually.\nHowever, there remains room for improvement:","countryContext":"Italy’s national health service is\ndecentralised, with each region delivering\nhealthcare through a combination of health\nunits and public and private hospitals.(1)\nItaly has universal health coverage for a package of services;\nhowever, residual payments are made for diagnostic\nprocedures, private specialist consultations, nonurgent\nvisits to emergency departments and\nsome pharmaceuticals, accounting for significant\nspending.","created_at":"2021-05-27T21:12:17.171Z","updated_at":"2021-05-27T21:12:17.171Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Italy: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":78,"title":"2020 - Italy Factsheet - EN","published":null,"published_at":"2021-05-28T17:04:24.618Z","created_at":"2021-05-28T17:04:24.630Z","updated_at":"2021-05-28T17:04:24.630Z","document":{"id":132,"name":"MS Barometer 2020_Country Factsheet_Italy_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"889e7f66d2d0425630ba4ec1e931a1d5","ext":".pdf","mime":"application/pdf","size":270.09,"url":"https://barometer.ams3.digitaloceanspaces.com/889e7f66d2d0425630ba4ec1e931a1d5.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:04:24.935Z","updated_at":"2021-05-28T17:04:24.935Z"}},{"id":79,"title":"2020 - Italy Factsheet - IT","published":null,"published_at":"2021-05-28T17:04:42.322Z","created_at":"2021-05-28T17:04:42.329Z","updated_at":"2021-05-28T17:04:42.329Z","document":{"id":133,"name":"MS Barometer 2020_Country Factsheet_Italy_IT.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"9249cc3eafd66d46b44c579153f0b4c2","ext":".pdf","mime":"application/pdf","size":239.54,"url":"https://barometer.ams3.digitaloceanspaces.com/9249cc3eafd66d46b44c579153f0b4c2.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:04:42.505Z","updated_at":"2021-05-28T17:04:42.505Z"}}],"findings":[{"id":86,"title":"Under","description":"of people with\nMS have full access to\nrehabilitation services.","highlightText":"50%","isHighlighted":true,"created_at":"2021-05-28T11:54:57.412Z","updated_at":"2021-05-28T11:54:57.412Z"},{"id":87,"title":"","description":"of people with MS\nare recorded on the\nnational MS registry\nestablished by FISM.","highlightText":"60%","isHighlighted":true,"created_at":"2021-05-28T11:55:14.618Z","updated_at":"2021-05-28T11:55:14.618Z"},{"id":88,"title":"There is ","description":"reimbursed symptomatic therapy to\nhelp with walking.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:56:32.663Z","updated_at":"2021-05-28T11:56:32.663Z"}],"recoms":[{"id":89,"title":"","description":"Approve national rehabilitation guidelines to secure\naccess to personalised rehabilitation in every region.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:56:45.152Z","updated_at":"2021-05-28T11:56:45.152Z"},{"id":90,"title":"","description":"Integrate clinical data from the national MS\nregister with administrative data from regional\nhealth services to improve public health services.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:56:54.314Z","updated_at":"2021-05-28T11:56:54.314Z"},{"id":91,"title":"","description":"Ensure all symptomatic treatments are fully\nreimbursed and available to every person with MS.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:57:05.069Z","updated_at":"2021-05-28T11:57:05.069Z"}],"countryName":"Italy","alpha2":"IT","alpha3":"ITA"},{"id":44,"added":true,"country":{"id":9,"countryName":"Czech Republic","alpha2":"CZ","alpha3":"CZE","created_at":"2021-05-27T21:08:53.100Z","updated_at":"2021-05-27T21:08:53.100Z"},"values":[{"value":"12.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"9.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"4.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"67","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"9.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"3.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"15.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"81","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"76","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"79","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"89","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"59","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"65","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_FULL","description":null,"displayName":"Full-time employment"},{"value":"11","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_PART","description":null,"displayName":"Part-time employment"},{"value":"31","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"10700000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"20000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"yes","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"76","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"Chronic and neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"11","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_PART","description":null,"displayName":"Part-time employed"},{"value":"65","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_FULL","description":null,"displayName":"Full-time employed"},{"value":"68.4","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Significant progress has been made in improving access to disease modifying\ndrugs and multidisciplinary care, increasing patient shared\ndecision-making and establishing a patient registry for MS. However,\nthere are many areas where progress is needed:","countryContext":"In the Czech Republic, healthcare is managed\nby the Ministry of Health, regional authorities\nand social health insurance funds.(1)\nSpending on health as a share of GDP is\nbelow the European Union (EU) average; however, as healthcare is\npredominantly financed by public contributions, the average copayment\namount is below the EU average.\nRecent reforms to the social health insurance funds\nhave led to better provision of care for people living\nwith chronic conditions.","created_at":"2021-05-27T21:08:53.100Z","updated_at":"2021-05-27T21:08:53.100Z","references":"(1)OECD/European Observatory on Health Systems Policies. 2019. Czech Republic: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies,\nBrussels","factsheets":[{"id":57,"title":"2020 - Czech Republic Factsheet - EN","published":null,"published_at":"2021-05-28T16:20:43.083Z","created_at":"2021-05-28T16:20:43.086Z","updated_at":"2021-05-28T16:20:43.086Z","document":{"id":111,"name":"MS Barometer 2020_Country Factsheet_CzechRepublic_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"0ede98ae7aa1c739409f6c480920c007","ext":".pdf","mime":"application/pdf","size":277.68,"url":"https://barometer.ams3.digitaloceanspaces.com/0ede98ae7aa1c739409f6c480920c007.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:20:43.323Z","updated_at":"2021-05-28T16:20:43.323Z"}},{"id":58,"title":"2020 - Czech Republic Factsheet - CZ","published":null,"published_at":"2021-05-28T16:21:05.451Z","created_at":"2021-05-28T16:21:05.458Z","updated_at":"2021-05-28T16:21:05.458Z","document":{"id":112,"name":"MS Barometer 2020_Country Factsheet_CzechRepublic_CZ.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"9508418dd38ec3382ad09e912e8fbc09","ext":".pdf","mime":"application/pdf","size":263.24,"url":"https://barometer.ams3.digitaloceanspaces.com/9508418dd38ec3382ad09e912e8fbc09.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:21:05.582Z","updated_at":"2021-05-28T16:21:05.582Z"}}],"findings":[{"id":39,"title":"There are","description":"legal\nprotections from healthrelated\ndismissal from\nemployment for people\nwith MS or disabilities","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:17:18.017Z","updated_at":"2021-05-28T11:17:18.017Z"},{"id":40,"title":"Under","description":"of people\nwith MS have access to\noccupational rehabilitation.","highlightText":"40%","isHighlighted":true,"created_at":"2021-05-28T11:17:36.011Z","updated_at":"2021-05-28T11:17:36.011Z"},{"id":41,"title":"Under","description":"of people\nwith MS have access to\ncognitive rehabilitation.","highlightText":"10%","isHighlighted":true,"created_at":"2021-05-28T11:17:53.494Z","updated_at":"2021-05-28T11:17:53.494Z"}],"recoms":[{"id":42,"title":"","description":"Establish legal provisions to protect people with\ndisabilities and MS against dismissal from employment\ndue to their condition.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:18:10.841Z","updated_at":"2021-05-28T11:18:10.841Z"},{"id":43,"title":"","description":"Expand access to specialist MS centres with a\nwider provision of occupational and cognitive\nrehabilitation and paediatric neurologists.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:18:18.820Z","updated_at":"2021-05-28T11:18:18.820Z"},{"id":44,"title":"","description":"Mandate inclusion of all people with\nMS in the MS patient registry","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:18:26.789Z","updated_at":"2021-05-28T11:18:26.789Z"}],"countryName":"Czech Republic","alpha2":"CZ","alpha3":"CZE"},{"id":62,"added":true,"country":{"id":26,"countryName":"Poland","alpha2":"PL","alpha3":"POL","created_at":"2021-05-27T21:17:11.736Z","updated_at":"2021-05-27T21:17:11.736Z"},"values":[{"value":"11.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"7.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"4.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"67","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"9.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"5.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"4.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"6.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"78","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"67","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"56","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"27","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"6.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"47","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"43","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"37900000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"50000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"55.5","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Poland has made recent improvements in MS care, which include\nexpanding access to disease-modifying drugs and paediatric MS care.\nHowever, gaps in care remain:","countryContext":"Healthcare in Poland is organised by the Ministry of Health\nat the municipal, county and district level. The country\nspends €1,507 per person on health, which is lower than\nthe European average.(1) Care is very fragmented but\nimprovement initiatives are underway.","created_at":"2021-05-27T21:17:11.736Z","updated_at":"2021-05-27T21:17:11.736Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Poland: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":96,"title":"2020 - Poland Factsheet - PL","published":null,"published_at":"2021-05-28T17:18:04.030Z","created_at":"2021-05-28T17:18:04.032Z","updated_at":"2021-05-28T17:18:04.032Z","document":{"id":150,"name":"MS Barometer 2020_Country Factsheet_Poland_PL.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"9b86b401c77955bf4cd74d65a170b557","ext":".pdf","mime":"application/pdf","size":243.99,"url":"https://barometer.ams3.digitaloceanspaces.com/9b86b401c77955bf4cd74d65a170b557.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:18:04.303Z","updated_at":"2021-05-28T17:18:04.303Z"}},{"id":97,"title":"2020 - Poland Factsheet - EN","published":null,"published_at":"2021-05-28T17:18:17.900Z","created_at":"2021-05-28T17:18:17.902Z","updated_at":"2021-05-28T17:18:17.902Z","document":{"id":151,"name":"MS Barometer 2020_Country Factsheet_Poland_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"0889f87b8f86197800214d3275e86860","ext":".pdf","mime":"application/pdf","size":268.15,"url":"https://barometer.ams3.digitaloceanspaces.com/0889f87b8f86197800214d3275e86860.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:18:18.081Z","updated_at":"2021-05-28T17:18:18.081Z"}}],"findings":[{"id":128,"title":"Only","description":"of people with MS\nhave annual access to essential\nphysical rehabilitation.","highlightText":"20-29%","isHighlighted":true,"created_at":"2021-05-28T16:01:44.811Z","updated_at":"2021-05-28T16:01:44.811Z"},{"id":129,"title":"There is ","description":"reimbursement\nfor many symptomatic\ntreatments, including for\nfatigue and pain.","highlightText":"0","isHighlighted":true,"created_at":"2021-05-28T16:02:04.898Z","updated_at":"2021-05-28T16:02:04.898Z"},{"id":130,"title":"After diagnosis, people with MS must often wait","description":"time, many months to access\ndisease-modifying drugs.","highlightText":"LONG","isHighlighted":true,"created_at":"2021-05-28T16:05:02.829Z","updated_at":"2021-05-28T16:05:02.829Z"}],"recoms":[{"id":131,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS, with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T16:05:26.196Z","updated_at":"2021-05-28T16:05:26.196Z"},{"id":132,"title":"","description":"Ensure each person with MS receives multidisciplinary\ncare including assessments for rehabilitation,\npsychiatric and social support each year.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T16:05:34.707Z","updated_at":"2021-05-28T16:05:34.707Z"},{"id":133,"title":"","description":"Ensure that each person with MS has adequate\nreimbursement and timely access to all available\ndisease-modifying drugs and symptomatic\ntreatments in a timely manner.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T16:05:45.300Z","updated_at":"2021-05-28T16:05:45.300Z"}],"countryName":"Poland","alpha2":"PL","alpha3":"POL"},{"id":65,"added":true,"country":{"id":29,"countryName":"Russian Federation","alpha2":"RU","alpha3":"RUS","created_at":"2021-05-27T21:18:31.565Z","updated_at":"2021-05-27T21:18:31.565Z"},"values":[{"value":"9.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"12.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"4.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"67","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"7.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"6.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"7.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"10.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"66","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"59","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"86","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"43","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"6.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"73","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"25","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_FULL","description":null,"displayName":"Full-time employment"},{"value":"10","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_PART","description":null,"displayName":"Part-time employment"},{"value":"58","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"145900000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"150000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"yes","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"National","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"35","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"10","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_PART","description":null,"displayName":"Part-time employed"},{"value":"25","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_FULL","description":null,"displayName":"Full-time employed"},{"value":"65.2","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"The Russian Federation has increased the number of disease-modifying\ndrugs (DMDs) with full reimbursement, and while\nreimbursement of symptomatic treatments is limited and variable,\navailability of treatments is good. However, there are regional\ndisparities in care and other gaps remain:","countryContext":"The Russian Federation has a centralised\nhealth system managed largely at the federal\nlevel.(1) Although spending on public health is\nlow, the country provides universal access to\na basic package of services.\nThe Russian Federation has mandatory health insurance,\nand although there is limited coverage for outpatient\nprescription medicines resulting in significant out-of pocket\npayments, medicines for chronic conditions\nincluding MS are reimbursed. There are stark\ndisparities in access to and quality of care between\nurban and rural areas in Russia, with rural areas\nhaving much poorer healthcare overall.","created_at":"2021-05-27T21:18:31.565Z","updated_at":"2021-05-27T21:18:31.565Z","references":"(1) European Observatory on Health Systems Policies. 2011. Russian Federation: Health systems in review. Copenhagen, Denmark","factsheets":[{"id":102,"title":"2020 - Russian Federation Factsheet - EN","published":null,"published_at":"2021-05-28T17:29:24.196Z","created_at":"2021-05-28T17:29:24.204Z","updated_at":"2021-05-28T17:29:24.204Z","document":{"id":156,"name":"MS Barometer 2020_Country Factsheet_Russia_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"beaa19968c02f822f8bd756943f8abf2","ext":".pdf","mime":"application/pdf","size":263.06,"url":"https://barometer.ams3.digitaloceanspaces.com/beaa19968c02f822f8bd756943f8abf2.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:29:24.453Z","updated_at":"2021-05-28T17:29:24.453Z"}},{"id":103,"title":"2020 - Russian Federation Factsheet - RU","published":null,"published_at":"2021-05-28T17:29:39.958Z","created_at":"2021-05-28T17:29:39.961Z","updated_at":"2021-05-28T17:29:39.961Z","document":{"id":157,"name":"MS Barometer 2020_Country Factsheet_Russia_RU.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"564966473dce1866143e176a47cc716d","ext":".pdf","mime":"application/pdf","size":250.31,"url":"https://barometer.ams3.digitaloceanspaces.com/564966473dce1866143e176a47cc716d.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:29:40.144Z","updated_at":"2021-05-28T17:29:40.144Z"}}],"findings":[{"id":165,"title":"Just","description":"of people with MS\nreceive DMDs.","highlightText":"30%","isHighlighted":true,"created_at":"2021-05-28T17:31:21.183Z","updated_at":"2021-05-28T17:31:21.183Z"},{"id":166,"title":"Less than","description":"of people\nwith MS have access to\npsychological rehabilitation,\nand fewer than 20% have\naccess to occupational\nrehabilitation.","highlightText":"30%","isHighlighted":true,"created_at":"2021-05-28T17:31:39.401Z","updated_at":"2021-05-28T17:31:39.401Z"},{"id":167,"title":"","description":"of people with MS are\nin full-time employment,\nand just 10% are in part-time\nemployment.","highlightText":"25%","isHighlighted":true,"created_at":"2021-05-28T17:31:59.070Z","updated_at":"2021-05-28T17:31:59.070Z"}],"recoms":[{"id":168,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS, with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:32:12.578Z","updated_at":"2021-05-28T17:32:12.578Z"},{"id":169,"title":"","description":"Reduce regional disparities in the provision of\ntherapies and rehabilitation services, ensuring\nthat every person with MS has access to specialist\ncare and fully reimbursed rehabilitation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:32:23.041Z","updated_at":"2021-05-28T17:32:23.041Z"},{"id":170,"title":"","description":"Improve support for people with MS to complete\ntheir education and find and maintain employment.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:32:33.305Z","updated_at":"2021-05-28T17:32:33.305Z"}],"countryName":"Russian Federation","alpha2":"RU","alpha3":"RUS"},{"id":50,"added":true,"country":{"id":15,"countryName":"Greece","alpha2":"GR","alpha3":"GRC","created_at":"2021-05-27T21:11:11.410Z","updated_at":"2021-05-27T21:11:11.410Z"},"values":[{"value":"11.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"7.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"2.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"33","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"10.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"6.2","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"3.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"86","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"70","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"77","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"22","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"5.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"47","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"20","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_FULL","description":null,"displayName":"Full-time employment"},{"value":"25","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_PART","description":null,"displayName":"Part-time employment"},{"value":"52","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"10400000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"21000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"Local or regional ","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"45","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"25","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_PART","description":null,"displayName":"Part-time employed"},{"value":"20","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_FULL","description":null,"displayName":"Full-time employed"},{"value":"56.3","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Greece has increased monthly access to physical rehabilitation, as\nwell as providing good access to other types of rehabilitation in two\nMS-focused units in Athens and Thessaloniki. The government also\nprovides full coverage of costs for approved and prescribed diseasemodifying\ndrugs (DMDs) and has recently approved two new DMDs for\nuse. However, important gaps in care for people with MS persist:","countryContext":"Healthcare provision in Greece is mixed –\nwith coverage provided by a public national\nhealth service, a social insurance provider\nand private providers.(1)\nPer person spending on healthcare is much lower than the\nEuropean Union (EU) average, driven in part by the 2008\neconomic crisis. Accordingly, out-of-pocket payments\nfor pharmaceuticals, nursing and private specialists\ncan be significant.","created_at":"2021-05-27T21:11:11.410Z","updated_at":"2021-05-27T21:11:11.410Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Romania: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":70,"title":"2020 - Greece Factsheet - GR","published":null,"published_at":"2021-05-28T16:50:40.855Z","created_at":"2021-05-28T16:50:40.860Z","updated_at":"2021-05-28T16:50:40.860Z","document":{"id":124,"name":"MS Barometer 2020_Country Factsheet_Greece_GR.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"fd51185aa0b9e872e2d1f50571a2dfd2","ext":".pdf","mime":"application/pdf","size":281.01,"url":"https://barometer.ams3.digitaloceanspaces.com/fd51185aa0b9e872e2d1f50571a2dfd2.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:50:41.069Z","updated_at":"2021-05-28T16:50:41.069Z"}},{"id":71,"title":"2020 - Greece Factsheet - EN","published":null,"published_at":"2021-05-28T16:50:56.564Z","created_at":"2021-05-28T16:50:56.567Z","updated_at":"2021-05-28T16:50:56.567Z","document":{"id":125,"name":"MS Barometer 2020_Country Factsheet_Greece_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"7325b3014f3258e602acd5bb422999c1","ext":".pdf","mime":"application/pdf","size":277.23,"url":"https://barometer.ams3.digitaloceanspaces.com/7325b3014f3258e602acd5bb422999c1.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:50:56.744Z","updated_at":"2021-05-28T16:50:56.744Z"}}],"findings":[{"id":68,"title":"There is ","description":"disease plan\nfor MS.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:42:35.555Z","updated_at":"2021-05-28T11:42:35.555Z"},{"id":69,"title":"There is","description":"national\nregistry for MS.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:42:54.787Z","updated_at":"2021-05-28T11:42:54.787Z"},{"id":70,"title":"There are very ","description":"public rehabilitation\nfacilities and no MS\ncentres outside of Athens\nand Thessaloniki.","highlightText":"limited","isHighlighted":true,"created_at":"2021-05-28T11:43:22.185Z","updated_at":"2021-05-28T11:43:22.185Z"}],"recoms":[{"id":71,"title":"","description":"Develop a national neurological disease plan which\nincludes a comprehensive approach to MS, with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:44:08.868Z","updated_at":"2021-05-28T11:44:08.868Z"},{"id":72,"title":"","description":"Establish publicly funded MS centres with\nfull access to a multidisciplinary team and\nspecialist rehabilitation in each region.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:44:17.482Z","updated_at":"2021-05-28T11:44:17.482Z"},{"id":73,"title":"","description":"Expand disability assessments for people\nwith MS to include invisible symptoms\nsuch as fatigue, pain and incontinence.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:44:27.606Z","updated_at":"2021-05-28T11:44:27.606Z"}],"countryName":"Greece","alpha2":"GR","alpha3":"GRC"},{"id":43,"added":true,"country":{"id":8,"countryName":"Croatia","alpha2":"HR","alpha3":"HRV","created_at":"2021-05-27T21:08:02.597Z","updated_at":"2021-05-27T21:08:02.597Z"},"values":[{"value":"11.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"2.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"1.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"17","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"2.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"2.5","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"2.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"9.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"24","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"65","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"79","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"16","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"2.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"17","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"21","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"4100000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"6000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"yes","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"None","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"34.4","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Recent years have seen some improvements to treatment\naccessibility, particularly for disease-modifying drugs (DMDs). This is\nlargely due to changes within the Croatian Health Insurance Fund.\nHowever, important gaps in care persist:","countryContext":"A broad package of care is available in\nCroatia through the mandatory public\ninsurance programme.(1) Croatia has a lower\nhealth expenditure per capita than the\nEuropean Union average, but people are\ngenerally protected from high out-of-pocket payments thanks to a\nhigh proportion of public expenditure.\nLong-term care, in particular, needs political attention\nto reduce fragmentation and improve overall health\nsystem efficiency.","created_at":"2021-05-27T21:08:02.597Z","updated_at":"2021-05-27T21:08:02.597Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Croatia: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":55,"title":"2020 - Croatia Factsheet - EN","published":null,"published_at":"2021-05-28T16:18:58.115Z","created_at":"2021-05-28T16:18:58.117Z","updated_at":"2021-05-28T16:18:58.117Z","document":{"id":109,"name":"MS Barometer 2020_Country Factsheet_Croatia_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"6242d93921daa3902b79f1cca7176039","ext":".pdf","mime":"application/pdf","size":338.08,"url":"https://barometer.ams3.digitaloceanspaces.com/6242d93921daa3902b79f1cca7176039.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:18:58.253Z","updated_at":"2021-05-28T16:18:58.253Z"}},{"id":56,"title":"2020 - Croatia Factsheet - HR","published":null,"published_at":"2021-05-28T16:19:35.425Z","created_at":"2021-05-28T16:19:35.432Z","updated_at":"2021-05-28T16:19:35.432Z","document":{"id":110,"name":"MS Barometer 2020_Country Factsheet_Croatia_HR.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"14a3552685333545c1cd007ae9d183da","ext":".pdf","mime":"application/pdf","size":325.23,"url":"https://barometer.ams3.digitaloceanspaces.com/14a3552685333545c1cd007ae9d183da.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T16:19:35.750Z","updated_at":"2021-05-28T16:19:35.750Z"}}],"findings":[{"id":33,"title":"There are ","description":"specialist MS\ncentres.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:09:51.941Z","updated_at":"2021-05-28T11:09:51.941Z"},{"id":34,"title":"There are","description":"multidisciplinary teams\navailable to treat people\nwith MS.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T11:10:18.934Z","updated_at":"2021-05-28T11:10:18.934Z"},{"id":35,"title":"People with MS are entitled to a maximum of","description":"of inpatient rehabilitation\neach year.","highlightText":"21 days","isHighlighted":true,"created_at":"2021-05-28T11:13:37.682Z","updated_at":"2021-05-28T11:13:37.682Z"}],"recoms":[{"id":36,"title":"","description":"Educate decision-makers and policymakers on the\nvalue of preventive MS rehabilitation and remove\nExpanded Disability Status Scale (EDSS) scores from\nneeds assessments.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:13:51.934Z","updated_at":"2021-05-28T11:13:51.934Z"},{"id":37,"title":"","description":"Establish one dedicated MS centre with\na multidisciplinary team incorporating a\nneurologist, paediatric neurologist, nurse\nand rehabilitation specialists.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:14:04.579Z","updated_at":"2021-05-28T11:14:04.579Z"},{"id":38,"title":"","description":"Establish a national MS registry with mandatory data\ncollection encompassing clinical, occupational and\npatient-reported data.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T11:14:14.935Z","updated_at":"2021-05-28T11:14:14.935Z"}],"countryName":"Croatia","alpha2":"HR","alpha3":"HRV"},{"id":69,"added":true,"country":{"id":2,"countryName":"Spain","alpha2":"ES","alpha3":"ESP","created_at":"2021-05-13T12:30:24.115Z","updated_at":"2021-05-13T12:30:24.115Z"},"values":[{"value":"12.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"6.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"50","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"8.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"3.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"12.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"11.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"74","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"76","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"100","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"75","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"40","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"25","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"46700000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"55000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"yes","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"Local or regional ","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"45","dataset":{"id":23,"name":"F16 Employment","units":"%","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z","datasetType":"country","published_at":"2021-05-30T10:22:38.176Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_EMP","description":null,"displayName":"Employment"},{"value":"Neurological only","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"45","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z","datasetType":"country","published_at":"2021-06-03T08:51:53.469Z","possibleValues":"number","possibleAnswers":null},"excelName":"EMP_CHART_EMP","description":null,"displayName":"Employed"},{"value":"62.9","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"MS care in Spain has many strengths, including full reimbursement\nof all approved disease-modifying drugs (DMDs) and symptomatic\ntreatments, and no limitations on treatment duration. However,\nsignificant gaps remain in other aspects of care:","countryContext":"Spain has a decentralised, universal\nhealthcare system; national planning and\nregulation are managed by the Ministry\nof Health, while operational planning,\nresource allocation, purchasing and care\ndelivery are managed by each autonomous community.\nHealth spending per capita is below the European Union\n(EU) average, while out-of-pocket payments have\nincreased in recent years and are now above the EU\naverage.(1)","created_at":"2021-05-13T12:30:24.115Z","updated_at":"2021-05-13T12:30:24.115Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Spain: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":108,"title":"2020 - Spain Factsheet - EN","published":null,"published_at":"2021-05-28T17:42:07.421Z","created_at":"2021-05-28T17:42:07.439Z","updated_at":"2021-05-28T17:42:07.439Z","document":{"id":162,"name":"MS Barometer 2020_Country Factsheet_Spain_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"b426bef563bd24285949c6d4b6ebaed3","ext":".pdf","mime":"application/pdf","size":495.65,"url":"https://barometer.ams3.digitaloceanspaces.com/b426bef563bd24285949c6d4b6ebaed3.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:42:07.697Z","updated_at":"2021-05-28T17:42:07.697Z"}},{"id":109,"title":"2020 - Spain Factsheet - ES","published":null,"published_at":"2021-05-28T17:42:25.196Z","created_at":"2021-05-28T17:42:25.198Z","updated_at":"2021-05-28T17:42:25.198Z","document":{"id":163,"name":"MS Barometer 2020_Country Factsheet_Spain_ES.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"073d0d4ec7be28f232ae50b7afb01da5","ext":".pdf","mime":"application/pdf","size":495.15,"url":"https://barometer.ams3.digitaloceanspaces.com/073d0d4ec7be28f232ae50b7afb01da5.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:42:25.454Z","updated_at":"2021-05-28T17:42:25.454Z"}}],"findings":[{"id":183,"title":"There is an average delay of ","description":"\nmonths between approval of drugs\nby the European Medicines Agency\n(EMA) and the national authorities.","highlightText":"9-11","isHighlighted":true,"created_at":"2021-05-28T17:43:33.107Z","updated_at":"2021-05-28T17:43:33.107Z"},{"id":184,"title":"Under","description":"of people with\nMS have access to physical\nrehabilitation, under 20%\nhave access to psychological\nrehabilitation and fewer than\n10% can access cognitive and\noccupational rehabilitation.","highlightText":"40%","isHighlighted":true,"created_at":"2021-05-28T17:43:50.549Z","updated_at":"2021-05-28T17:43:50.549Z"},{"id":185,"title":"Employed people with MS have","description":"\nprotection against dismissal\ndue to their condition until\nthey meet a threshold\ndisability status of 33%.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T17:44:34.291Z","updated_at":"2021-05-28T17:44:34.291Z"}],"recoms":[{"id":186,"title":"","description":"Allocate a dedicated budget to implementing the Spanish\nneurodegenerative strategy, Estrategia en Enfermedades\nNeurodegenerativas del Sistema Nacional de Salud.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:44:53.330Z","updated_at":"2021-05-28T17:44:53.330Z"},{"id":187,"title":"","description":"Improve access to social support by removing disability\nscores as the only option from needs assessments for\nthese essential services, #33AHORA advocacy campaign.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:45:03.683Z","updated_at":"2021-05-28T17:45:03.683Z"},{"id":188,"title":"","description":"Improve employment opportunities for people with\nMS by enacting flexible and supportive working\nlegislation, and providing financial and practical\nsupport to help people with MS complete their\neducation and vocational training.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:45:13.536Z","updated_at":"2021-05-28T17:45:13.536Z"}],"countryName":"Spain","alpha2":"ES","alpha3":"ESP"},{"id":63,"added":true,"country":{"id":27,"countryName":"Portugal","alpha2":"PT","alpha3":"PRT","created_at":"2021-05-27T21:17:31.216Z","updated_at":"2021-05-27T21:17:31.216Z"},"values":[{"value":"12.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"50","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"7.8","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"4.9","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"3.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"4.2","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"66","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"76","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"35","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"22","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"3.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"0","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"41","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"10100000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"8364","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"None","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"Chronic only","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"40.2","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"Portugal has made important progress towards better management of\nMS, including unanimous Parliamentary approval to develop a national\nMS register as well as strong support for a forthcoming National Strategic\nConsensus for Multiple Sclerosis. However, significant disparities persist:","countryContext":"The Ministry of Health manages health\nplanning and regulation, while regional\nhealth administrations manage care\ndelivery.(1)\nIn recent years, healthcare spending in Portugal has decreased\nto below the European Union average, partly in response to\ncost-cutting measures. This has increased the share of copayments\nand out-of-pocket spending, particularly for\nrehabilitation services.(1) However, recent legislation\nhas abolished user charges for primary care and\nprescriptions.","created_at":"2021-05-27T21:17:31.216Z","updated_at":"2021-05-27T21:17:31.216Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Portugal: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":98,"title":"2020 - Portugal Factsheet - PT","published":null,"published_at":"2021-05-28T17:18:54.647Z","created_at":"2021-05-28T17:18:54.654Z","updated_at":"2021-05-28T17:18:54.654Z","document":{"id":152,"name":"MS Barometer 2020_Country Factsheet_Portugal_PT.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"0071b5066db57f5c416ce881e33bb4f5","ext":".pdf","mime":"application/pdf","size":390.62,"url":"https://barometer.ams3.digitaloceanspaces.com/0071b5066db57f5c416ce881e33bb4f5.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:18:54.961Z","updated_at":"2021-05-28T17:18:54.961Z"}},{"id":99,"title":"2020 - Portugal Factsheet - EN","published":null,"published_at":"2021-05-28T17:19:12.331Z","created_at":"2021-05-28T17:19:12.335Z","updated_at":"2021-05-28T17:19:12.335Z","document":{"id":153,"name":"MS Barometer 2020_Country Factsheet_Portugal_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"007bbeb20a3e488e0b761f5f9256feef","ext":".pdf","mime":"application/pdf","size":384.64,"url":"https://barometer.ams3.digitaloceanspaces.com/007bbeb20a3e488e0b761f5f9256feef.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:19:12.631Z","updated_at":"2021-05-28T17:19:12.631Z"}}],"findings":[{"id":152,"title":"While specialist multidisciplinary care is available, access is","description":"and\nthere are significant\ngeographical\ninequities.","highlightText":"limited","isHighlighted":true,"created_at":"2021-05-28T17:21:16.978Z","updated_at":"2021-05-28T17:21:16.978Z"},{"id":153,"title":"People with MS receive","description":"financial support\nfor occupational,\npsychological\nor cognitive\nrehabilitation.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T17:21:36.393Z","updated_at":"2021-05-28T17:21:36.393Z"},{"id":154,"title":"It is","description":"what\npercentage of people\nwith MS are in full- or\npart-time employment,\nand stigma remains\na problem in both\nworkplaces and schools.","highlightText":"unknown","isHighlighted":true,"created_at":"2021-05-28T17:22:01.540Z","updated_at":"2021-05-28T17:22:01.540Z"},{"id":155,"title":"Symptomatic treatments are","description":"fully reimbursed.","highlightText":"NOT","isHighlighted":true,"created_at":"2021-05-28T17:22:23.467Z","updated_at":"2021-05-28T17:22:23.467Z"}],"recoms":[{"id":156,"title":"","description":"Reduce regional disparities and secure financing for\nspecialist care, therapies and equipment such as magnetic\nresonance imaging (MRI), so that every person with MS can\nreceive a prompt diagnosis and disease-modifying drugs\nappropriate to their personal needs.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:22:39.293Z","updated_at":"2021-05-28T17:22:39.293Z"},{"id":157,"title":"","description":"Ensure adequate funding for all people with MS to\naccess specialist rehabilitation including occupational,\npsychological and cognitive rehabilitation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:22:49.014Z","updated_at":"2021-05-28T17:22:49.014Z"},{"id":158,"title":"","description":"Provide self-management training for people with MS\nand their carers to better empower and support the\nactivities of daily life.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:22:58.610Z","updated_at":"2021-05-28T17:22:58.610Z"}],"countryName":"Portugal","alpha2":"PT","alpha3":"PRT"},{"id":59,"added":true,"country":{"id":21,"countryName":"Luxemburg","alpha2":"LU","alpha3":"LUX","created_at":"2021-05-27T21:13:25.321Z","updated_at":"2021-05-27T21:13:25.321Z"},"values":[{"value":"10.6","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_DMD","description":null,"displayName":"Disease-modifying drugs"},{"value":"0.0","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_RES","description":null,"displayName":"Research"},{"value":"1.1","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_POL","description":null,"displayName":"Policy"},{"value":"17","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z","datasetType":"country","published_at":"2021-05-28T19:39:27.147Z","possibleValues":"number","possibleAnswers":null},"excelName":"POLICY_SCR","description":null,"displayName":"National scores on MS policy"},{"value":"9.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_OCD","description":null,"displayName":"Optimal care delivery"},{"value":"4.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_EMP","description":null,"displayName":"Employment and social support"},{"value":"10.3","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_REH","description":null,"displayName":"Rehabilitation"},{"value":"7.4","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_SYTR","description":null,"displayName":"Symptomatic treatments"},{"value":"81","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z","datasetType":"country","published_at":"2021-05-29T09:08:47.232Z","possibleValues":"number","possibleAnswers":null},"excelName":"SCR_CARED","description":null,"displayName":"Scores on care delivery"},{"value":"63","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z","datasetType":"country","published_at":"2021-05-29T09:20:58.740Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_DMD","description":null,"displayName":"National score on DMD"},{"value":"63","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z","datasetType":"country","published_at":"2021-05-29T09:26:34.089Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_SYMT","description":null,"displayName":"National score on symptomatic treatments"},{"value":"61","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z","datasetType":"country","published_at":"2021-05-29T09:40:27.840Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_REHAB","description":null,"displayName":"National score on rehabilitaton"},{"value":"0.7","dataset":{"id":8,"name":"F1 Total scores","units":null,"created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z","datasetType":"country","published_at":"2021-05-28T18:13:32.827Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_PAED","description":null,"displayName":"Paediatric MS"},{"value":"0","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z","datasetType":"country","published_at":"2021-05-30T10:23:25.369Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_RES","description":null,"displayName":"National score on research"},{"value":"40","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z","datasetType":"country","published_at":"2021-05-30T10:19:04.534Z","possibleValues":"number","possibleAnswers":null},"excelName":"NAT_EMPSOC","description":null,"displayName":"National score on Employment"},{"value":"626000","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_POP","description":null,"displayName":"Population"},{"value":"700","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"GEN_PEOPMS","description":null,"displayName":"People with MS"},{"value":"Does not include","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z","datasetType":"country","published_at":"2021-05-29T09:06:48.342Z","possibleValues":"string","possibleAnswers":["Does include","Does not include"]},"excelName":"CON_MS","description":null,"displayName":"MS in policy consultation"},{"value":"no","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z","datasetType":"country","published_at":"2021-05-29T09:27:53.858Z","possibleValues":"string","possibleAnswers":["yes","no"]},"excelName":"PAL_CARE","description":null,"displayName":"Availability of palliative care"},{"value":"None","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z","datasetType":"country","published_at":"2021-05-30T10:25:40.789Z","possibleValues":"string","possibleAnswers":["National","Local or regional ","None"]},"excelName":"DIS_REG","description":null,"displayName":"Diease registry"},{"value":"No Chronic or neurological","dataset":{"id":10,"name":"F3 Disease policy","units":null,"created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z","datasetType":"country","published_at":"2021-05-28T19:47:00.923Z","possibleValues":"string","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"]},"excelName":"DISEASE_POL","description":null,"displayName":"Chronic disease policy"},{"value":"44.6","dataset":{"id":27,"name":"General","units":"People","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z","datasetType":"country","published_at":"2021-05-30T10:48:31.798Z","possibleValues":"number","possibleAnswers":null},"excelName":"TOT_TOT","description":null,"displayName":"Total score"}],"barometerFindings":"People with MS have good access to disease-modifying drugs (DMDs)\nand symptomatic treatments, with full reimbursement of all approved\ntherapies. Luxembourg has launched a national action plan for rare\ndiseases including paediatric MS, and there have been gains in social\nsupport for people with MS. However, important gaps remain:","countryContext":"Healthcare in Luxembourg is highly centralised\nand is managed by various government\nministries.(1) Spending on healthcare per capita\nis among the highest in Europe.\nThe country has compulsory social health insurance that provides\ncoverage for 95% of the population and offers cover for long-term\nhealth conditions. While out-of-pocket payments are low,\npeople with severe chronic conditions are exempt from\nany such payments.","created_at":"2021-05-27T21:13:25.321Z","updated_at":"2021-05-27T21:13:25.321Z","references":"(1) OECD/European Observatory on Health Systems Policies. 2019. Austria: Country Health Profile 2019. State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels","factsheets":[{"id":84,"title":"2020 - Luxemburg Factsheet - EN","published":null,"published_at":"2021-05-28T17:07:21.134Z","created_at":"2021-05-28T17:07:21.138Z","updated_at":"2021-05-28T17:07:21.138Z","document":{"id":138,"name":"MS Barometer 2020_Country Factsheet_Luxembourg_EN.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"aa804b887653892d6ea037ee73ee39f0","ext":".pdf","mime":"application/pdf","size":277.98,"url":"https://barometer.ams3.digitaloceanspaces.com/aa804b887653892d6ea037ee73ee39f0.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:07:21.296Z","updated_at":"2021-05-28T17:07:21.296Z"}},{"id":85,"title":"2020 - Luxemburg Factsheet - DE","published":null,"published_at":"2021-05-28T17:07:39.039Z","created_at":"2021-05-28T17:07:39.041Z","updated_at":"2021-05-28T17:07:39.041Z","document":{"id":139,"name":"MS Barometer 2020_Country Factsheet_Luxembourg_DE.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"6b5ff87b33e9c67f1e06c012c8cd54bd","ext":".pdf","mime":"application/pdf","size":1322.72,"url":"https://barometer.ams3.digitaloceanspaces.com/6b5ff87b33e9c67f1e06c012c8cd54bd.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:07:39.203Z","updated_at":"2021-05-28T17:07:39.203Z"}},{"id":86,"title":"2020 - Luxemburg Factsheet - FR","published":null,"published_at":"2021-05-28T17:07:52.511Z","created_at":"2021-05-28T17:07:52.522Z","updated_at":"2021-05-28T17:07:52.522Z","document":{"id":140,"name":"MS Barometer 2020_Country Factsheet_Luxembourg_FR.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"5d61cc22fd0c13bfe4c036d32a2fec71","ext":".pdf","mime":"application/pdf","size":253.57,"url":"https://barometer.ams3.digitaloceanspaces.com/5d61cc22fd0c13bfe4c036d32a2fec71.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:07:52.767Z","updated_at":"2021-05-28T17:07:52.767Z"}},{"id":87,"title":"2020 - Luxemburg Factsheet - LB","published":null,"published_at":"2021-05-28T17:08:07.008Z","created_at":"2021-05-28T17:08:07.011Z","updated_at":"2021-05-28T17:08:07.011Z","document":{"id":141,"name":"MS Barometer 2020_Country Factsheet_Luxembourg_LB.pdf","alternativeText":null,"caption":null,"width":null,"height":null,"formats":null,"hash":"a6a07cdafcc15fcdbb76704bc8c7a3d5","ext":".pdf","mime":"application/pdf","size":256.24,"url":"https://barometer.ams3.digitaloceanspaces.com/a6a07cdafcc15fcdbb76704bc8c7a3d5.pdf","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-05-28T17:08:07.195Z","updated_at":"2021-05-28T17:08:07.195Z"}}],"findings":[{"id":146,"title":"It is","description":" what\npercentage of people with MS\nare receiving DMDs or different\nrehabilitation options, as there\nis no specialised MS centre.","highlightText":"unknown","isHighlighted":true,"created_at":"2021-05-28T17:10:02.021Z","updated_at":"2021-05-28T17:12:11.509Z"},{"id":147,"title":"Luxemburg have","description":"MS disease registry, and\nthere is poor availability of\ndata for MS.","highlightText":"NO","isHighlighted":true,"created_at":"2021-05-28T17:11:08.168Z","updated_at":"2021-05-28T17:11:08.168Z"},{"id":148,"title":"It is ","description":"what\npercentage of people with\nMS are in full- or part-time\nemployment.","highlightText":"unknown","isHighlighted":true,"created_at":"2021-05-28T17:12:29.516Z","updated_at":"2021-05-28T17:12:29.516Z"}],"recoms":[{"id":149,"title":"","description":"Develop a national neurological disease plan that\nincludes a comprehensive approach to MS, with an\nadequate budget for implementation.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:12:42.899Z","updated_at":"2021-05-28T17:12:42.899Z"},{"id":150,"title":"","description":"Establish a national MS registry with mandatory\ndata collection encompassing clinical, occupational,\nprogramme evaluation and patient-reported data.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:12:52.775Z","updated_at":"2021-05-28T17:12:52.775Z"},{"id":151,"title":"","description":"Expand offerings for people with MS in general\nrehabilitation centres, create a long-term MS care\nunit for people with advanced MS and develop a\nnetwork of MS specialists to improve access to\nspecialist rehabilitation and clinical care.","highlightText":"","isHighlighted":false,"created_at":"2021-05-28T17:13:03.703Z","updated_at":"2021-05-28T17:13:03.703Z"}],"countryName":"Luxemburg","alpha2":"LU","alpha3":"LUX"}],"datasets":[{"id":26,"name":"F19 Not recorded","units":"%","possibleValues":"number","datasetType":"general","possibleAnswers":null,"published_at":"2021-05-30T10:26:19.623Z","created_at":"2021-05-30T10:26:19.628Z","updated_at":"2021-05-30T10:26:19.628Z"},{"id":20,"name":"F13 Types of rehabilitation","units":"%","possibleValues":"number","datasetType":"general","possibleAnswers":null,"published_at":"2021-05-29T09:41:36.421Z","created_at":"2021-05-29T09:41:36.426Z","updated_at":"2021-05-29T09:41:36.426Z"},{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:26:34.089Z","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z"},{"id":14,"name":"F7 Nat scores on DMD","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:20:58.740Z","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z"},{"id":21,"name":"F14 No access for rehab","units":"%","possibleValues":"number","datasetType":"general","possibleAnswers":null,"published_at":"2021-05-29T09:45:36.904Z","created_at":"2021-05-29T09:45:36.919Z","updated_at":"2021-05-29T09:45:36.919Z"},{"id":25,"name":"F18 Disease registry ","units":null,"possibleValues":"string","datasetType":"country","possibleAnswers":["National","Local or regional ","None"],"published_at":"2021-05-30T10:25:40.789Z","created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z"},{"id":11,"name":"F6 Multi-disciplinary MS teams","units":"%","possibleValues":"number","datasetType":"general","possibleAnswers":null,"published_at":"2021-05-28T19:50:34.494Z","created_at":"2021-05-28T19:50:34.498Z","updated_at":"2021-05-29T09:19:32.791Z"},{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:19:04.534Z","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z"},{"id":8,"name":"F1 Total scores","units":null,"possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T18:13:32.827Z","created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z"},{"id":24,"name":"F17 Nat Research","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:23:25.369Z","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z"},{"id":16,"name":"F9 Progressive MS","units":"%","possibleValues":"string","datasetType":"general","possibleAnswers":["People on MDMs","People not on MDMs"],"published_at":"2021-05-29T09:25:32.055Z","created_at":"2021-05-29T09:25:32.101Z","updated_at":"2021-05-29T09:25:32.101Z"},{"id":18,"name":"F 11 Pallative care","units":null,"possibleValues":"string","datasetType":"country","possibleAnswers":["yes","no"],"published_at":"2021-05-29T09:27:53.858Z","created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z"},{"id":29,"name":"Total score","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-06-09T11:18:04.745Z","created_at":"2021-06-09T11:18:04.763Z","updated_at":"2021-06-09T11:18:04.763Z"},{"id":15,"name":"F8 MS with no DMD","units":"%","possibleValues":"number","datasetType":"general","possibleAnswers":null,"published_at":"2021-05-29T09:22:39.389Z","created_at":"2021-05-29T09:22:39.393Z","updated_at":"2021-05-29T09:22:39.393Z"},{"id":28,"name":"EMPLOYMENT_CHART","units":"%","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-06-03T08:51:53.469Z","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z"},{"id":27,"name":"General","units":"People","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:48:31.798Z","created_at":"2021-05-30T10:48:31.806Z","updated_at":"2021-05-30T10:48:31.806Z"},{"id":23,"name":"F16 Employment","units":"%","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:22:38.176Z","created_at":"2021-05-30T10:22:38.182Z","updated_at":"2021-05-30T10:22:38.182Z"},{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:40:27.840Z","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z"},{"id":9,"name":"F2 Policy scores","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T19:39:27.147Z","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z"},{"id":13,"name":"F5 Care delivery","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:08:47.232Z","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z"},{"id":12,"name":" F4 MS included policy cons group","units":"","possibleValues":"string","datasetType":"country","possibleAnswers":["Does include","Does not include"],"published_at":"2021-05-29T09:06:48.342Z","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z"},{"id":10,"name":"F3 Disease policy","units":null,"possibleValues":"string","datasetType":"country","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"],"published_at":"2021-05-28T19:47:00.923Z","created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z"}],"charts":[{"id":4,"title":"Different healthcare professionals in MS teams","description":"Percentage of countries reporting different healthcare professionals in their multi-disciplinary MS teams","dataset":{"id":11,"name":"F6 Multi-disciplinary MS teams","units":"%","possibleValues":"number","datasetType":"general","possibleAnswers":null,"published_at":"2021-05-28T19:50:34.494Z","created_at":"2021-05-28T19:50:34.498Z","updated_at":"2021-05-29T09:19:32.791Z"},"chartType":"InvertedBar","legend":[{"id":12,"alt":"Neurologist","name":"Neurologist","color":"#2185D0"},{"id":13,"alt":"Nurse","name":"Nurse","color":"#2185D0"},{"id":14,"alt":"Physiotherapist","name":"Physiotherapist","color":"#2185D0"},{"id":15,"alt":"Rehabilitation doctor","name":"Rehabilitation doctor","color":"#2185D0"},{"id":16,"alt":"Occupational therapist","name":"Occupational therapist","color":"#2185D0"},{"id":17,"alt":"Rehabilitation therapist","name":"Rehabilitation therapist","color":"#2185D0"},{"id":18,"alt":"No multi-disciplinary team available ","name":"No multi-disciplinary team available ","color":"#2185D0"}],"dataType":"general","created_at":"2021-05-29T10:29:34.400Z","updated_at":"2021-06-03T08:13:58.681Z"},{"id":21,"title":"Employment of people with MS","description":"*The 20 countries that did not respond to this question are not included in this analysis.\n\nWhat percentage of people with MS are in full-time or part-time employment?","dataset":{"id":28,"name":"EMPLOYMENT_CHART","units":"%","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-06-03T08:51:53.469Z","created_at":"2021-06-03T08:51:53.484Z","updated_at":"2021-06-03T08:51:53.484Z"},"chartType":"InvertedStackedBar","legend":[{"alt":"Employed","name":"EMP_CHART_EMP","color":"#C1D3DF"},{"alt":"Part-time employed","name":"EMP_CHART_PART","color":"#70D1D4"},{"alt":"Full-time employed","name":"EMP_CHART_FULL","color":"#2185D0"}],"dataType":"country","created_at":"2021-06-03T09:05:29.852Z","updated_at":"2021-06-15T10:29:12.278Z"},{"id":14,"title":"National scores on rehabilitation","description":"National scores on rehabilitation","dataset":{"id":19,"name":"F12 Nat Rehabilitation","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:40:27.840Z","created_at":"2021-05-29T09:40:27.846Z","updated_at":"2021-05-29T09:40:27.846Z"},"chartType":"InvertedBar","legend":[{"name":"National score on rehabilitaton","color":"#2185D0"}],"dataType":"country","created_at":"2021-06-03T08:23:06.338Z","updated_at":"2021-06-04T10:27:33.592Z"},{"id":13,"title":"Availability of palliative care services","description":"Availability of specialized early palliative care services","dataset":{"id":18,"name":"F 11 Pallative care","units":null,"possibleValues":"string","datasetType":"country","possibleAnswers":["yes","no"],"published_at":"2021-05-29T09:27:53.858Z","created_at":"2021-05-29T09:27:53.866Z","updated_at":"2021-05-30T18:45:03.547Z"},"chartType":"Columns","legend":[{"alt":"Has specialised early palliative care services","name":"yes","color":"#70D484"},{"alt":"Does not have specialised early palliative care services","name":"no","color":"#EEA574"}],"dataType":"country","created_at":"2021-06-03T08:17:34.827Z","updated_at":"2021-06-15T10:28:08.162Z"},{"id":19,"title":"Types of disease registry","description":"Countries with a national, local or regional, or no MS disease registry","dataset":{"id":25,"name":"F18 Disease registry ","units":null,"possibleValues":"string","datasetType":"country","possibleAnswers":["National","Local or regional ","None"],"published_at":"2021-05-30T10:25:40.789Z","created_at":"2021-05-30T10:25:40.795Z","updated_at":"2021-05-30T10:25:40.795Z"},"chartType":"Columns","legend":[{"alt":"National MS disease registry","name":"National","color":"#70D484"},{"alt":"Local or regional MS disease registry","name":"Local or regional ","color":"#EEA574"},{"alt":"No MS disease registry","name":"None","color":"#DB6767"}],"dataType":"country","created_at":"2021-06-03T08:34:18.595Z","updated_at":"2021-06-15T10:30:02.614Z"},{"id":18,"title":"National scores on research","description":"*Belarus, Bosnia and Herzegovina, Estonia, Iceland, Latvia,\nLuxembourg, Moldova, Portugal and Slovenia scored 0%\n\nNational scores on research","dataset":{"id":24,"name":"F17 Nat Research","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:23:25.369Z","created_at":"2021-05-30T10:23:25.375Z","updated_at":"2021-05-30T11:05:18.717Z"},"chartType":"InvertedBar","legend":[{"name":"National score on research","color":"#2185D0"}],"dataType":"country","created_at":"2021-06-03T08:32:46.528Z","updated_at":"2021-06-15T10:29:34.826Z"},{"id":9,"title":"National scores on disease-modifying drugs","description":"National scores on disease-modifying drugs","dataset":{"id":14,"name":"F7 Nat scores on DMD","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:20:58.740Z","created_at":"2021-05-29T09:20:58.761Z","updated_at":"2021-05-29T09:20:58.761Z"},"chartType":"InvertedBar","legend":[{"name":"National score on DMD","color":"#2185D0"}],"dataType":"country","created_at":"2021-06-03T08:08:51.162Z","updated_at":"2021-06-03T08:08:51.170Z"},{"id":10,"title":"People with MS with no DMDs receiving ","description":"*The 5 countries that did not respond to this question are not included in this analysis.\n\nPercentage of people with MS in Europe who did not receive DMD treatment in 2018","dataset":{"id":15,"name":"F8 MS with no DMD","units":"%","possibleValues":"number","datasetType":"general","possibleAnswers":null,"published_at":"2021-05-29T09:22:39.389Z","created_at":"2021-05-29T09:22:39.393Z","updated_at":"2021-05-29T09:22:39.393Z"},"chartType":"Pie","legend":[{"id":19,"alt":"Did not receive DMD treatment ","name":"Did not receive DMD treatment ","color":"#EEA574"},{"id":20,"alt":"Did receive DMD treatment ","name":"Did receive DMD treatment ","color":"#2185D0"}],"dataType":"general","created_at":"2021-06-03T08:10:51.568Z","updated_at":"2021-06-15T10:33:18.486Z"},{"id":8,"title":"Countries including people with MS in their policy consultation group","description":"Countries which include people with MS and/or the national MS society in their MS related policy consultation group","dataset":{"id":12,"name":" F4 MS included policy cons group","units":"","possibleValues":"string","datasetType":"country","possibleAnswers":["Does include","Does not include"],"published_at":"2021-05-29T09:06:48.342Z","created_at":"2021-05-29T09:06:48.375Z","updated_at":"2021-05-29T09:06:48.375Z"},"chartType":"Columns","legend":[{"alt":"Does include people with MS and/ or the national MS society in their MS related policy consultation group","name":"Does include","color":"#70D484"},{"alt":"Does not include people with MS and/ or the national MS society in their MS related policy consultation group","name":"Does not include","color":"#EEA574"}],"dataType":"country","created_at":"2021-06-03T08:02:56.851Z","updated_at":"2021-06-15T10:30:48.781Z"},{"id":7,"title":"National scores on MS policy","description":"*Austria, Belarus and Romania scored 0%\n\nNational scores on MS policy","dataset":{"id":9,"name":"F2 Policy scores","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T19:39:27.147Z","created_at":"2021-05-28T19:39:27.161Z","updated_at":"2021-05-30T11:03:50.960Z"},"chartType":"InvertedBar","legend":[{"name":"National scores on MS policy","color":"#2185D0"}],"dataType":"country","created_at":"2021-06-03T07:59:15.736Z","updated_at":"2021-06-15T10:15:33.194Z"},{"id":5,"title":"Total scores by countries","description":"Total scores by countries","dataset":{"id":8,"name":"F1 Total scores","units":null,"possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-28T18:13:32.827Z","created_at":"2021-05-28T18:13:32.950Z","updated_at":"2021-05-29T09:07:11.865Z"},"chartType":"InvertedStackedBar","legend":[{"alt":"Disease-modifying drugs ","name":"TOT_DMD","color":"#73bfbd"},{"alt":"Research","name":"TOT_RES","color":"#b8bfdc"},{"alt":"Policy","name":"TOT_POL","color":"#343d91"},{"alt":"Optimal care delivery","name":"TOT_OCD","color":"#676767"},{"alt":"Employment and social support","name":"TOT_EMP","color":"#212e50"},{"alt":"Rehabilitation","name":"TOT_REH","color":"#239f9f"},{"alt":"Paediatric MS","name":"TOT_PAED","color":"#7180b9"},{"alt":"Symptomatic treatments","name":"TOT_SYTR","color":"#239f9f"}],"dataType":"country","created_at":"2021-06-01T17:10:18.855Z","updated_at":"2021-06-04T10:26:18.645Z"},{"id":17,"title":"National scores on employment and social support","description":"*Bosnia and Herzegovina scored 0%\n\nNational scores on employment and social support","dataset":{"id":22,"name":"F15 Nat Employment and Soc supp.","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-30T10:19:04.534Z","created_at":"2021-05-30T10:19:04.576Z","updated_at":"2021-05-30T11:03:20.145Z"},"chartType":"InvertedBar","legend":[{"name":"National score on Employment","color":"#2185D0"}],"dataType":"country","created_at":"2021-06-03T08:30:36.420Z","updated_at":"2021-06-15T10:28:51.606Z"},{"id":20,"title":"Not recorded people with MS","description":"*The two countries that did not respond to this question are not included in this analysis.\n\nPercentage of people with MS in Europe who are not recorded in national registries","dataset":{"id":26,"name":"F19 Not recorded","units":"%","possibleValues":"number","datasetType":"general","possibleAnswers":null,"published_at":"2021-05-30T10:26:19.623Z","created_at":"2021-05-30T10:26:19.628Z","updated_at":"2021-05-30T10:26:19.628Z"},"chartType":"Pie","legend":[{"id":31,"alt":"Not recorded on registries","name":"Not recorded on registries","color":"#EEA574"},{"id":32,"alt":"Recorded on registries","name":"Recorded on registries","color":"#2185D0"}],"dataType":"general","created_at":"2021-06-03T08:36:07.383Z","updated_at":"2021-06-15T10:35:26.319Z"},{"id":22,"title":"Chronic disease policy or neurological disease policy that includes MS","description":"Chronic disease policy or neurological disease policy that includes MS","dataset":{"id":10,"name":"F3 Disease policy","units":null,"possibleValues":"string","datasetType":"country","possibleAnswers":["Chronic only","Neurological only","No Chronic or neurological","Chronic and neurological"],"published_at":"2021-05-28T19:47:00.923Z","created_at":"2021-05-28T19:47:00.958Z","updated_at":"2021-05-29T09:07:48.211Z"},"chartType":"Columns","legend":[{"alt":"Chronic disease management policy only","name":"Chronic only","color":"#2185D0"},{"alt":"Neurological disease management policy only","name":"Neurological only","color":"#C1D3DF"},{"alt":"No chronic or neurological disease management policies","name":"No Chronic or neurological","color":"#EEA574"},{"alt":"Chronic and neurological disease management policies","name":"Chronic and neurological","color":"#70D484"}],"dataType":"country","created_at":"2021-06-15T10:23:18.147Z","updated_at":"2021-06-16T12:26:26.287Z"},{"id":12,"title":"National scores on symptomatic treatments","description":"*Belarus scored 0%\n\nNational scores on symptomatic treatments","dataset":{"id":17,"name":"F10 Nat symptomatic treatments","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:26:34.089Z","created_at":"2021-05-29T09:26:34.094Z","updated_at":"2021-05-29T09:26:34.094Z"},"chartType":"InvertedBar","legend":[{"alt":"Score on symptomatic treatments","name":"National score on symptomatic treatments","color":"#2185D0"}],"dataType":"country","created_at":"2021-06-03T08:15:33.875Z","updated_at":"2021-06-15T10:26:50.132Z"},{"id":16,"title":"People with MS not having access to rehabilitation","description":"*The 11 countries that did not respond to this question are not included in this analysis.\n\nPercentage of people with MS in Europe who do not have access to physical rehabilitation services","dataset":{"id":21,"name":"F14 No access for rehab","units":"%","possibleValues":"number","datasetType":"general","possibleAnswers":null,"published_at":"2021-05-29T09:45:36.904Z","created_at":"2021-05-29T09:45:36.919Z","updated_at":"2021-05-29T09:45:36.919Z"},"chartType":"Pie","legend":[{"id":29,"alt":"Have no access to physical rehabilitation services","name":"Have no access to physical rehabilitation services","color":"#EEA574"},{"id":30,"alt":"Have access to physical rehabilitation services","name":"Have access to physical rehabilitation services","color":"#2185D0"}],"dataType":"general","created_at":"2021-06-03T08:27:28.709Z","updated_at":"2021-06-15T10:35:01.351Z"},{"id":15,"title":"Types of rehabilitation","description":"* involving physiotherapy ** involving occupational therapy\n\nAvailability of different types of rehabilitation among surveyed countries (percentage reporting service available)","dataset":{"id":20,"name":"F13 Types of rehabilitation","units":"%","possibleValues":"number","datasetType":"general","possibleAnswers":null,"published_at":"2021-05-29T09:41:36.421Z","created_at":"2021-05-29T09:41:36.426Z","updated_at":"2021-05-29T09:41:36.426Z"},"chartType":"InvertedBar","legend":[{"id":23,"alt":"Physical rehabailitation*","name":"Physical rehabailitation","color":"#2185D0"},{"id":24,"alt":"Occupational rehabilitation**","name":"Occupational rehabilitation","color":"#2185D0"},{"id":25,"alt":"Physiological rehabilitation","name":"Physiological rehabilitation","color":"#2185D0"},{"id":26,"alt":"Cognitive rehabilitation","name":"Cognitive rehabilitation","color":"#2185D0"},{"id":27,"alt":"No rehabilitation services available","name":"No rehabilitation services available","color":"#2185D0"},{"id":28,"alt":"Nor known","name":"Nor known","color":"#2185D0"}],"dataType":"general","created_at":"2021-06-03T08:24:58.962Z","updated_at":"2021-06-15T10:34:45.216Z"},{"id":11,"title":"DMD treatment in progressive MS","description":"*The 14 countries that did not respond to questions on the number of people with progressive MS and the percentage of people with progressive MS receiving appropriate DMD treatment are not included in this analysis.\n\nPercentage of people with progressive MS in Europe receiving appropriate DMD treatment","dataset":{"id":16,"name":"F9 Progressive MS","units":"%","possibleValues":"string","datasetType":"general","possibleAnswers":["People on MDMs","People not on MDMs"],"published_at":"2021-05-29T09:25:32.055Z","created_at":"2021-05-29T09:25:32.101Z","updated_at":"2021-05-29T09:25:32.101Z"},"chartType":"Pie","legend":[{"id":21,"alt":"People on DMDs","name":"People on DMDs","color":"#2185D0"},{"id":22,"alt":"People with progressive MS not on DMDs","name":"People with progressive MS not on DMDs","color":"#EEA574"}],"dataType":"general","created_at":"2021-06-03T08:12:47.324Z","updated_at":"2021-06-15T10:34:05.165Z"},{"id":6,"title":"National scores on care delivery ","description":"National scores on care delivery ","dataset":{"id":13,"name":"F5 Care delivery","units":"Score","possibleValues":"number","datasetType":"country","possibleAnswers":null,"published_at":"2021-05-29T09:08:47.232Z","created_at":"2021-05-29T09:08:47.245Z","updated_at":"2021-05-30T11:04:19.910Z"},"chartType":"InvertedBar","legend":[{"alt":"","name":"Scores on care delivery","color":"#2185D0"}],"dataType":"country","created_at":"2021-06-03T07:54:26.901Z","updated_at":"2021-06-16T11:55:33.419Z"}],"generalStructures":[{"id":20,"displayName":"Did receive DMD treatment ","excelName":null,"description":null,"dataset":15,"value":"57","published_at":"2021-05-29T10:14:35.189Z","created_at":"2021-05-29T10:14:35.199Z","updated_at":"2021-05-29T10:14:35.242Z"},{"id":30,"displayName":"Have access to physical rehabilitation services","excelName":null,"description":null,"dataset":21,"value":"48","published_at":"2021-05-29T10:27:05.096Z","created_at":"2021-05-29T10:27:05.100Z","updated_at":"2021-05-29T10:27:05.113Z"},{"id":27,"displayName":"No rehabilitation services available","excelName":null,"description":null,"dataset":20,"value":"0","published_at":"2021-05-29T10:25:35.089Z","created_at":"2021-05-29T10:25:35.096Z","updated_at":"2021-05-29T10:25:35.102Z"},{"id":12,"displayName":"Neurologist","excelName":null,"description":null,"dataset":11,"value":"94","published_at":"2021-05-29T09:53:06.212Z","created_at":"2021-05-29T09:53:06.238Z","updated_at":"2023-07-18T20:31:34.909Z"},{"id":15,"displayName":"Rehabilitation doctor","excelName":null,"description":null,"dataset":11,"value":"71","published_at":"2021-05-29T09:54:29.529Z","created_at":"2021-05-29T09:54:29.539Z","updated_at":"2021-05-29T09:54:29.560Z"},{"id":21,"displayName":"People on DMDs","excelName":null,"description":null,"dataset":16,"value":"24","published_at":"2021-05-29T10:16:12.307Z","created_at":"2021-05-29T10:16:12.312Z","updated_at":"2021-05-29T10:16:12.321Z"},{"id":25,"displayName":"Physiological rehabilitation","excelName":null,"description":null,"dataset":20,"value":"77","published_at":"2021-05-29T10:24:41.856Z","created_at":"2021-05-29T10:24:41.875Z","updated_at":"2021-05-29T10:24:41.887Z"},{"id":29,"displayName":"Have no access to physical rehabilitation services","excelName":null,"description":null,"dataset":21,"value":"52","published_at":"2021-05-29T10:26:40.363Z","created_at":"2021-05-29T10:26:40.385Z","updated_at":"2021-05-29T10:26:40.397Z"},{"id":26,"displayName":"Cognitive rehabilitation","excelName":null,"description":null,"dataset":20,"value":"69","published_at":"2021-05-29T10:25:06.080Z","created_at":"2021-05-29T10:25:06.087Z","updated_at":"2021-05-29T10:25:06.111Z"},{"id":17,"displayName":"Rehabilitation therapist","excelName":null,"description":null,"dataset":11,"value":"54","published_at":"2021-05-29T09:58:57.022Z","created_at":"2021-05-29T09:58:57.036Z","updated_at":"2021-05-29T09:58:57.053Z"},{"id":16,"displayName":"Occupational therapist","excelName":null,"description":null,"dataset":11,"value":"60","published_at":"2021-05-29T09:57:29.709Z","created_at":"2021-05-29T09:57:29.720Z","updated_at":"2021-05-29T09:57:29.729Z"},{"id":23,"displayName":"Physical rehabailitation","excelName":null,"description":null,"dataset":20,"value":"94","published_at":"2021-05-29T10:22:15.582Z","created_at":"2021-05-29T10:22:15.586Z","updated_at":"2021-05-29T10:22:15.592Z"},{"id":22,"displayName":"People with progressive MS not on DMDs","excelName":null,"description":null,"dataset":16,"value":"76","published_at":"2021-05-29T10:16:42.320Z","created_at":"2021-05-29T10:16:42.326Z","updated_at":"2021-05-29T10:16:42.334Z"},{"id":18,"displayName":"No multi-disciplinary team available ","excelName":null,"description":null,"dataset":11,"value":"6","published_at":"2021-05-29T10:00:12.746Z","created_at":"2021-05-29T10:00:12.751Z","updated_at":"2021-05-29T10:00:12.757Z"},{"id":13,"displayName":"Nurse","excelName":null,"description":null,"dataset":11,"value":"91","published_at":"2021-05-29T09:53:23.434Z","created_at":"2021-05-29T09:53:23.439Z","updated_at":"2021-05-29T09:53:23.445Z"},{"id":28,"displayName":"Nor known","excelName":null,"description":null,"dataset":20,"value":"6","published_at":"2021-05-29T10:25:47.605Z","created_at":"2021-05-29T10:25:47.627Z","updated_at":"2021-05-29T10:25:47.636Z"},{"id":19,"displayName":"Did not receive DMD treatment ","excelName":null,"description":null,"dataset":15,"value":"43","published_at":"2021-05-29T10:02:43.460Z","created_at":"2021-05-29T10:02:43.483Z","updated_at":"2021-05-29T10:02:43.498Z"},{"id":24,"displayName":"Occupational rehabilitation","excelName":null,"description":null,"dataset":20,"value":"83","published_at":"2021-05-29T10:22:51.919Z","created_at":"2021-05-29T10:22:51.927Z","updated_at":"2021-05-29T10:22:51.935Z"},{"id":14,"displayName":"Physiotherapist","excelName":null,"description":null,"dataset":11,"value":"86","published_at":"2021-05-29T09:54:08.407Z","created_at":"2021-05-29T09:54:08.417Z","updated_at":"2021-05-29T09:54:08.426Z"},{"id":32,"displayName":"Recorded on registries","excelName":null,"description":null,"dataset":26,"value":"35","published_at":"2021-05-30T10:27:50.651Z","created_at":"2021-05-30T10:27:50.655Z","updated_at":"2021-05-30T10:27:50.662Z"},{"id":31,"displayName":"Not recorded on registries","excelName":null,"description":null,"dataset":26,"value":"65","published_at":"2021-05-30T10:27:27.412Z","created_at":"2021-05-30T10:27:27.418Z","updated_at":"2021-05-30T10:27:27.425Z"}],"findings":[{"id":227,"title":"Just","description":"countries provide social support specific to carers of children and adolescents with MS.","highlightText":"16","isHighlighted":true,"created_at":"2021-06-09T10:03:27.164Z","updated_at":"2021-06-09T10:03:27.164Z"},{"id":226,"title":"Among responding countries, only","description":"of people with MS\nhave access to physical rehabilitation. Access is even lower\nfor psychological, cognitive and occupational rehabilitation. \n","highlightText":"48%","isHighlighted":true,"created_at":"2021-06-09T10:02:47.947Z","updated_at":"2021-06-09T10:02:47.947Z"},{"id":225,"title":"People with progressive MS are being left behind as only about among responding countries, received","description":"appropriate DMD treatment in 2018.","highlightText":"26%","isHighlighted":true,"created_at":"2021-06-09T10:01:24.005Z","updated_at":"2021-06-09T10:01:24.005Z"},{"id":230,"title":"","description":" of people with MS in Europe are not recorded in\nnational MS disease registries.","highlightText":"65%","isHighlighted":true,"created_at":"2021-06-09T10:05:16.388Z","updated_at":"2021-06-09T10:05:16.388Z"},{"id":220,"title":"The survey has identified that there are almost ","description":"(million) people with MS in Europe.","highlightText":"1.2 M","isHighlighted":true,"created_at":"2021-06-09T09:46:31.188Z","updated_at":"2021-06-09T09:46:31.188Z"},{"id":219,"title":"The 2020 MS Barometer was developed with survey responses from","description":"national multiple sclerosis (MS)\nsocieties representing 35 countries in Europe.","highlightText":"35","isHighlighted":true,"created_at":"2021-06-09T09:45:06.683Z","updated_at":"2021-06-09T09:45:06.683Z"},{"id":221,"title":"","description":"countries do not include people with MS or MS\npatient groups in government consultation groups for MS policies.","highlightText":"20","isHighlighted":true,"created_at":"2021-06-09T09:47:09.340Z","updated_at":"2021-06-09T09:49:51.260Z"},{"id":222,"title":"","description":"countries do not have a neurological or chronic disease policy which includes MS.","highlightText":"24","isHighlighted":true,"created_at":"2021-06-09T09:49:40.934Z","updated_at":"2021-06-09T09:49:40.934Z"},{"id":228,"title":"In at least","description":"countries, people with MS are not legally\nprotected from dismissal due to their disease.","highlightText":"7","isHighlighted":true,"created_at":"2021-06-09T10:04:09.325Z","updated_at":"2021-06-09T10:04:09.325Z"},{"id":224,"title":"Treatment rates vary enormously , raging between","description":"where Lithuania, Malta, and Switzerland getting a high 90%, Serbia and Bosnia Herzegovina getting a low, 12-10% rate.","highlightText":"10-90%","isHighlighted":true,"created_at":"2021-06-09T10:00:40.779Z","updated_at":"2021-06-09T10:00:40.779Z"},{"id":229,"title":"Among responding countries, only","description":"of people with MS are in employment.","highlightText":"48%","isHighlighted":true,"created_at":"2021-06-09T10:04:46.948Z","updated_at":"2021-06-09T10:04:46.948Z"},{"id":223,"title":"Among responding countries, just","description":"of people with MS received DMDs in 2018.","highlightText":"57%","isHighlighted":true,"created_at":"2021-06-09T09:50:33.396Z","updated_at":"2021-06-09T09:50:33.396Z"}],"FAQs":[{"id":5,"description":"Key Findings","question":"What are the key findings of the MS Barometer 2020?","answer":"The 2020 MS Barometer was developed with survey responses from 36 national multiple sclerosis (MS) societies representing 35 countries in Europe. The survey has identified that there are almost 1.2 million people with MS in Europe. The key findings of the MS barometer 2020 include the following:\n\nThe MS community is being left out of health policy: \n\n • 20 countries do not include people with MS or MS patient groups in government consultation groups for MS policies. \n • 24 countries do not have a neurological or chronic disease policy which includes MS. \n\nAvailability of disease-modifying drugs (DMDs) has improved since 2015, but more progress is needed: \n\n • Among responding countries, just 57% of people with MS received DMDs in 2018. \n • Treatment rates vary enormously, ranging from as high as 90% in Lithuania, Malta and Switzerland to as low as 12% in Serbia and 10% in Bosnia and Herzegovina. \n • People with progressive MS are being left behind with only about 26% among responding countries, receiving appropriate DMD treatment in 2018. \n\nThe symptoms of MS are not adequately managed: \n\n • There is lower availability and lower reimbursement of symptomatic treatments compared with DMDs across all surveyed countries. \n\nRehabilitation is a neglected cornerstone of care: \n\n • Among responding countries, only 48% of people with MS have access to physical rehabilitation. Access is even lower for psychological, cognitive and occupational rehabilitation. \n\nChildren and adolescents with paediatric MS and their carers need targeted support: \n\n • Just 16 countries provide social support specific to carers of children and adolescents with MS. \n\nPeople with MS face barriers to joining and staying in the workplace: \n • In at least 7 countries, people with MS are not legally protected from dismissal due to their disease. \n • Among responding countries, only 48% of people with MS are in employment. \n\nData collection is often inadequate: \n\n • 65% of people with MS in Europe are not recorded in national MS disease registries. ","created_at":"2021-06-14T14:02:13.220Z","updated_at":"2021-06-14T14:25:03.634Z","links":[],"documents":[]},{"id":6,"description":"","question":"When was the last MS Barometer created? ","answer":"The last MS Barometer’s data was collected in the end of 2019 and the beginning of 2020. Its key highlights were launched on 3 December 2020 – the International Day of Persons with Disabilities. The full report with the country factsheets were launched through an overarching campaign during Brain Awareness Week 2021 (15-21 March 2021). The interactive platform was launched on 22 July 2021, on World Brain Day.","created_at":"2021-06-14T14:27:10.077Z","updated_at":"2021-07-07T09:20:23.073Z","links":[],"documents":[]},{"id":10,"description":"","question":"How do I use the MS Barometer toolkit?","answer":"You can find the MS Barometer social media tools on the toolkit page. If you would like to translate these tools and/or the full report, please contact us at mate.tagaj@emsp.org so that we can provide you with the editable source files. \nFeel free to add your own key messages based on the information available in the MS Barometer to match your own goals. To access the social media tools and other assets please visit : http://msbarometer.eu/2020/advocacy","created_at":"2021-06-14T14:38:01.178Z","updated_at":"2021-06-14T14:38:01.178Z","links":[],"documents":[]},{"id":9,"description":"","question":"Who are the authors of the MS Barometer 2020 report?","answer":"The MS Barometer 2020 report was written by Catherine H. Whicher and Christine Merkel of The Health Policy Partnership, with Nora Kriauzaitė, Elisabeth Kasilingam and Emma Rogan of the European Multiple Sclerosis Platform, and contributing analysis from Tom Albone, Adam Taylor and Daniel Ratchford of Quality Health. ","created_at":"2021-06-14T14:33:56.268Z","updated_at":"2021-06-14T14:33:56.268Z","links":[],"documents":[]},{"id":4,"description":"","question":"Where can I access previous editions of the MS Barometer? ","answer":"You can access the previous editions of the MS Barometer below","created_at":"2021-06-14T13:58:55.461Z","updated_at":"2021-06-14T13:58:55.461Z","links":[{"id":3,"title":"MS Barometer 2017","url":"http://www.emsp.org/wp-content/uploads/2017/02/BAROMETER-2015-Final-10.05.2017.pdf"},{"id":4,"title":"MS Barometer 2015","url":"http://www.emsp.org/wp-content/uploads/2017/02/BAROMETER-2015-Final-10.05.2017.pdf"},{"id":5,"title":"MS Barometer 2013","url":"http://www.emsp.org/wp-content/uploads/2015/06/130530-MS-Barometer-2013.pdf"},{"id":6,"title":"MS Barometer 2011","url":"http://www.emsp.org/wp-content/uploads/2015/07/MS_Barometer_2011.pdf"},{"id":7,"title":"MS Barometer 2009","url":"http://www.emsp.org/wp-content/uploads/2015/07/MS_Barometer_2009_results.pdf"}],"documents":[]},{"id":11,"description":"","question":"How do I use the MS Barometer tool?","answer":"See the below-attached reference file. ","created_at":"2021-06-14T14:39:43.000Z","updated_at":"2021-06-14T14:39:43.000Z","links":[],"documents":[]},{"id":7,"description":"About the new methodology to prepare the MS Barometer","question":"Why is the 2020 edition special?","answer":"The new MS Barometer assesses not only health care but also social care systems for both people with MS and their carers, and is an improved questionnaire inspired by the World Health Organisation vision: “All people have equal access to quality health services; services meet life course needs, services are coordinated across the continuum of care, carers operate in a supportive environment.” \n\nThe MS Barometer assesses 5 indicators of health and social care including: \n\n1. Health care service delivery – Including the number of MS health facilities and the number of MS-related health workers \n\n2. Health information – Including MS epidemiology, MS data collection, and MS research \n\n3. Access to treatments – Including access to disease-modifying drugs (DMDs) and symptomatic medical treatments and therapies \n\n4. Governance, leadership, and health financing – Including existing MS-relevant policies, patient engagement, and health financing \n\n5. Participation in society – Including education/employment opportunities for people with MS and social support available to people with MS and their carers \n\nThe results outline areas where policy decision-makers can improve: \n\n • Personalised care \n\n • Social and finacial protection \n\n • Quality of life for people affected by MS \n\nIn 2020, EMSP used a different methodology to prepare the MS Barometer and more MS Societies than ever before participated in providing key data. Different from previous editions, the 2020 version included country specific factsheets and an interactive online platform to access and compare key information about MS in Europe. ","created_at":"2021-06-14T14:28:33.727Z","updated_at":"2021-06-14T14:31:12.733Z","links":[],"documents":[]},{"id":3,"description":"About the MS Barometer","question":"What is the MS Barometer?","answer":"The MS Barometer is a comparative survey collecting key information on Multiple Sclerosis (MS) in over 30 countries in Europe. It serves as a benchmarking tool to provide an accurate picture of MS management across Europe. \nThe Barometer results will serve to improve the health and social care systems by outlining areas for improvement and encourage decision-makers to take actions to improve the quality of life of people affected by multiple sclerosis. \nFirst launched in 2008, the MS Barometer is a collection of MS data gathered by national MS societies and centralised by EMSP – finally reached its 6th edition in 2020-2021. ","created_at":"2021-06-14T13:57:47.097Z","updated_at":"2021-06-14T13:57:47.097Z","links":[],"documents":[]},{"id":8,"description":"","question":"What citation do I use if I quote the MS Barometer 2020 data?","answer":"The MS Barometer data is open-source, so you are free to use its data. Please cite this report as: “European MS Platform. 2020 MS Barometer. Brussels: EMSP”. ","created_at":"2021-06-14T14:32:34.431Z","updated_at":"2021-06-14T14:32:34.431Z","links":[],"documents":[]}],"toolkits":[{"id":5,"title":"MS Barometer Logo","description":"All MS Barometer related logos","published_at":"2021-06-15T08:01:34.651Z","created_at":"2021-06-15T08:01:34.668Z","updated_at":"2021-06-15T08:01:34.668Z","thumbnail":{"id":213,"name":"Barometer Logo.svg","alternativeText":null,"caption":null,"width":466,"height":466,"formats":null,"hash":"8c234307c79a9706c30cef9315c2ad90","ext":".svg","mime":"image/svg+xml","size":4.01,"url":"https://barometer.ams3.digitaloceanspaces.com/8c234307c79a9706c30cef9315c2ad90.svg","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-15T08:01:34.904Z","updated_at":"2021-06-15T08:01:34.904Z"}},{"id":6,"title":"Social Media Graphics","description":"Social media vector graphics","published_at":"2021-06-15T09:32:52.070Z","created_at":"2021-06-15T09:32:52.082Z","updated_at":"2021-06-15T09:39:44.749Z","thumbnail":{"id":218,"name":"12Artboard 1.png","alternativeText":null,"caption":null,"width":500,"height":500,"formats":{"thumbnail":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/5233c3526bf887175ed3d16006fb96bc.png","hash":"5233c3526bf887175ed3d16006fb96bc","mime":"image/png","name":"thumbnail_12Artboard 1.png","path":null,"size":22.15,"width":156,"height":156}},"hash":"3170f9e7d56180ad9aaf8da1f5d1e127","ext":".png","mime":"image/png","size":28.97,"url":"https://barometer.ams3.digitaloceanspaces.com/3170f9e7d56180ad9aaf8da1f5d1e127.png","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-15T09:32:53.005Z","updated_at":"2021-06-15T09:32:53.005Z"}},{"id":7,"title":"Social Media Assets","description":"Social Media Frames and Header","published_at":"2021-06-15T10:06:23.016Z","created_at":"2021-06-15T10:06:23.032Z","updated_at":"2021-06-15T10:06:23.032Z","thumbnail":{"id":243,"name":"mockup_small.png","alternativeText":null,"caption":null,"width":834,"height":730,"formats":{"small":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/f1831ebe80f235fd707057fdd967c183.png","hash":"f1831ebe80f235fd707057fdd967c183","mime":"image/png","name":"small_mockup_small.png","path":null,"size":251.26,"width":500,"height":438},"medium":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/e4ecaf43c8c4ae9e4118e94c56ed9634.png","hash":"e4ecaf43c8c4ae9e4118e94c56ed9634","mime":"image/png","name":"medium_mockup_small.png","path":null,"size":521.9,"width":750,"height":656},"thumbnail":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/c2f5aea80ce8046006dfda9201b37c08.png","hash":"c2f5aea80ce8046006dfda9201b37c08","mime":"image/png","name":"thumbnail_mockup_small.png","path":null,"size":41.89,"width":178,"height":156}},"hash":"b6564df47d0b100df3077d608ff4401d","ext":".png","mime":"image/png","size":118.07,"url":"https://barometer.ams3.digitaloceanspaces.com/b6564df47d0b100df3077d608ff4401d.png","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-06-15T10:06:26.385Z","updated_at":"2021-06-15T10:06:26.385Z"}},{"id":8,"title":"Additional documentation","description":"MS Barometer 2020 Questionnaire and Methodology","published_at":"2021-07-20T11:15:01.961Z","created_at":"2021-07-20T11:15:01.979Z","updated_at":"2021-07-20T11:15:01.979Z","thumbnail":{"id":305,"name":"method_cover.png","alternativeText":null,"caption":null,"width":1886,"height":1886,"formats":{"large":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/331e7f370f5c8e74e652d2ab0b9b88ff.png","hash":"331e7f370f5c8e74e652d2ab0b9b88ff","mime":"image/png","name":"large_method_cover.png","path":null,"size":660.8,"width":1000,"height":1000},"small":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/f0ae4afb9af342c15a95129dc03616b7.png","hash":"f0ae4afb9af342c15a95129dc03616b7","mime":"image/png","name":"small_method_cover.png","path":null,"size":187.15,"width":500,"height":500},"medium":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/ec80a75e47af3c1654bb4fb6caa81f35.png","hash":"ec80a75e47af3c1654bb4fb6caa81f35","mime":"image/png","name":"medium_method_cover.png","path":null,"size":393.74,"width":750,"height":750},"thumbnail":{"ext":".png","url":"https://barometer.ams3.digitaloceanspaces.com/e86e9638b86c8d5cc743a13eae47bf4a.png","hash":"e86e9638b86c8d5cc743a13eae47bf4a","mime":"image/png","name":"thumbnail_method_cover.png","path":null,"size":27.68,"width":156,"height":156}},"hash":"18f154dc42c59299c2a678a9f3ebc1bc","ext":".png","mime":"image/png","size":1083.55,"url":"https://barometer.ams3.digitaloceanspaces.com/18f154dc42c59299c2a678a9f3ebc1bc.png","previewUrl":null,"provider":"do","provider_metadata":null,"created_at":"2021-07-20T11:15:14.480Z","updated_at":"2021-07-20T11:15:14.480Z"}}]}}},"page":"/[edition]","query":{"edition":"2020"},"buildId":"O58h6gsZqJ66cxMs6ZM1d","isFallback":false,"gsp":true,"appGip":true,"scriptLoader":[]}</script></body></html>